INVENTORY to the STANISLAV GROF PAPERS, Circa 1955-2008

INVENTORY TO THE STANISLAV GROF PAPERS, circa 1955-2008

Purdue University Libraries Archives and Special Collections 504 West State Street West Lafayette, Indiana 47907-2058 (765) 494-6414

http://www.lib.purdue.edu/spcol/

Descriptive Summary

Creator Information Grof, Stanislav, 1931-

Title Stanislav Grof papers

Collection Identifier MSP 1

Date Span circa 1955-1995, bulk 1965-1979

Abstract This collection contains writings that document the career and research interests of psychiatrist and author Stanislav Grof. It consists primarily of published research articles and clippings discussing the therapeutic effects of psychoactive substances as well as some first-hand accounts of transcendental experiences.

Extent 9 cubic feet (25 boxes)

Finding Aid Author Stephanie Schmitz and Sammie Morris, 2008

Languages English, German, Czech

Repository Virginia Kelly Karnes Archives and Special Collections Research Center, Purdue University Libraries

Administrative Information

Location Information: ASC

Access Patient Notes (Series I-D), Student Experiences (Series II), and Research Restrictions: Studies, Projects and Proposals (Series III-A) containing confidential information are restricted for 75 years from the date they were created.

Custodial Stanislav Grof’s papers were initially deposited with Betsy Gordon. In History: 2006 they were transferred from Betsy Gordon to Purdue Archives and Special Collections. Additional materials were donated by Grof to the Archives in 2006 and he continues to donate materials to the collection.

Accession Numbers: 20060525 20060717 20061218 20080228 20080331

3/14/2012 2 20080609 20081208 20081219 20081224 20090113 20090318 20090506 20090629.1 20090727 20090903.1 20100309 20100813 20100914 20110412

Preferred Stanislav Grof papers, Archives and Special Collections, Purdue Citation: University Libraries

Copyright The donor has assigned the copyright in his papers to the Archives; Notice: copyright in some items of the collection may be held by their respective authors or publishers. Consult a reference archivist for details.

3/14/2012 3 Subjects and Genres

Persons

Grof, Stanislav, 1931-

Organizations

Sandoz Pharmaceuticals Maryland Psychiatric Research Center Esalen Institute

Topics

Hallucinogenic drugs--Therapeutic use LSD (Drug) Psychotropic drugs—Therapeutic use Neuro-psychopharmacology Altered states of consciousness Psilocybin Mescaline Marijuana Ketamine

Form and Genre Types

Annotated bibliographies Articles Clippings (information artifacts) Conference Proceedings Cd-roms Dvds Interviews Manuscripts for publication Pamphlets Presentations (communicative events) Research (document genres)

Occupations

Psychiatry Psychology Psychotherapy

3/14/2012 4 Biography of Stanislav Grof

Stanislav (Stan) Grof, noted psychiatrist, author, consciousness researcher, and pioneer of transpersonal psychology, was born on July 1, 1931 in Prague, Czechoslovakia to Stanislav (a chemical engineer) and Maria Petnik Grof. Heavily influenced by the works of Freud early in his studies, Grof was inspired to become a psychiatrist and earned an M.D. at the Charles University School of Medicine in Czechoslovakia in 1956, and a Ph.D. at the Czechoslovakian Academy of Sciences in 1965.

Dr. Grof’s interest in the clinical use of psychedelic substances was spurred in the 1960s when the Sandoz pharmaceutical company approached the Psychiatric Research Institute in Prague, requesting that studies be conducted on LSD-25 in order to ascertain whether or not the substance had therapeutic properties. Grof subsequently volunteered to participate in a research program which explored LSD as a tool for experiential training, allowing psychiatrists and psychologists to experience the “inner-world” of psychotic patients. He eventually became principal investigator of this program, and has gone on to devote his career to examining the therapeutic potential of psychedelic substances.

In 1967, he was invited to Johns Hopkins University as a research scientist, and in 1969 continued on at the Maryland Psychiatric Research Center where he served as Chief of Psychiatric Research and Assistant Professor of Psychiatry. In 1973, Grof became a scholar- in-residence at the Esalen Institute, a non-profit organization devoted to the exploration of human potential in Big Sur, California. While there, he authored books, lectured, and developed Holotropic Breathwork, an innovative form of experiential psychotherapy, with his wife Christina. Dr. Grof is also the founder and president of the International Transpersonal Association (ITA), and has organized major international conferences on transpersonal psychology.

Grof’s major fields of research interest include therapeutic and heuristic aspects of non- ordinary states of consciousness, the use of psychedelics and non-drug techniques in psychotherapy, alternative approaches to psychoses, spiritual emergency and treatment of transpersonal crises, biology, brain research, and consciousness studies. He also maintains interests in other non-ordinary states of consciousness such as shamanism, Eastern spiritual systems, mysticism, the rites of passage of aboriginal cultures, and near-death experiences.

Dr. Grof is a Professor of Psychology at the California Institute of Integral Studies (CIIS) in the Department of Philosophy, Cosmology, and Consciousness, and also teaches in the Pacifica Graduate Institute in Santa Barbara, CA.

In October 2007, Dr. Grof received a VISION 97 award granted by the Foundation of Dagmar and Vaclav Havel in Prague. The foundation’s mission supports cultural and social projects with the potential to bring meaningful change to the future.

Dr. Grof has written extensively on LSD and its use in psychotherapy and about other methods and types of psycho-spiritual work.

3/14/2012 5 Sources:

Association for Holotropic Breathwork International, “About Breathwork.” Accessed June 30, 2008.

DiCarlo, Russell E. "The Multi-Dimensional Psych" (Interview with Stan Grof), Healthworld Online, 1996. Accessed June 30, 2008.

Encyclopedia of Occultism and Parapsychology. “Stanislav Grof,” 5th ed. Gale Group, 2001. Reproduced in Biography Resource Center. Farmington Hills, Mich.: Thomas Gale, 2007.

Grof, Stan. Curriculum Vitae.

Snider, Gerry. “Has Psychology Failed the Acid Test?” [Interview with Stanislav Grof by Gerry Snider.] Magical Blend Magazine, December 1996.

3/14/2012 6 Chronology

July 1, 1931 Born in Prague, Czechoslovakia; son of Stanislav Grof and Maria Petnik Grof.

1950-1956 Student at the Charles University School of Medicine, Prague, Czechoslovakia.

1954-1956 Participation in clinical LSD research and the study of artisitic expression of psychiatric patients.

1956-1959 Psychiatric residency at the State Mental Hospital in Kosmonosy, near Prague.

1957-1960 Participating researcher in a multidimensional dynamic study of psychedelic drugs and anticholinergic delirogens in the Research Institute in Prague.

1959-1960 Outpatient Psychiatrist at the Psychiatric Clinic of the National Institute of Health, Prague.

1961-1967 Principle Investigator in a psychedelic research program at Psychiatric Research Institute, Prague, Czechoslovakia. Also involved in a team studying the mechanisms of psychogenic disorders and psychotherapy.

1965 Completes postgraduate training at the Czecho-slovakian Academy of Science, recieves Ph.D. degree (Doctor of Philosophy in Medicine).

1967-1969 Clinical and research fellow, Department of Psychiatry and Behavioral Science, Johns Hopkins University, Baltimore, MD.

1967-1973 Chief of Psychiatric Research, Maryland Psychiatric Research Center, Catonsville, MD. Assistant professor of Psychiatry at the Department of Psychiatry and Behavioral Science, Johns Hopkins University, Baltimore, MD.

1973-1987 Scholar-in-residence at the Esalan Institute in Big Sur, CA.

1987- Self-employed, conducting professional training in Holotropic Breathwork and transpersonal psychology, lecturing, and writing.

1994- Professor of Psychology at the California Institute of Integral Studies (CIIS), Institute of Psychology, Cosmology, and Consciousness, San Francisco, CA.

3/14/2012 7 Collection Description

Scope and Contents of the Papers

The Stanislav Grof papers (1955-2008; 6 cubic feet) document the professional interests of Stanislav Grof over the course of his career. The collection consists mainly of scholarly articles that reflect his research interests during the 1960s and 1970s. Also included in the collection are electronic copies of Grof’s artwork and writings, presentations, his doctoral dissertation, and a handwritten manuscript.

Other materials of interest include firsthand accounts of spiritual experiences written by Grof’s students; annotated bibliographies; pamphlets and issues of periodicals on the nature of psychedelic research (some of which are vibrantly illustrated); and photocopies of unique items such as Joann and Timothy Leary’s Neurologic and “Handbook for the Therapeutic Use of Lysergic Acid Diethylamide-25,” by Blewett and Chwelos.

The Stanislav Grof papers are arranged in five series, two of which have been further arranged in subseries.

I. Stan Grof’s Writings and Biographical Information A. Manuscripts and Typescripts B. Published works C. Presentations D. Patient Notes E. Biographical/Promotional Material

II. Student Experiences

III. Research Materials A. Research Studies, Projects, and Proposals B. Research Articles C. Conference Proceedings D. Bibliographies, References and Citations E. Journals, Pamphlets, and Magazines (arranged by title) F. Books, Reports, and Theses

IV. Photos and Slides

V. Correspondence

VI. Miscellaneous Materials

VII. Electronic Materials A. Data CDs and DVDs B. Multimedia CDs, DVDs, and VHSs

3/14/2012 8 C. Cassette Tapes D. Floppy Discs

Arrangement

Series I: Writings and Biographical Information Series I contains information produced by Stanislav Grof. It is divided into five subseries: Manuscripts and Typescripts; Published Works; Presentations; Patient Notes; and Biographical/Promotional Material. Materials include Grof’s four-page account of a dream; articles authored or co-authored by Grof from circa 1960-1993; papers that Grof has written and/or presented at conferences which may or may not have been published; his doctoral dissertation (1965); an article Grof conducted with Albert Hofmann in 1984; a first-hand account of a therapy session from one of Grof’s patients [access restricted until 2045]; Grof’s notes on the aforementioned patient [access restricted until 2045]; and clippings and biographical information on Grof from newspapers and magazines.

Series II: Student Experiences, 1981 Series II comprises written accounts of students who participated in a workshop with Grof at the California Institute of Integral Studies. Items are arranged alphabetically by author’s last name. These items are restricted for use by the public until the year 2056. In some cases they may be made available for use with the sensitive information redacted.

Series III: Research Materials, circa 1950-2011 Series III consists of secondary source materials Stanislav Grof consulted during the course of his career and is divided into 6 subseries: Research Studies, Projects, and Proposals; Research Articles; Conference Proceedings; Bibliographies, References and Citations; Journals and Pamphlets (arranged by title); and Books and Reports.

Subseries III-A (Research Projects, Proposals and Studies) is arranged chronologically and consists of an application to administer LSD for training purposes, as well as information on a research study concerning DPT (Dipropyltryptamine) assisted therapy, presumably undertaken by Grof. It also contains an outline of a proposed study concerning the “Narcotic Addiction- Psychedelic Therapy Research Program.”

Suberies III-B (Research Articles) includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations. This subseries consists of both scholarly material as well as items that would appeal to a general audience. Articles have been arranged alphabetically by the primary author’s last name. In cases where there are multiple articles by the same

3/14/2012 9 author, articles have been arranged chronologically by date when possible. A complete list of authors that appear in the subseries is available in Appendix One.

Subseries III-C (Conference Proceedings) contains selected papers and abstracts of the cancelled 4th International Congress of the European Medical Society for Psycholytic Therapy which was to be held in Prague, 1968.

Subseries III-D (Bibliographies, References, and Citations) contains a collection of articles and citations pertaining to Dipropyltryptamine, extensive bibliographies and article citations pertaining to LSD, and a bibliography on psychotomimetics.

Suberies III-E (Journals, Pamphlets, and Magazines) consists of journals which contain significant articles pertaining to or written by Stanislav Grof, or something pertinent to his research interests. Visually captivating items in this series include two issues of the Observer from 1966, a 1984 issue of Syphinx featuring Albert Hofmann on the cover, and an informational pamphlet on the Institute for Psychedelic Research of San Francisco State College. Other items of interest in this series include pamphlets entitled “God in a Pill?” and “Sessions Games People Play: A Manual for the Use of LSD”; a publication entitled “Hallucinations and Delusions” produced by the National Institute of Mental Health; and an informational pamphlet on phanerothyme.

Subseries III-F (Books, Reports, and Theses) contains seven items including the doctoral dissertation of Mary Elizabeth McCarthy; photocopies of unique monographs such as Joanna and Timothy Leary’s Neurologic; a handbook about using LSD in a therapeutic setting; and reports published by the Militarpsykologiska Institutet of Sweden.

Series IV: Photographs and Slides This series contains three photographs and one slide. Two of the photographs depict nature scenes and are dated May, 1971. One depicts three people on a covered porch, and has a caption written in Czech. The slide depicts a woman seated on a park bench.

Series V: Correspondence This series contains Grof’s correspondence concerning the Esalen Institute and the screenplay Brainstorm. The correspondence also documents Grof’s achievements, as well as a letter from the Czech president. This series includes an email between Michael Horowitz and Ralph Metzner and a letter to Dr. Willis Harman from and signed by Albert Hofmann.

Series VI: Miscellaneous Materials This series contains a variety of materials from Grof’s collection that are not representative of any of the series in his collection. There is a typed Tribute to Willia Harman that has no author, information on meetings, seminars, and workshops at the Esalen Institute; the series also contains what appears to be a typed presentation titled Psychology of the Future: Lessons from Modern Consciousness Research

3/14/2012 10 by Grof, a certificate from the Institut De Recherche Sur Les Experiences Extraordinaires declaring Stanislav Grof as a member of honour, and a two page document by Roger Liggenstorfer and Chris Heidrich discussing Albert Hofmann’s estate in German.

Series VII Electronic Materials

Subseries VII-A (Data CDs and DVDs) contains Stanislav Grof’s writings, presentation slides, biographical material, artwork, and photographs.

Subseries VII-B (Multimedia CDs, DVDs, and VHSs) contains lectures, interviews, and presentaitons.

Subseries VII-C (Cassettee Tapes) contains evening talks presumably conducted at the Gathering of the Elders event.

Subseries VII-D (Floppy Discs) contains transcriptions of interviews conducted at the Council of the Elders Gathering. The discs may contain materials from other workshops. Some of the discs are not labeled and the content is unknown.

Descriptive Rules Anglo-American Cataloguing Rules, 2nd Edition / Describing Archives: A Content Standard

Processing Information

All materials have been rehoused in acid-free folders and boxes. Rusted staples have been removed from the materials and plastic paper clips or file folder inserts have been used in their place. Oversized materials have been kept in their original series; however, items requiring storage in a larger container have been moved to a box labeled “OVERSIZE” and a separation sheet has been put in place where items have been moved from original location within the series.

Series III-2 (Research Articles) appears to have once been arranged with an alpha-numeric system, but upon consulting with Stanislav Grof about the practicality of maintaining this order, the alpha-numeric system was abandoned in favor of alphabetizing the articles by author’s last name.

Portions of the collection contain sensitive information and have been restricted in order to respect confidentiality. These items have separated from their original location in the collection and moved to Box 16. They will be made available for research in 2083.

Additions

Materials continue to be received for this collection, and archival processing is ongoing.

3/14/2012 11 DETAILED DESCRIPTION OF THE COLLECTION

Series 1: Stanislav Grof Writings and Biographical Information

Subseries A: Manuscripts and Typescripts

Box Folder 1 1 Account of dream at Esalen Institute, circa 1963-1967

1 1 Papers with handwritten notes

1 1 “Basic Perinatal Matrices” charts

16 1 Oversize “Basic Perinatal Matrices” chart

1 1 “Dipropltyptamine (DPT) as an Adjunct in the Counseling of Cancer Patients”

1 1 “Comparison of the conceptual frameworks of Sigmund Freud and C.G. Jung”

1 1 Stanislav Grof interview with Dr. Albert Hofmann at the Esalen Institute in Big Sur, California, 1984

1 1 “The Holonomic Theory: A New Paradigm for Consciousness Research”

19 2 “H. R. Giger and the Zeitgeist of the Twentieth Century.”

21 2 Doctoral Dissertation: Grof, S. and Z. Dytrych. LSD 25: Vyuziti V Klinicke Praxi. Volume II, 1965. [LSD: Use in Clinical Practice; In Czech.] (signed by Grof)

21 3 Doctoral Dissertation: Grof, S. and Z. Dytrych. LSD A Jeho Vyuziti V Klinicke Praxi. Volume I, 1964. (signed by Grof)

Subseries B: Published Works

Box Folder Articles authored by Grof, 1960-1993 1 2 Grof, Stanislav. “Beyond Psychoanalysis,” Darshana International, Vol. 10, No. 3, July 1970, 55-73. (photocopy)

1 2 Grof, Stanislav and Zdenek Dytrych. Blocking of LSD Psychosis by Means of Premedication of Niamid. (photocopy)

3/14/2012 12 20 1 Grof, Stanislav and Z. Dytrych. “Blocking of LSD reaction by premedication with Niamid.” (reprint?)

20 1 Grof, Stanislav and Z. Dytrych. “Blocking of LSD reaction by premedication with Niamid.” (reprint?)

21 1 Grof, Stanislav and Joan Halifax. Chelovek Pered Licom Smerti. The Human Encounter with Death. (printed by Samizdat, a Russian underground press and signed by Grof.)

20 1 Grof, Stanislav, et al. “Clinical and Experimental Study of Central Effects of Adrenochrome,” Journal of Neuropsychiatry. Vol. 5, No. 1, 1963. (reprint)

20 1 Grof, Stanislav. “Consciousness Evolution and Planetary Survival: Psychological Roots of Human Violence and Greed,” World Futures. Vol.47, 1996. (reprint)

1 2 Grof, Stanislav. “Counsciousness Evolution as Human Survival,” R.M.S.E.N. Times, March 1993.

1 2 Grof, Stanislav. “Die Erfahrung des Todes,” Integrative Therapie, February/March 1980, pages 157-180. (reprint)

20 1 Grof, Stanislav. “Die holonomische Theorie Ein neues Paradigma fur die Bewusstseinsforschung.” (photocopy)

1 2 Grof, Stanislav. “Diethylamid Kyseliny D-Lsergové (LSD),” Casopis Lekaru Ceskych – Lekarska Veda V Zahranici, 1960.

20 1 Grof, Stanislav. “Diethylamid Kyseliny D-Lsergové (LSD),” Casopis Lekaru Ceskych – Lekarska Veda V Zahranici, 1960.

20 1 Grof, Stanislav. “DPT as an Adjunct in Psychotherapy of Alcoholics,” International Pharmacopsychiatry. 1973. (reprint)

3/14/2012 13

1 2 Grof, S., R.A. Soskin, W.A. Richards and A.A. Kurland. “DPT as an Adjunct in Psychotherapy of Alcoholics,” Int. Pharmacopsychiat. Vol. 8, 1973.

20 1 Grof, Stanislav. “Druha mezinarodni conference o pouziti LSD v psychoterapii.” Referaty Ze Sjezdu A Pracovist. (reprint)

20 1 Grof, Stanislav. “East and West: Ancient Wisdom and Modern Science,” The World and I. May 1986. (clipping)

1 2 Grof, Stanislav. “The Effect of LSD on Chromosomes, Genetic Mutation, Fetal Development and Malignancy,” Appendix to Theory and Practice of LSD Psychotherapy,” undated. (photocopied typescript)

20 1 Grof, Stanislav and Milos Vojtechovsky. “Experimentalni Psychoza Po Poziti 200mg Benactyzinu,” Ceskoslovenska Psychiatrie. Vol. 54, No. 6, 1958. (reprint)

1 2 Grof, Stanislav. “Holonomic Theory and Psychedelic Experience,” Dromenon, A Journal of New Ways of Being, Vol. 2, No. 5/6, 1980, pages 11-17. (Note: This item has been removed for cataloging.)

20 1 Grof, Stanislav. “Holotropic Breathwork and the Hyperventilation Syndrome,” The Inner Door. Vol. 9, No. 2, May 1997. (preprint?)

20 1 Grof, Stanislav. “The Implications of Psychedelic Research for Anthropology: Observations from LSD Psychotherapy,” Symbols and Sentiments. London: Academic Press, 1976. (reprint)

20 1 Grof, Stanislav. “K Problematice Optickych Poruch V Autoexperimentech S Hallucinogeny,” Ceskoslovenska Psychiatrie. 60, 3, 1964. (reprint)

20 1 Grof, Stanislav, et al. “LSD-Assisted Psychotherapy in Patients with Terminal Cancer,” International Pharmacopsychiatry. 8, 1973. (reprint)

3/14/2012 14

1 2 Grof, Stanislav. “LSD in de Begugnung mit dem Tod – Ein Beitrag zur Humanisierung des Sterbens,” Zeitschrift fur Humanistische Psychologie, 1979. (Note: This item has been removed for cataloging.)

1 2 Grof, Stanislav. “LSD Psychotherapy and Human Culture,” The Journal for the Study of Consciousness, Vol. 3, 1970. (photocopy)

1 2 Grof, Stanislav. “LSD und das menschliche Unbewusste,” Kindheit, Vol. 3, 1981. (reprint)

20 1 Grof, Stanislav. “LSD und das menschliche Unbewusste,” Kindheit, Vol. 3, 1981. (reprint)

20 2 Grof, Stanislav. “Man kann die Astrologie nicht bejahen, ohne auch ihr Weltbild zu ubernehmen,” Astrologie Heute. No. 8, April/May 2004. (photocopy)

1 2 Grof, Stanislav. “Modern Consciousness Research and Human Survival,” ReVision, the Journal of Consciousness and Change, Vol. 8, No.1, 1985. (Note: This item has been removed for cataloging.)

20 2 Grof, Stanislav. “Nature, Mind, and Consciousness: Gregory Bateson and the New Paradigm,” Phoenix: Journal of Transpersonal Psychology. 5, 1981. (photocopy)

20 2 Grof, Stanislav. “Nature, Mind, and Consciousness: Gregory Bateson and the New Paradigm,” Phoenix: Journal of Transpersonal Anthropology. Vol. 5, No. 2, 1981. (reprint)

20 2 Grof, Stanislav. “Neobvylky Pripad Religiozni Paranoidni Psychozy,” Ceskoslovenska Psychiatrie. 60, 4, 1959. (reprint)

20 2 Grof, Stanislav and ZD. Dytrych. “Novy Pristup K Nekterym Psychologickym Problemum,” Ceskoslovenska Psychologie. 8, 1964. (reprint)

20 7 Grof, Stanislav. Oblasti Chelovyecheskogo Bessoznatelnogo: Opyt Issledovaniy C Pomoshchyu LSD. Realms of the Human Unconscious: Observations from LSD Research. (printed by Samizdat, a Russian underground press and signed by Grof)

1 2 Grof, Stanislav. “Perinatal Roots of Wars, Totaltarianism, and Revolutions: Observations from LSD Research,” The Journal of Psychohistory. Vol. 4, No. 3, Winter 1977. (Note: This item has been removed for cataloging.)

3/14/2012 15

20 2 Grof, Stanislav. “Perinatale Ursprunge von Kriegen, Revolutionen und Totalitarismus,” Kindheit. Vol. 5, No. 1, 1983. (clipping)

20 2 Grof, Stanislav. “Proslov,” Prazska krizovatka. 4, 2007. (reprint)

20 2 Grof, Stanislav. “Psychedelische Therapie und holonome Integration: Therapeutisches Potential aussergewohnlicher Bewusstseinszustande,” Ethnopsychotherapie. Vol. 7, No. 17, 1987. (reprint)

20 2 Grof, Stanislav. “Psychotogenni Ucinky Derivatu Adrenalinu,” Souborny Referat. 2, 4, 1960. (reprint)

20 2 Grof, Stanislav. “Serotonin A Jeho Vyznam Pro Psychiatrii,” Souborne Referaty.

1 2 Grof, Chistina and Stan. “ Spritual Emergency: The Understanding and Treatment if Transpersonal Crisis,” ReVision, The Journal of Consciousness and Change, Vol. 8, No. 2, 1986, pages 7-20. (Note: This item has been removed for cataloging.)

1 2 Grof, Stanislav. “Sprituality, Addiction, and Western Science.” ReVision, The Journal of Consciousness and Change, Vol. 10, No. 2, Fall 1987, pages 5-18. (Note: This item has been removed for cataloging.)

20 2 Grof, Stanislav. “Use of LSD in Personality Diagnostics and Therapy of Psychogenic Disorders.” (photocopy of preprint)

1 2 Grof, Stanislav. “Varieties of Transpersonal Experiences: Observations from LSD Psychotherapy,” Journal of Transpersonal Psychology, Vol. 4, No. 1, 1972. (reprint)

1 2 Kurn, E., K. Rysanek, V. Vitek, M. Vojtechovsk and S. Grof. “Multidimensional Approach to the Psychopharmacological Experiment,” Psychopharmalogical Methods, 1963.

1 2 Pahnke, W. and A.A. Kurland, S. Unger, Ch. Savage, and S. Grof. “The Experimental Use of Psychedelic (LSD) Psychotherapy,” International Journal of Clinical Pharmacology, Therapy, and Toxicocology, Vol. 4,

3/14/2012 16 1971.

1 2 Richards, William, Stanislav Grof, Louis Goodman, and Albert Kurland. “LSD-Assisted Psychotherapy and the Human Encounter with Death,” The Journal of Transpersonal Psychology, Vol. 2, 1972.

Subseries C: Presentations

Box Folder 1 3 Presentations, 1965-1973 17 16 Paper presented at conference in Fort Knoxville, Colorado, 2009.

Subseries D: Patient Notes

Box Folder 1 4 Patient Notes, Circa 1970 [Note: Access to this information is restricted and materials have been moved to Box 16, “Restricted Information,” until 2083.]

Subseries E, Biographical/Promotional material

Box Folder 17 17 Clippings, 1971-2008

1 5 Biographical/Promotional material, 1975-1985

17 18 Promotional material, circa 1980s

17 14 Newspaper and publication clippings pertaining to Stanislav Grof, circa 1980s

17 1 Correspondence pertaining to 1982 MGM movie, Brainstorm

16 1 Photocopy of promotional poster, 1985

17 15 Clippings, correspondence, and funeral program, 2008-2009

Series II: Student Experiences

Box Folder

3/14/2012 17 1 2 Student Experiences, 1981 [Note: Access to a portion of this information is restricted until 2056.]

Series III: Research Materials

Subseries A: Research Studies, Projects, and Proposals

Box Folder 1 7 Narcotic Addiction- Psychedelic therapy Research Program, 1968 1 7 Application to Amend IND-3250 for the Administration of LSD for Training Purposes, 1969 1 7 Residential Treatment of Adult Male Offenders, 1971 [Please note: Access to this document is restricted until 2046.] 17 10 Transcript of Humphry Osmond interview, 1976 (typed in 1998) 17 3 Laura Huxley interview, 1998 17 4 Materials pertaining to Elders Psychedelic conference at the Fetzer Institute, 1998 17 12 17 5 Planning documents for Gathering of the Elders convention, 1998 17 6 Program documents from the Psychedelic Elders conference, 1998 17 7 Transcripts of interview with Willis Harman, 1998

Subseries B, Research Articles

Box Folder Research Articles: A

2 1 Aaronson, Bernard S. “Distance, Depth, and Schizophrenia,” The American Journal of Clinical Hypnosis. Vol. 9, No. 3, January 1967. (photocopy)

2 1 Aaronson, Bernard S. “LSD: Experimental Findings,” Parapsychology. June 1967. (photocopy)

2 1 Aaronson, Bernard S. Some Hypnotic Analogues to the Psychedelic State. (print out)

2 1 Abraham, David Henry. LSD-25: Differentiable Sensitivities in Human Beings. January 21, 1980. (print out)

2 1 Abramson, Harold A. “Lysergic Acid Diethlamide (LSD-25): III. As an Adjunct to Pyschotherapy with Elimination of Fear of Homosexuality,” The Journal of Psychology. 35, 1955. (reprint)

3/14/2012 18 Box Folder 2 1 Abramson, H. A. “Discussion Second Symposium,” Neuro- Psychopharmacology. 1956 (?). (reprint)

2 1 Abramson, Harold A., Andre Rolo, and Jeanne Stache. “Lysergic Acid Diethylamide (LSD-25) Antagonists: Chlorpromazine,” Journal of Neuropsychiatry. Vol. 1, No. 6, July-August 1960. (reprint)

2 1 Abramson, H. A., B. Sklarofsky, M. O. Baron, and H. H. Gettner. “Lysergic Acid Diethylamide (LSD-25) Antagonists,” A. M. A. Archives of Neurology and Psychiatry. Vol. 77, April 1957. (reprint)

2 1 Abramson, Harold A. and Bernard Sklarofsky. “Lysergic Acid Diethylamide (LSD-25) Antagonists,” A. M. A. Archives of General Psychiatry. Vol. 2, January 1960. (reprint)

2 1 Abramson, H. A. and Evans, L. T. “Lysergic Acid Diethylamide (LSD 25): II. Psychobiological Effects on the Siamese Fighting Fish,” Science. Vol. 120, No. 3128, December 10, 1954. (reprint)

2 1 Abramson, H. A., M. E. Jarvik, and M. W. Hirsch. “Lysergic Acid Diethylamide (LSD-25): VII. Effect Upon Two Measures of Motor Performance,” The Journal of Psychology, 39, 1955. (reprint)

2 1 Abramson, H. A. , S. E. Waxenberg, A. Levine, M. R. Kaufman, and C. Kornetsky. “Lysergic Acid Diethylamide (LSD-25) XIII. Effect on Bender-Gestalt Test Performance,” The Journal of Psychology. 40, 1955. (reprint)

3/14/2012 19 Box Folder

2 1 Abramson, Harold A. and Murray E. Jarvik. “Lysergic Acid Diethylamide (LSD-25): IX. Effect on Snails,” The Journal of Psychology. 40, 1955. (reprint)

2 1 Abramson, H. A., M. E. Jarvik, and M. W. Hirsch. “Lysergic Acid Diethylamide (LSD-25): X. Effect on Reaction Time to Auditory andVisual Stimuli,” The Journal of Psychology. 50, 1955. (reprint)

2 1 Abramson, H. A., C. Kornetsky, M. E. Jarvik, M. R. Kaufman, and M. W. Ferguson. “Lysergic Acid Diethylamide (LSD-25): XI. Content Analysis of Clinical Reactions,” The Journal of Psychology. 40, 1955. (reprint)

2 1 Abramson, H. A., M. E. Jarvik, A. Levine, M. R. Kaufman, and M. W. Hirsch. “Lysergic Acid Diethylamide (LSD-25): XV. The Effects Produced by Substitution of a Tap Water Placebo,” The Journal of Psychology. 40, 1955. (reprint)

2 1 Abramson, H. A., M. E. Jarvik, M. H. Gorin, and M. W. Hirsch. “Lysergic Acid Diethylamide (LSD-25): XVII. Tolerance Development and its Relationship to a Theory of Psychosis,” The Journal of Psychology. 41, 1956. (reprint)

2 1 Abramson, Harold A. “Lysergic Acid Diethylamide (LSD-25): XXII. Effect on Transference,” The Journal of Psychology. 42, 1956. (reprint)

2 1 Abramson, Harold A. “Lysergic Acid Diethylamide (LSD-25): XIX. As an Adjunct to Brief Psychotherapy, with Special Reference to Ego Enhancement,” The Journal of Psychology. 41, 1956. (reprint)

2 1 Abramson, Harold A. “Lysergic Acid Diethylamide (LSD-25): XXII. Effect on Transference,” The Journal of Psychology. 42, 1956. (reprint)

2 1 Abramson, H. A. “Lysergic Acid Diethylamide (LSD-25): XXIX. The Response Index as a Measure of Threshold Activity of Psychotropic Drugs in Man,” The Journal of Psychology. 48, 1959. (reprint)

2 1 Abramson, H. A. “Lysergic Acid Diethylamide (LSD-25): XXX. The Questionnaire Technique with Notes on its Use,” The

3/14/2012 20 Box Folder Journal of Psychology. 49, 1960. (reprint)

2 1 Abramson, H. A., and A. Rolo. “Lysergic Acid Diethylamide (LSD-25): XXXVIII. Comparison with Action of Methysergide and Psilocybin on Test Subjects,” The Journal of Asthma Research. Vol. 2, No. 4, June 1965. (preprint)

2 1 Abramson, H. A. “Lysergic Acid Diethylamide (LSD-25): XXX. The Questionnaire Technique with Notes on its Use,” The Journal of Psychology. 49, 1960. (reprint)

2 1 Abramson, H. A., M. E. Jarvik, and M. W. Hirsch. “Lysergic Acid Diethylamide (LSD-25): X. Effect on Reaction Time to Auditory and Visual Stimuli,” The Journal of Psychology. 40, 1955. (reprint)

2 1 Abramson, H. A., A. Rolo, B. Skylarofsky, and J. Stache. “Production of Cross-Tolerance to Psychosis Producing Doses of Lysergic Acid Diethylamide and Psilocybin,” The Journal of Psychology. 49, 1960. (reprint)

2 1 Abramson, H. A., M. P. Hewitt, H. Lennard, W. J. Turner, F. J. O’Neill, and S. Merlis. “The Stablemate Concept of Therapy as Affected by LSD in Schizophrenia,” The Journal of Psychology. 45, 1958. (reprint)

2 2 Abuzzahab, F. S. and B. J. Anderson. “A Review of LSD Treatment in Alcoholism,” International Pharmacopsychiatry. 6, 1971. (photocopy)

2 2 Adey, W. Ross, Frederick R. Bell, and Barbara J. Dennis. “Effects of LSD-25, psilocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat,” Neurology. Vo. 12, No. 9, September 1962. (reprint)

2 2 Aggernaes, Martin. “A Study of Kleptomania with Illustrative Cases,” Acta Psychiatrica Et Neurologica Scandinavica. Vol. 36, Fasc. 1, 1961. (reprint)

2 2 Aghajanian, G. K., W. E. Foote, and M. H. Sheard. “Action of Psychotogenic Drugs on Single Midbrain Raphe Neurons,” The Journal of Pharmacology and Experimental Therapeutics. Vol. 171, No. 2, 1970. (photocopy)

2 2 Aghajanian, George K. and Daniel X. Freedman. “Biochemical

3/14/2012 21 Box Folder and Morphological Aspects of LSD Pharmacology,” Psychopharmacology: A Review of Progress, 1957-1967. December 1967. (reprint)

2 2 Aghajanian, George K. and Daniel X. Freedman. “Biochemical and Morphological Aspects of LSD Pharmacology,” Psychopharmacology: A Review of Progress, 1957-1967. December 1967. (photocopy)

2 2 Aghajanian, George K., Warren E. Foote, and Michael H. Sheard. “Lysergic Acid Diethylamide: Sensitive Neuronal Units in the Midbrain Raphe,” Science. Vol. 161, August 1968. (photocopy)

2 2 Agnew, N. and A. Hoffer. “Nicotinic Acid Modified Lysergic Acid Diethylamide Psychosis,” The Journal of Mental Science. Vol. 101, No. 422, January 1955. (reprint)

2 2 Aiken, John. The Psychedelic Experience as a Religious Sacrament. (pamphlet)

2 2 Alexander, George J., Bruno Ed. Miles, George M. Gold, and Rita B. Alexander. “LSD: Injection Early in Pregnancy Produces Abnormalities in Offspring of Rats,” Science. Vol. 157, July 1967. (photocopy)

2 2 Alhadeff, Benjamin Wilson. “Aspects cliniques de l’emploi du delyside et de l’indocybine en psychiatrie,” JSPh. Vol. 101, No. 245, 1963. (reprint)

2 2 Alhadeff, Benjamin Wilson. “Les effets psychotomimetiques du Delyside (LSD 25) et de l’Indocybine (Psilocybine) dans l’exploration Clinique de la personannalite,” Medecine et Hygiene: Journal d’informations medicales. 20, May 1962. (reprint)

2 2 Alhadeff, B. W. “Les effets psychotomimetiques du LSD et de la psilocybine dans l’exploration Clinique de l personnalite,” Neurologie, Neurochirurgie and Psychiatrie. Band 92, Heft 1, 1963. (reprint)

3/14/2012 22 Box Folder

2 2 Alnaes, Randolf. Therapeutic Application of the Change in Consciousness Produced by Psycholytica (LSD, Psilocybin). (preprint)

2 2 Ames, Frances. “A Clinical and Metabolic Study of Acute Intoxication with Cannabis Sativa and its Role in the Model Psychoses,” The Journal of Mental Science. Vol. 104, No. 437, October 1958. (reprint)

2 2 Anastasopoulos, George and Harry Photiades. “Effects of LSD- 25 on Relatives of Schizophrenic Patients,” The Journal of Mental Science. Vol. 108, No. 452, January 1962. (reprint) (includes a review typed in German)

2 2 Appel, James B. “Effects of LSD on Time-Based Schedules of Reinforcement,” Psychopharmacologia. 21, 1971. (photocopy)

2 2 Appel, James B. “The Effect of Psychotomimetic Drugs on Animal Behavior,” Psychopharmacology: A Review of Progress 1957-1967. December 1967. (photocopy)

2 2 Aprison, M. H., K. M. Hanson, and D. C. Austin. “Studies on Serum Oxidase (Ceruloplasmin) Inhibition by Tryptophan Metabolites,” The Journal of Nervous and Mental Disease. Vol. 128, No. 3, March 1959. (reprint)

2 2 Apter, Julia T. and Carl C. Pfeiffer. “The Effect of the Hallucinogenic Drugs LSD-25 and Mescaline on the Electroretinogram,” Annals of the New York Academy of Sciences. Vol. 66, Article 3, March 1957. (reprint)

2 2 Ardis, J. Amor and Peter McKellar. “Hypnagogic Imagery and Mescaline,” The Journal of Mental Science. Vol. 102, No. 426, January 1956. (reprint)

2 2 Arendsen-Hein, G. W. “Group Therapy with Criminal Psychopaths,” International Journal for Psychotherapy. Vol. 7, 1959. (reprint)

2 2 Arendsen-Hein, G. W. “LSD in the Treatment of Criminal Psychopaths,” The Proceedings of The Quarterly Meeting of the Royal Medico-Psychological Association. London: H. K. Lewis & Co. Ltd., 1963. (reprint)

3/14/2012 23 Box Folder 2 2 Arendsen-Hein, G. W. “Treatment of the Neurotic Patient, Resistant to the Usual Techniques os Psychotherapy, with Special Reference to LSD,” Topic. Probl. Psychother. Vol. 4, 1963. (reprint)

2 2 Arendsen-Hein, G. W. “The Psychedelic Experience, A New Value in Psychotherapy,” Excerpta Medica International Congress Series No. 150. September 1966. (reprint)

2 2 Arnold, O. H. and Hofmann, G. “Untersuchungen uber Bernsteinsaureeffekte bei LSD.-25 Vergiftungen und Schizophrenien” in Wiener Zeitschrift fur Nervenheilkunde und Deren Grenzbebiete. Band 11, Heft 1, 1955. (reprint)

2 2 Arnold, O. H., G. Hofmann, and H. Leupold-Lowenthal. “Untersuchungen zum Schizophrenieproblem,” Wiener Zeitschrift fur Nervenheilkunde und Deren Grenzbebiete. Band 13, Heft 4, 1957. (reprint)

2 2 Arnold, O. H . and H.Hofmann. “Untersuchungen uber die Wirkungsweise von Lysergsaurediathylamid,” Wiener Zeitschrift fur Nervenheilkunde und Deren Grenzbebiete. Band 6, Heft 2-3, 1953. (reprint)

2 2 Arnold, O. H., G. Hofmann, and H. Leupold-Lowenthal. “Untersuchungen zum Schizophrenieproblem,” Wiener Zeitschrift fur Nervenheilkunde und Deren Grenzbebiete. Band 13, Heft 4, 1957. (reprint)

2 2 Arnold, O. H., G. Hofmann, and H. Leupold-Lowenthal. 2“Untersuchungen uber Bernsteinsaureeffekte bei LSD.-25 Vergiftungen und Schizophrenien,” Wiener Zeitschrift fur Nervenheilkunde und Deren Grenzbebiete. Band 11, Heft 1, 1955. (reprint)

2 2 Aronson, H. and G. D. Klee. “Effect of Lysergic Acid Diethylamide (LSD-25) on Impulse Control,” The Journal of Nervous and Mental Disease. Vol. 131, No. 6, December 1960. (reprint)

3/14/2012 24 Box Folder 2 2 Aronson, H., C. E. Watermann, and G. D. Klee. “The Effect of D-Lysergic Acid Diethylamide (LSD-25)on Learning and Retention,” Journal of Clinical and Experimental Psychopathology & Quarterly Review of Psychiatry and Neurology. Vol. 23, No. 1, January-March 1962. (reprint)

2 2 Aronson, Harriet, Arthur B. Silverstein, Gerald D. Klee. “The Influences of Lysergic Acid Diethylamide (LSD-25) on Subjective Time,” Archives of General Psychiatry. 1959. (print out)

2 2 Asher, Jules. “Whatever happened to Psychedelic Research?” American Psychological Association Monitor. November 1975. (photocopy)

2 2 Ashley, Richard. “The Other Side of LSD,” The New York Times. October 19, 1975. (photocopy)

2 2 Assagioli, Roberto. “Symbols of Transpersonal Experiences,” Journal of Transpersonal Psychology. Spring 1969. (reprint)

2 2 Avorn, Jerry. “Beyond Dying: Experiments using psychedelic drugs to ease the transition from life,” Harper’s Magazine. Vol. 246, No. 1474, March 1973. (clipping)

2 2 Axelrod, Julius, Roscoe O. Brady, Bernard Witkop, and Edward V. Evarts. “The Distribution and Metabolism of Lysergic Acid Diethylamide,” Annals of The New York Academy of Sciences. Vol. 66, Article 3, March 1957. (reprint)

Research Articles: B

2 3 Bain, James A. “A Review of the Biochemical Effects IN VITRO of Certain Psychotomimetic Agents,” Annals of The New York Academy of Sciences. Vol. 66, Article 3, March 1957. (reprint)

2 3 Bapat, S. K., Vimal Chandra, A. C. Jauhari, K. U. Ansari and B. N. Dhawan. “A Study of Mode of Pyretogenic Effect of LSD25 in Rabbits,” Indian Journal of Medical Research. Vol. 58, No. 4, May 1970. (photocopy)

2 3 Bapat, S. K., Vimal Chandra, A. C. Jauhari, K. U. Ansari and B. N. Dhawan. “A Study of Mode of Pyretogenic Effect of LSD25 in Rabbits,” Indian Journal of Medical Research. Vol. 58, No.

3/14/2012 25 Box Folder 4, May 1970. (photocopy)

2 3 Balestrieri, A. “Crossed Tolerance between LSD-25 and Mescaline,” Psychotropic Drugs. (reprint)

2 3 Balestrieri, A. On the Action Mechanisms of LSD 25. 1962. (preprint)

2 3 Baker, E.F.W. LSD Psychotherapy; LSD Psychoexploration: Three Reports. (preprint)

2 3 Barker, Steven, John A. Monti, and Samuel T. Christian. “N N- Dimethyltryptamine: An Endogenous Hallucinogen,” International Review of Neurology. Vol. 22, 1981. (photocopy)

2 3 Barolin, G. S. “Erstes Europaisches Symposion fur Psychotherapie unter LSD-25, Gottingen, November 1960,” Wiener Medizinische Wochenschrift. No. 27, 1961. (reprint) (includes review typed in German)

2 3 Barolin, G. S. “Principes de la Psychotherapie Sous Agents Psycholytiques,” L’Evolution Psychiatrique. No. 2, 1962. (reprint)

2 3 Barratt, Ernest S. “The Effects of Thiazesim, LSD-25, and Bilateral Lesions of the Amygdalae on the Release of a Suppressed Response,” Recent Advances in Biological Psychiatry. Vol. 9, No. 229, 1966. (reprint)

2 3 Bastiaans, J. Therapeutic Experiences with LSD-Treatment of Neurotics. London: 1969. (print out)

2 3 Bates, Roy C. “Psychedelics and the Law” from The Psychedelic Reader, ed. Timothy Leary. New York: Citadel Press Books, 1965, 1993. (photocopy)

2 3 Baumann, Peter. “Halluzinogen – unterstutzte Psychotherapie heute,” Schweizerische Arztezeitung. Band 67, Heft 47, 1986. (photocopy)

2 3 Baumeister, Roy F. and Kathleen S. Placidi. Social Conflict and Experiential Change: The LSD Controversy. 1982. (print out)

2 3 Becker, A. M. “Zur Psychopathologie der Lysergsaurediathylamidwirkung,” Wiener Zeitschrift fur

3/14/2012 26 Box Folder Nervenheilkunde und deren Grenzgebiete. Band 2, Heft 4, 1949. (reprint)

2 3 Becker, A. M. “Zur Psychopathologie der Lysergsaurediathylamidwirkung,” Wiener Zeitschrift fur Nervenheilkunde und deren Grenzgebiete. Band 2, Heft 4, 1949. (reprint)

2 3 Bender, Lauretta and D. V. Siva Sankar. “Chromosome Damage Not Found in Leukocytes of Children Treated with LSD-25,” Science. Vol. 159, No. 749, 1968. (photocopy)

2 3 Benzi, Marino. “Voisins Des Huichols Sous L’Effet Du Peyotl,” L’Hygiene Mentale. No. 3, 1969. (photocopy)

2 4 Berde, B. and A. Cerletti. “Uber den Angriffspunkt von D- Lysergsaure-diathylamid und 5-Hydroxytryptamin im Melanophorentest,” Zeitschrift fur die gesamle experimentelle Medizin. Band 129, 1957. (reprint)

2 4 Berde, B. and A. Cerletti. “Uber den Melanophoreneffekt von D-Lysergsaure-diathylamid und verwandten Verbindungen,” Helvetica Physiologica et Pharmacologica Acta. Vol. 14, Fasc. 3, 1956. (reprint)

2 4 Berde, B. and A. Cerletti. “Uber den Angriffspunkt von D- Lysergsaurediathylamid und 5-Hydroxytryptamin im Melanophorentest,” Zeitschrift fur die gesamle experimentelle Medizin. Band 129, 1957. (reprint)

2 4 Berde, B. and A. Cerletti. “Uber die Wirkungsdauer einiger Serotoninantagonisten,” Helvetica Physiologica et Pharmacologica Acta. Vol. 18, Fasc. 4, 1960. (reprint)

2 4 Berendes, Margret. “Formation of Typical, Dynamic Stages in Psychotherapy Before and After Psychodelic Drug Intervention,” Journal of Altered States of Consciousness. Vol. 5, No. 4, 1979-80. (reprint)

2 4 Bergen, J. R., D. Krus, and G. Pincus. “Suppression of LSD-25

3/14/2012 27 Box Folder Effects in Rats by Steroids,” Proc. Soc. Exp. Biol. 1960. (photocopy)

2 4 Beuret, Lawrence. “A Technique to Enhance the Recall of Birth-Related Unconscious Material.” (photocopy)

2 4 Bhattacharya, B. K. “A Pharmacological Study on the Effect of 5-Hydroxytryptamine and its antagonists on the Bronchial Musculature,” Pharmacodynamie et de Therapie. Vol. 103, Fasc. 2-3, October 1955. (reprint)

2 4 Blacker, K. H., Reese T. Jones, George C. Stone, and Dolf Pfefferbaum. “Chronic Users of LSD: The Acidheads,” American Journal of Psychiatry. Vol. 125, No. 3, September 1968. (photocopy)

2 4 Bleibtreu, John N. “LSD and the Third Eye,” The Atlantic. September 1966. (photocopy)

2 4 Bleuler, M. “Psychiatrische rrtumer in der Serotonin- Forschung,” Deutsche Medizineische Wochenschrift. No. 20, July 1956. (reprint)

2 4 Bleuler, M. “The Role of Serotonin in the Pathogenesis of Schizophrenia: A Critique,” German Medical Monthly. Vol. 1, No. 9, September 1956. (reprint)

2 4 Blewett, Duncan. “Psychelic Drugs in Parapsychological Research,” International Journal of Parapsychology. Vol. 5, No. 1, Winter 1963. (reprint)

2 4 Bonnet, M. H., Helene Bonnet, and J. P. Leciak. “Etat confuse- delirant post-intervallaire après coma oxycarbone,” Le Journal de Medecine de Lyon. October 1967. (photocopy)

2 4 Bonny, Helen L. and Walter N. Pahnke. “The Use of Music in Psychedelic (LSD) Psychotherapy,” Journal of Music Therapy. Vol. 9, No. 2, Summer 1972. (photocopy)

2 4 Borenstein, Chatelier G. “Etude electrographique et comportementale chez le Singe sous le LSD 25,” Therapie. Vol. 23, 1968. (carbon copy)

2 4 Bosomworth, Peter P. “Ketamine Symposium – Comments by Moderator,” Anesthesia and Analgesia. Vol. 50, No. 3, May-

3/14/2012 28 Box Folder June 1971. (photocopy)

2 4 Boyd, E. S. “The Metabolism of Lysergic Acid Diethylamide,” Pharmacodynamie et de Therapie. Vol. 120, Fasc. 3-4, July 1959. (reprint)

2 4 Brack, A., R. Brunner and H. Kobel. “Mikrobiologische Hydroxyliergungen an Mutterkornalkaloiden vom Clavin-Typus mit dem mexikanischen Rauschpilz,” Helvetica Chimica Acta. Vol. 45, No. 33, 1962. (reprint)

2 4 Brady, A. H., Elisabeth M. Brady, and F. C. Boucek. “Optical Activity of LSD-DNA Mixtures,” Nature. Vol. 232, July 1971. (photocopy)

2 4 Brandrup, E. and T. Vanggaard. “LSD treatment in a severe case of compulsive neurosis,” Acta Psychiat. Scand. Vol. 55, No. 2, 1977. (photocopy)

2 4 Brattemo, Carl-Erik and Borje Lassenius. “Lysergsyradietylamid: En Klinisk och Psykologisk Studie,” Sartryck ur Nordisk Medicin. 1969. (reprint)

2 4 Brown, Barbara B. “Subjective and EEG Responses to LSD in Visualizer and Non-Visualizer Subjects,” Electroenceph. Clin. Neurophysiol. 1968. (photocopy)

2 4 Brown, Barbara B. “Effect of LSD on Visually Evoked Responses to Color in Visualizer and Non-Visualizer Subjects,” Electroenceph. Clin. Neurophysiol. 1969. (photocopy)

2 4 Browning, Luolin S. “Lysergic Acid Diethylamide: Mutagenic Effects in Drosophila,” Science. Vol. 161, September 1968. (photocopy)

2 4 Buckley, Robert E. “Hypothalamic Tuning and the Initial Responses in the LSD Experience,” Schizophrenia. 1969. (photocopy)

2 4 Buckman, John. “Social and Medical Aspects of Illicit Use of LSD,” presented at The Second International congress of Social Psychiatry. London: August 4-8, 1969. (printout of rough draft)

2 4 Buckman, John. Theoretical Aspects of LSD Therapy. (preprint)

3/14/2012 29 Box Folder 19 3 Bultasova, H. et al. “Die Psychopathologie und Biochemie der durch anticholinergische Halluinogene hervorgerufenen experimentellen Psychosen,” Ideggyogyaszati Szemle. (reprint)

19 3 Bultasova, H. et al. “Psychopathologie a Biochemie Experimentalnich Psychoz Vyvolanych Anticholingergnimi Halucinogeny,” Ceskoslovenska Psychiatrie. 56, 1, 1960. (reprint)

2 4 Bunag, Ruben D. and Edward J. Walaszek. “Blockade of Depressor Responses to Serotonin and Tryptamine by Lysergic Acid Derivatives in the Chicken,” Pharmacodynamie et de Therapie. Vol. 135, No. 1-2, January 1962. (reprint)

2 4 Burton, Robert Main, Mary Ann Sodd, and Abraham Goldin. “The Analeptic Action of Lysergic Acid Diethylamide and d- Amphetamine on Reserpine-Sedated Mice,” Pharmacodynamie et de Therapie. Vol. 112, No. 1-2, October 1957. (reprint)

2 4 Burton, Robert Main, Mary Ann Sodd, and Abraham Goldin. “Some Effects of Lysergic Acid Diethylamide on Barbituate Anesthesia,” Pharmacodynamie et de Therapie. Vol. 113, No. 1-2, December 1957. (reprint)

2 4 Busch, Anthony K., Warren C. Johnson. “L.S.D. 25 As an Aid in Psychotherapy,” 1950. (photocopy).

2 4 Bush, Anthony K. and Warren C. Johnson. “LSD-25 As an Aid in Psychotherapy (Preliminary Report of a New Drug),” Dis. Nerv. Syst. Vol. 11, No. 8, August 1950. (typed manuscript)

Research Articles: C

3 1 Cabe, Patrick. “2,5-Dimethoxy-4-Methyl-Amphetamine: New Hallucinogenic Drug,” Science. Vol. 159, March 1968. (photocopy)

3 1 Caldwell, Anne E. “The Golden Age of Psychopharmacology,” Chapter 6 in Origins of Psychopharmacology. Illinois: Charles C. Thomas, 1970. (photocopy) A photocopy of references from the book is included.

3 1 Carson, I. W., J. Moore, J. P. Balmer, J. W. Dundee, and T. G. McNabb. “Laryngeal Competence with Ketamine and Other Drugs,” Anesthesiology. Vol. 38, No. 2, February 1973. (photocopy)

3/14/2012 30

3 1 Carlson, V. R. “Individual Pupillary Reactions to Certain Centrally Acting Drugs in Man,” The Journal of Pharmacology and Experimental Therapeutics. Vol. 121, No. 4, December 1957. (reprint)

3 1 Fernandez-Cerdeno, A. and H. Leuner. “Das Erleben der oralen Regression unter Einfluss von Halluzinogenen (LSD-25 und Psylocybin,” Zietschrift fur Psycho-somatische Medizin. Vol. 11, No. 1, March 1965. (reprint)

3 1 Cerletti, A. and B. Berde. “Die Wirkung von D-Lysergsaure- diathylamid (LSD 25) und 5-Oxytryptamin auf die Chromatophoren von Poecilia reticulates,” Experientia. Vol. 11, No. 8, 1955. (reprint)

3 Cerletti, A. and H. Konzett. “Spezifische Hemmung von 5- Oxytryptamin-Effekten durch Lysergsaurediathylamid and ahnliche Korper,” Archive for Experimental Pathologie and Pharmakologischen Gesellschaft. Vol. 228, No. 1-2, 1956. (reprint)

3 1 Cerletti, A. and W. Doepfner. “Uber die 5-oxytryptamin-hemmende Wirkung von LSD-Derivaten and andern Lysergsaureamiden am isolierten Rattenuterus,” International Congress of Physiology. July 1956. (reprint)

3 1 Cerletti, A. “Neuere Aspekte der Pharmakologie des vegatativen Nervensysterms,” Munchener Medizinische Wochenschrift. Vol. 98, No. 30, 1956. (reprint)

3 1 Cerletti, A. “Quelques aspects nouveaux de la pharmacologie du systeme nerveux vegetative,” Medecine et Hygiene. No. 349, January 1957. (reprint)

3 1 Cerletti, A. and W. Doepfner. “Comparative Study on the Serotonin Antagonism of Amide Derivatives of Lysergic Acid and of Ergot Alkaloids,” The Journal of Pharmacology and Experimental Therapeutics. Vol. 122, No. 1, January 1958. (reprint)

3 1 Cerletti, A. “Biochimie, physiologie et pharmacologie de la 5- hydroxytryptamime,” Medecine et Hygiene. No. 396, May 1958. (reprint)

3/14/2012 31 3 1 Cerletti, A. “Biochemie, Physiologie and Pharmakologie des 5- Hydroxytryptamins (Serotonin, Enteramin),” Helvetica Medica Acta. Vol. 25, Fasc. 4, 1958. (reprint)

3 1 Cerletti, A. “Etude Pharmacologique de la Psilocybine” in R. Heim and R. G. Wasson’s Les Champignons Hallucinogenes du Mexique. Paris: 1958. (photocopy)

3 1 Cerletti, A. “Pharmacology of Psilocybin,” Neuro- Psychopharmacology. Proceedings of the 1st International Congress of Neuro-Psychopharmacology, Rome, September 1958. (reprint)

3 1 Cerletti, A. “Teonanacatl and Psilocybin,” Deutsche Medizinische Wochenschrift. Vol. 84, No. 52, December 1959. (reprint)

3 1 Cerletti, A. “Teonanacatl and Psilocybin,” Deutsche Medizinische Wochenschrift. Vol. 84, No. 52, December 1959. (photocopy)

3 1 Cerletti, A. “Comparison of abnormal behavior states induced by psychotropic drugs in animals and man,” Neuro-Psychopharmacology. Proceedings of the 1st International Congress of Neuro- Psychopharmacology, Rome, September 1958. (reprint)

3 1 Cerletti, A. “Pharmacology of Psilocybin,” Neuro- Psychopharmacology. Proceedings of the 1st International Congress of Neuro-Pscyhopharmacology, Rome, September 1958. (reprint)

3 1 Cerletti, A. “Uber Vorkommen und Bedeutung der Indolstruktur in der Medizin und Biologie,” Fortschritte der Arzneimittleforschung. Vol. 2, 1960. (reprint)

3 1 Cerletti, A. “Pharmakodynamische Grundlagen zur differenzierten Psychopharmakotherapie,” Gerontologia Clinica. 1962. (reprint)

3 1 Cerletti, A. and H. Weidmann. “Untersuchungen zur Differenzierung des Vasokonstriktorischen Effektes von Serotonin,” Pharmacodynamie et de Therapie. Vol. 139, Fasc. 1-2, September 1962. (reprint)

3/14/2012 32

3 1 Cerletti, A. and A. Hofmann. “Mushrooms and Toadstools,” Letter to the Editor in The Lancet. January 5, 1963. (reprint)

3 1 Cerletti, A. and A. Hofmann. “Mushrooms and Toadstools,” Letter to the Editor in The Lancet. January 5, 1963. (photocopy)

3 1 Chandler, Arthur L. and Mortimer A. Hartman. “Lysergic Acid Diethylamide (LSD-25) as a Facilitating Agent in Psychotherapy,” A. M. A. Archives of General Psychiatry. Vol. 2, March 1960. (reprint)

3 1 Chapman, Loring F. and Richard D. Walter. “Actions of Lysergic Acid Diethylamide on Averaged Human Cortical Evoked Responses to Light Flash,” Recent Advances in Biological Psychiatry. Vol. 6, Joseph Wortis ed. New York: Plenum Press, 1965. (photocopy)

3 1 Cholden, Louis S., Albert Kurland, and Charles Savage. “Clinical Reactions and Tolerance to LSD in Chronic Schizophrenia,” The Journal of Nervous and Mental Disease. Vol. 122, No. 3, September 1955. (reprint)

3 1 Chauchard, P. and H. Mazoue. “Action de la Psilocybine sur L’Excitabilite des Centres Nerveux,” Comptes Rendus des Seances de la Societe de Biologie. Vol. 155, No. 1, 1961. (reprint)

3 1 Cheek, Frances and Carolyn M. Holstein. LSD-25 Dosage Levels, Group Differences and Social Interaction. October, 1970. (typed manuscript)

3 1 Chwelos, N., D. B. Blewett, C. M. Smith, and A. Hoffer. “Use of D- Lysergic Acid Diethylamide in the Treatment of Alcoholism,” Quarterly Journal of Studies on Alcohol. Vol. 20, No. 3, September 1959. (reprint)

3 2 Clark, Walter Houston. “The Mystical Consciousness and World Understanding,” Journal for the Scientific Study of Religion. Vol. 4, No. 2, April 1965. (reprint)

3 2 Clark, Walter. “Psychedelic Research: Obstacles and Values,” Journal of Humanistic Psychology. Vol. 15, No.3, Summer 1975. (reprint)

3 2 Clark, Walter Houston. “Religious Aspects of Psychedelic Drugs,” California Law Review. Vol. 56, No. 86, 1968. (reprint)

3 2 Clark, Walter Houston. “What Light Do Drugs Throw on the Spiritual and the Transpersonal?” The Academy of Religion and Psychical Research. Vol. 4, No. 2, April 1981. (photocopy)

3/14/2012 33

3 2 Clark, Lincoln D. and Louise S. Clark. “The Effects of Cortisone on LSD-25 Intoxication in Schizophrenic Patients,” The Journal of Nervous and Mental Disease. Vol. 123, No. 6, June 1958. (reprint)

3 2 Cline, Herbert S. and Harry Freeman. “Resistance to Lysergic Acid in Schizophrenic Patients,” The Psychiatric Quarterly. October 1956. (reprint)

3 2 Clyman, Bob. LSD Psychotherapy: A Review of the Literature and Some Proposals for Future Research. (photocopy)

3 2 Cohen, Bertram D., Gerald Rosenbaum, Elliot D. Luby, and Jacques S. Gottlieb. “Comparison of Phencyclidine Hydrochloride (Sernyl) with Other Drugs,” Archives of General Psychiatry. Vol. 6, May 1962. (reprint)

2 Cohen, Maimon M. and Anil B. Mukherjee. “Meiotic Chromosome Damage induced by LSD-25,” Nature. Vol. 219, No. 5158, September 1968. (photocopy of reprint)

3 2 Cohen, Maimon M. and Yosef Shiloh. “Genetic Toxicology of Lysergic Acid Diethylamide (LSD-25),” Mutation Research. 47, 1977/1978. (photocopy)

3 2 Cohen, M. M. “LSD and Chromosomes,” Science Journal. September 1968. (photocopy)

3 2 Cohen, Maimon M., Kurt Hirschhorn, and William A. Frosch. “In Vivo and Vitro Chromosomal Damage Induced by LSD-25,” New England Journal of Medicine. Vol. 227, November 1967. (photocopy)

3 2 Cohen, Sidney, Lionel Fichman, and Betty Grover Eisner. “Subjective Reports of Lysergic Acid Experiences in a Context of Psychological Test Performance,” The American Journal of Psychiatry. Vol. 115, No. 1, July 1958. (reprint)

3 2 Cohen, Sidney and Betty Grover Eisner. “Use of Lysergic Acid Diethylamide in a Psychotherapeutic Setting,” A. M. A. Archives of Neurology & Psychiatry. Vol. 81, May 1959. (reprint)

3 2 Cohen, Sidney. “Lysergic Acid Diethylamide: Side Effects and Complications,” The Journal of Nervous and Mental Disease. Vol. 130, No. 1, January 1960. (reprint)

3 2 Cohen, Sidney. “Notes on the Hallucinogenic State,” Brentwood

3/14/2012 34 Neuropsychiatric Hospital. Vol. 173, No. 6, June 1960. (reprint)

3 2 Cohen, Sidney and Keith S. Ditman. “Complications Associated with Lysergic Acid Diethylamide,” The Journal of The American Medical Association. Vol. 181, July 1962. (reprint)

3 2 Cohen, Sidney and Keith S. Ditman. “Prolonged Adverse Reactions to Lysergic Acid Diethylamide,” Archives of General Psychiatry. Vol. 8, May 1963. (reprint)

3 2 Cohen, Sidney. “Drugs and Drugged Behavior: Medicolegal Considerations,” The Journal of Clinical Pharmacology. January- February, 1969. (photocopy)

3 2 Cohen, Sidney. “Psychotomimetic Agents,” Annual Review of Pharmacology. Vol. 7, 1967. (reprint)

3 2 Cohen, Sidney. “A Classification of LSD Complications,” Psychosomatics. Vol. 7, May-June 1966. (reprint)

3 2 Cohen, Sidney. “Discussion Second Symposium,” Neuro- Psychopharmacology. (reprint)

3 2 Collard, J., P. Divry, and J. Bobon. “La Lysergo-Analyse Comme Technique Propedeutique en Psychiatrie,” Neuro- Psychopharmacology. (reprint)

3 2 Comeau, Allan J. and Ronald A. Harvey. LSD and Related Drugs: An Introduction. September 1972. (typed manuscript)

3 2 Condrau, Gion. “Klinische Erfahrungen an Geisterskranken mit Lysergsaure-Diathylamid,” 1949. (reprint)

3 2 Condrau, Gion. “Klinische Erfahrungen an Geisterskranken mit Lysergsaure-Diathylamid,” Acta Psychiatrica et Neurologica Scandinavica. Vol. 24, No. 1, 1949. (reprint)

3 2 Coppen, Alec. “The Biochemistry of Affective Disorders,” Brit. J. Psychiat. 113, 1967. (photocopy)

3 2 Corssen, G. in Anaesthesiology. Proceedings of the Fifth World Congress of Anaesthesiologists, Kyoto, September 9-13, 1972. New

3/14/2012 35 York: American Elsevier Publishing Co., 1973. (photocopy)

3 2 Cooper, Clare. “The House as Symbol of the Self” in Designing for Human Behavior, John Lang (et al) ed. Pennsylvania: Dowden, Hutchinson, & Ross, 1974. (photocopy)

3 2 Czigany, L. G. “The Use of Hallucinogens and the Shamanistic Tradition of the Finno-Ugrian People,” SEER. Vol. 58, No. 2, April 1980. (photocopy)

3 3 Dahlberg, Charles C., Ruth Mechaneck, and Stanley Feldstein. “LSD Research: The Impact of Lay Publicity,” Amer. J. Psychiat. Vol. 125, No. 5, November 1968. (photocopy)

3 3 Dahlberg, Charles Clay. LSD Facilitation of Psychoanalytic Treatment: A Case Study In Depth. (typed manuscript)

3 3 Davidson, Bill. “The Hidden Evils of LSD,” The Saturday Evening Post. (photocopy)

3 3 Davis, Emma Lou. No Title. Science. Vol. 160. (photocopy)

3 3 Dean, Stanely R. “Beyond the Unconscious: The Ultraconscious,” Psychologia. 8, 1965. (reprint)

3 3 Dean, Stanley R. “Is There an Ultraconscious Beyond the Unconscious?” Canadian Psychiatric Association Journal. Vol. 15, No. 1, February 1970. (photocopy)

3 3 Delay, J., P. Pichot, and T. Lemperiere. “La Psilocybine,” La Presse Medicale. Vol. 67, No. 47, October 10, 1959 and Vol. 67, No. 49, October 24, 1959. (reprint)

3 3 Delay, J., P. Pichot, and T. Lemperiere. “La Psilocybine Actions Psychologique et Therapeutique,” La Presse Medicale. Vol. 67, No. 49, October 24, 1959. (reprint)

3 3 Delay, J., P. Pichot, and T. Lemperiere. “The Therapeutic Implications of Psilocybine,” The Proceedings of the Quarterly Meeting of the Royal Medico-Psychological Association. London: H. K. Lewis & Co. Ltd., 1963. (reprint)

3 3 Dement, William (et al). “Hallucinations and Dreaming,” Chapter 24 in unspecified publication.

3 3 Denber, Herman C. B. “Mescaline and Lysergic Acid Diethylamide:

3/14/2012 36 Therapeutic Implications of the Drug-Induced State,” Diseases of the Nervous System. Vol. 33, February 1969. (photocopy of reprint)

3 3 Denson, R. “Lysergide in the Treatment of Neurosis,” Diseases of the Nervous System. Vol. 27, No. 8, August 1966. (photocopy)

3 3 Derbolowsky, U. “Einsamkeit, medizinisch-psychologisch, religios, soziologisch,” Zeitschrift fur Psychotherapie und Medizinische Psychologie. Vol. 16, No. 5, September 1966. (reprint)

3 3 de Saint Phalle, Anne. “An Exploration of LSD, Richard Alpert, and Higher Forms of Consciousness,” The Crimson Supplement. Cambridge, Massachusetts, April 23, 1969. (original)

de Saint Phalle, Anne. “An Exploration of LSD, Richard Alpert, and Higher Forms of Consciousness,” The Crimson Supplement. Cambridge, Massachusetts, April 23, 1969. (original)

3 3 Dewhurst, Kenneth. “Delayed Psychosis due to L. S. D.,” The Lancet. December 5, 1970. (photocopy)

3 3 Di Leo, Francesco B. “Psychotherapy with Psychedelic Drugs: A Case Report,” Journal of Psychoactive Drugs. Vol. 13, No. 4, Oct-Dec 1981. (photocopy)

19 3 Di Leo, Francesco, Stanislav Grof, and Joan Kellogg. “The Use of a Mind Revealing Drug (D.P.T.), Music, and Mandalas in Psychotherapy: A Case Presentation.” (reprint?)

3 3 Di Leo, Francesco. Transintegrative Psychedelic Therapy. September 1977. (typed manuscript)

3 3 Di Leo, Francesco B. “Position paper by A.A.P.A.P.M. President,” American Association of Physicians for the Advancement of Psychedelic Medicine. June 5, 1985 version. (photocopy)

3 3 DiMascio, Alberto and Max Rinkel. “Prediction of Clinical Effectiveness of Psychopharmacologic Agents from Drug Action Profiles in Normal Human Subjects,” Chapter 20 in Recent Advances in Biological Psychiatry. New York: Grune & Stratton, 1960. (reprint)

3 3 DiMascio, Alberto and Max Rinkel. “Personailty and Drugs., Specific or Non-Specific Influence on Drug Actions,” Chapter 7 in unspecified publication. (photocopy)

3 3 DiPaolo, J. A., Harry M. Givelber, Howard Erwin. “Evaluation of

3/14/2012 37 Teratogenicity of Lysergic Acid Diethylamide,” Nature. Vol. 220, November 2, 1968. (photocopy)

3 3 DiPaolo, J. A., Harry M. Givelber, Howard Erwin. “Evaluation of Teratogenicity of Lysergic Acid Diethylamide,” Nature. Vol. 220, November 2, 1968. (photocopy)

3 3 Ditman, Keith S. and John R. B. Whittlesy. “Comparison of the LSD- 25 Experience and Delirium Tremens,” A. M. A. Archives of General Psychiatry. Vol. 1, July 1959. (reprint)

3 3 Ditman, Keith S. “Psychotomimetics: Pharmacodynamic and Psychotherapeutic Properties,” Proceedings of the Western Pharmacology Society. Vol. 6, 1963. (reprint)

3 3 Ditman, Keith S., Thelma Moss, Edward W. Forgy, Leonard M. Zunin, Robert D. Lynch, and Wayne A. Funk. “Dimensions of the LSD, Methylphenidate and Chlordiazepoxide Experiences,” Psychopharmacologia. 14, 1969. (photocopy)

3 3 Ditman, K. S., M. Hayman, J. R. B. Whittlesey. Abstract of “Nature and Frequency of Claims Following LSD,” J. Nerv. Ment. Dis. 134, 1962. (carbon copy of typed manuscript)

3 3 Ditman, Keith S., Thelma Moss, Edward Forgy, Leonard Zunin, Wayne Funk, and Robert Lynch. “Characteristics of Alcoholics Volunteering for Lysergide Treatment.” (photocopy)

3 3 Ditman, Keith S., Walter Tietz, Blanche S. Prince, Edward Forgy, and Thelma Moss. (typed manuscript before publication)

3 3 Dixon, A. K. “Evidence of Catecholamine Mediation in the ‘Aberrant’ Behaviour Induced by Lysergic Acid Diethylamide (LSD) in the Rat,”

3/14/2012 38 Experientia. 24, 1968. (photocopy)

3 3 Dobkin, Allen B. and John H. Harland. “Drugs which Stimulate Affective Behavior,” Anaesthesia. Vol. 15, No. 1, January 1960. (reprint)

3 3 Dobkin, Allen B., John L. Pearson, and James S. Barr. “The Effect of Lysergic Acid Diethylamide (Delysid, LSD-25) on Thiopental Recovery,” Can. Anaes. Soc. J., Vol. 7, No. 1, January 1960. (reprint)

3 4 Dobkin, Marlene. “Folk Curing with a Psychedelic Cactus in the North Coast of Peru,” The International Journal of Social Psychiatry. Vol. 15, No. 1, 1968. (reprint)

3 4 Dobkin de Rios, Marlene. “The Wilderness of Mind: Sacred Plants in Cross-Cultural Perspective,” Sage Research Papers in the Social Sciences. Vol. 5, 1976. (original first printing)

3 4 Dobkin de Rios, Marlene. Man, Culture and Hallucinogen: An Overview. (typed manuscript)

3 4 Dobkin de Rios, Marlene. Cultura Persona in Drug-Induced Altered States of Consciousness. (typed manuscript to be published in Proceedings, Southern Anthopol. Assoc. Meeting, 1973)

3 4 Dobkin de Rios, Marlene. An Anthropological Theory of Drug- Induced Hallucinations. (typed manuscript to be published in Proceedings, 9th International Congress of Anthro. And Ethno. Sciences, Chicago)

3 4 Dobkin de Rios, Marlene. “The Influence of Psychotropic Flora and Fauna on Maya Religion,” Current Anthropology. Vol. 15, No. 2, June 1974. (reprint)

3 4 Dobkin de Rios, Marlene. “Some Relationships between Music and Hallucinogenic Ritual: The Jungle Gym in Consciousness,” ETHOS. Vol. 3, No. 1, Spring 1975. (reprint)

3 4 Dobkin de Rios, Marlene. “Plant Hallucinogens and the Religion of the Mochica – an Ancient Peruvian People,” Economic Botany. Vol. 31, No. 2, April-June 1977. (reprint)

3 4 Dobkin de Rios, Marlene. “Plant Hallucinogens, Out-of-Body Experiences and New World Monumental Earthworks” in Drugs, Rituals and Altered States of Consciousness, Brian M. Du Toit ed. Rotterdam: A. A. Balkema, 1977. (reprint)

3/14/2012 39

3 4 Doblin, Rick. An Esalen Teaching Story. October 1982. (typed manuscript)

3 4 Doepfner, W. and A. Cerletti. “Comparison of Lysergic Acid Derivatives and Antihistamines as Inhibitors of the Edema Provoked in the Rat’s Paw by Serotonin,” International Archives of Allergy and Applied Immunology. Vol. 12, No. 1-2, 1958. (reprint)

3 4 Doepfner, W. “Uber die Entstehung von Serotonin aus 5- Hydroxytryptophan nach UV. – Bestrahlung,” Experientia. Vol. 14, No. 10, 1958. (reprint)

3 4 Doepfner, W. and A. Cerletti. “Uber den Serotonin-Antagonismus einiger Antihistaminika unter Berucksichtigung ihrer chemischen Struktur,” International Archives of Allergy and Applied Immunology. Vol. 10, No. 6, 1957. (reprint)

3 4 Doepfner, W. “Biochemical Observations on LSD-25 and Deseril,” Experientia. 18, 1962. (reprint)

3 4 Dohner, V. Alton. “LSD and Marihuana: Where Are the Answers?” Science. Vol. 160, June 7, 1968. (photocopy)

3 4 Dolezal, V. and M. Hausner. “Nase zkusenosti s individualni a kolektivni psychoterapii za pomoci LSD.” 1962. (reprint?)

3 4 Domarus, Helmut V. “Thrombocytopenia in a Patient with Polycythaemia,” The Lancet. October 24, 1970. (photocopy)

3 4 Dorrance, David L. “Chromosomal and Teratogenic Effects of LSD: A Literature Review,” The New Physician. Vol. 18, No. 7, July 1969. (photocopy)

3 4 Dorrance, David, Oscar Janiger, and Raymond L. Teplitz. “In Vivo Effects of Illicit Hallucinogens on Human Lymphocyte Chromosomes,” JAMA. Vol. 212, No. 9, June 1, 1970. (photocopy)

3 4 Dorrance, D. L., D. J. Beighlie, V. Yoshii, O. Janiger, A. M.

3/14/2012 40 Brodetsky, and R. L. Teplitz. Studies on the Mechanism of Interaction Between Lysergic Acid and Chromosomes. (photocopy of typed manuscript)

3 4 Downing, Joseph J. Something’s Happening: The New Drug Revolution in America. (typed manuscript)

3 4 Draskoci, M. “Assay of Lysergic Acid Diethylamide and its Passage from Blood into the Perfused Cerebral Ventricles,” British Journal of Pharmacology and Chemotherapy. Vol. 15, No. 1, March 1960. (reprint)

3 4 Duche, D. J. Les Effets de la Psilocybine Dans un cas d’Hysterie. (typed manuscript)

3 4 Durand, V. J. “Diethylamide de L’Acide Lysergique et Psychiatrie,” Annales Medico-Psychologiques. Vol. 1, No. 3, March 1960. (reprint)

19 3 Dyck, Erika. Conclusion from Psychedelic Psychiatry: LSD from Clinic to Campus. Baltimore: The Johns Hopkins University Press. (photocopy)

Box Folder 4 1 Eberle, P. and H. Leuner. “Chromosomendefekte bei Psilocybin- Patienten,” Humangenetik. 9, 1970. (photocopy)

19 3 Echenhofer, Frank G. “Toward a Neurophenomenology of Transformatrive Visions: A Model Integrating Cognitive Neuroscience, Psychotherapy, Comparative Myysticism, and Ayahuasca EEG Experienctial Research.” (photocopy)

4 1 Edmonston, William E. “An Experimental Investigation of Hypnotic Age-Regression,” The American Journal of Clinical Hypnosis. Vol. 3, No. 3, January 1961. (reprint)

4 1 Edwards, Allan E. and Sidney Cohen. “Visual Illusion, Tactile Sensibility and Reaction Time under LSD-25,” Psychopharmacologia. 2, 1961. (reprint)

4 1 Edwards, Allan E. and Sidney Cohen. “Persistence of an Evaluative Response Conditioned under LSD and Sensory Deprivation,” Chapter 3 in Recent Advances in Biological Psychiatry. Vol.7. New York: Plenum Press, 1965. (photocopy)

4 1 Edwards, Allen E. and Sidney Cohen. “Interaction of LSD and Quantity of Encoded Visual Data upon Size Estimation,” Journal of

3/14/2012 41 Psychopharmacology. Vol. 1, No. 3, 1966. (reprint)

4 1 Eggert, Delmer C. and Charles Shagass. “Clinical Prediction of Insightful Response to a Single Large Dose of LSD,” Psychopharmacologia. 9, 1966. (photocopy)

4 1 Egozcue, Jose, Samuel Irwin, and Cesar A. Maruffo. “Chromosomal Damage in LSD Users,”JAMA. Vol. 204, No. 3, April 15, 1968. (photocopy)

4 1 Egozcue, Jose and Samuel Irwin. “Effect of LSD-25 on Mitotic and Meiotic Chromosomes of Mice and Monkeys,” Humangenetik. 8, 1969. (photocopy)

4 1 Eidelberg, E., M. Long, and M. K. Miller. “Spectrum Analysis of EEG Changes Induced by Psychotomimetic Agents,” Int. J. Neuropharmacol. 1965. (photocopy)

4 1 Eisner, Betty Grover and Sidney Cohen. “Psychotherapy with Lysergic Acid Diethylamide,” Journal of Nervous and Mental Disease. Vol. 127, No. 6, December 1958. (reprint)

4 1 Eisner, Betty Grover. “Notes of the Use of Drugs to Facilitate Group Psychotherapy,” Psychiatric Quarterly. Vol. 38, April 1964. (reprint) Signed by Betty Grover Eisner.

4 1 Eisner, Betty Grover. The Importance of the Non-Verbal. For Presentation at the Second Conference on LSD and Psychotherapy. May 1965. (preprint)

4 1 Eisner, Betty Grover and Ernest Katz. Notes of the Versatility of Ritalin and its Psychedelic Elements when used as a Psychotherapeutic Aid. (typed manuscript)

4 1 Elder, John T. and M. Kent Shellenberger. “Antagonism of Lysergic Acid Diethylamide (LSD)-Induced Hyperthermia,” The Journal of Pharmacology and Experimental Therapeutics. Vol. 136, No. 3, June 1962. (reprint)

3/14/2012 42 1962. (reprint)

4 2 Elkes, J. “Behavioral Pharmacology in Relation to Psychiatry,” Psychiatrie de Gegenwart. 1, 1967. (reprint)

4 2 Elkes, J. “The Dysleptics: Note on a No Man’s Land,” Comprehensive Psychiatry. Vol. 4, No. 3, June 1963. (reprint)

4 2 Elkes, Joel. “Psychoactive Drugs: Some Problems and Approaches,” Psychiatric Drugs. 1966. (reprint)

4 2 Elkes, J. “Amines in Relation to Behavior: Some Problems and Approaches,” in Monoamines et Systeme Nerveux Central, J. Ajuriaguerra ed. 1962. (reprint)

4 2 Elkes, J. “Drug Effects in Relation to Receptor Specificity within the Brain: Some Evidence and Provisional Formulation,” Ciba Foundation Symposium on the Neurological Basis of Behavior. 1958. (reprint)

4 2 Elkes, J. “Drugs Influencing Affect and Behavior: Possible Neutral Correlates in Relation to Mode of Action” in The Physiology of Emotions by Alexander Simon, Charles Herbert, and Ruth Straus. Illinois: Charles C. Thomas. (reprint)

4 2 Elkes, J. “Effects of Psychosomimetic Drugs in Animals and Man,” in Neuropharmacology. Transaction of Third Conference. 1957. (reprint)

4 2 Elkes, J. “Schizophrenic Disorder in Relation to Levels of Neural Organization: The Need for Some Conceptual Points of Reference,” in The Chemical Pathology of the Nervous System, J. Folch-Pi ed. London: Pergamon Press, 1961. (reprint)

4 2 Elkes, Joel J. “Psychotropic Drugs Observations on Current Views and Future Problems,” Lectures on Experimental Psychiatry. 1961. (reprint)

4 2 Elkin, Edwin H. The Use and Abuse of Psychedelic Drugs as a Mental

3/14/2012 43 Health Paradox. 7th International Congress of Mental Health, London, England. August 12, 1968. (photocopy)

4 2 Elkin, Edwin H. A Systematic Study of the Effects of LSD-25 on Human Behavior. (photocopy)

4 2 Elkin, Edwin H. “LSD and the Realization of Human Potential.” (pamphlet)

4 2 Eller, J. L. “LSD: What Index of Suspicion?” Letter to the editor. (photocopy)

4 2 Engel, Kenneth S. R. New Cartographies of the Mind: Stanislav Grof. (typed manuscript)

4 2 Epstein, Arthur W. and Frank Ervin. “Psychodynamic Significance of Seizure Content in Psychomotor Epilepsy,” Psychosomatic Medicine. Vol. 18, No. 1, 1956. (photocopy)

4 2 Esecover, Harold, Sidney Maltiz, and Bernard Wilkens. “Clinical Profiles of Paid Normal Subjects Volunterring for Hallucinogen Drug Studies,” The American Journal of Psychiatry. Vol. 117, No. 10, April 1961. (reprint)

4 2 Evans, L. T., L. H. Geronimus, C. Kornetsky, H. A. Abramson. “Effect of Ergot Drugs on Betta Splendens,” Science. Vol. 123, No. 3184, January 6, 1956. (reprint)

4 2 Evans, Franklin. “The Effect of Several Psychotomimetic Drugs on Human Serum Cholinesterase,” Psychopharmacologia. Vol. 1, No. 3, 1960. (reprint)

4 2 Evarts, Edward V. “A Review of the Neurophysiological Effects of Lysergic Acid Diethylamide (LSD) and Other Psychotomimetic Agents,” Annals of The New York Academy of Sciences. Vol. 66, Article 3, March 14, 1957. (reprint)

4 2 Evarts, Edward V., William Landau, Walter Freygang, Jr. and Wade H. Marshall. “Some Effects of Lysergic Acid Diethylamide and Bufotenine on Electrical Activity in the Cat’s Visual System,” The American Journal of Physiology. Vol. 182, No. 3, September 1955. (reprint)

3/14/2012 44

4 2 Evarts, Edward V. “Some Effects of Bufotenine and Lysergic Acid Diethylamide on the Monkey,” A. M. A. Archivse of Neurology and Psychiatry. Vol. 75, January 1956. (reprint)

4 2 Evarts, Edward V. “Some Effects of Bufotenine and Lysergic Acid Diethylamide on the Monkey,” A. M. A. Archivse of Neurology and Psychiatry. Vol. 75, January 1956. (photocopy)

Research Articles: F 4 3 Fabing, Howard D. “New Blocking Agent Against the Devolopment of LSD-25 Psychosis,” Science. Vol. 121, No. 3137, February 11, 1955. (reprint)

4 3 Fabing, H. D. “The Dimensions of Neurology,” Neurology. 5, 1955. (typed manuscript)

4 3 Fabing, Howard D. “Frenquel, a Blocking Agent Against Experimental LSD-25 and Mescaline Psychosis,” Neurology. Vol. 5, May 1955. (reprint)

4 3 Fabing, Howard D. “Frenquel, a Blocking Agent Against Experimental LSD-25 and Mescaline Psychosis,” Neurology. Vol. 5,

3/14/2012 45 May 1955. (reprint)

4 3 Fabing, Howard D. “New Blocking Agent Against the Devolopment of LSD-25 Psychosis,” Science. Vol. 121, No. 3137, February 11, 1955. (reprint)

4 3 Fabing, Howard D. “On Going Berserk: a Neurochemical Inquiry,” The Scientific Monthly. Vol. 83, No. 5, November 1956. (reprint)

4 3 Faillace, L. A., A. Vourlekis and S. Szara. “N.N-Dipropyltryptamine, A New Psycholdysleptic Drug,” Excerpta Medica International Congress Series. No. 129, March 1966. (reprint)

4 3 Faillace, Louis A., Alkinoos Vourlekis, and Stephen Szara. “Clinical Evaluation of Some Hallucinogenic Tryptamine Derivatives,” The Journal of Nervous and Mental Disease. Vol. 145, No. 4, 1967. (reprint)

4 3 Faillace, Louis A. and Stephen Szara. “Hallucinogenic Drugs: Influence of Mental Set and Setting,” Diseases of the Nervous System. Vol. 29, February 1968. (reprint)

4 3 Fanchamps, A. “La Psychopharmacologie Moderne et les Drogues Magiques Mexicaines,” Revue Medicale de la Suisse Romade. Vol. 82, No. 1, January 1962. (reprint)

4 3 Fanchamps, A. “Des Drogues Magiques des Azteques a la Therapie Psycholytique,” Acta Psychotherapeutica. 10, 1962. (reprint)

4 3 Faretra, Gloria and Lauretta Bender. “Autonomic Nervous System Responses in Hospitalized Children Treated with LSD and UML,” in Recent Advances in Biological Psychiatry, Vol. 7. Joseph Wortis ed. New York: Plenum Press, 1965. (photocopy)

4 3 Farrow, John T. and Helen Van Vunakis. “Binding of d-Lysergic Acid Diethylamide to Subcellular Fractions from Rat Brain,” Nature. Vol. 237, No. 5351, May 19, 1972. (photocopy)

4 3 Feld, Myron, Joseph R. Goodman, and John A. Guido. “Clinical and Laboratory Observations on LSD-25,” The Journal of Nervous and Mental Disease. Vol. 126, No. 2, February 1958. (reprint)

3/14/2012 46 4 3 Felsinger, John M., Louis Lasagna, and Henry K. Beecher. “The Response of Normal Men to Lysergic Acid Derivatives (Di-And Mono-Ethyl Amides),” Journal of Clinical and Experimental Psychopathology & Quarterly Review of Psychiatry and Neurology. Vol. 17, No. 4, December 1956. (reprint)

4 3 Felsinger, John M., Louis Lasagna, and Henry K. Beecher. “The Response of Normal Men to Lysergic Acid Derivatives (Di-And Mono-Ethyl Amides),” Journal of Clinical and Experimental Psychopathology & Quarterly Review of Psychiatry and Neurology. Vol. 17, No. 4, December 1956. (photocopy)

4 3 Fernandez, J., T. Brennan, J. Masterson, and M. Power. “Cytogenetic Studies in the Offspring of LSD Users,” Brit. J. Psychiat. 124, 1974. (photocopy)

4 3 Ferenczi, Sandor. Thalassa: A Theory of Genitality. (photocopy) Finney, Ben R. “An Experiment in Ancient Marine Technology,” INFOTECH. Summer-Fall 1976. (photocopy)

4 3 Fischer, Roland, F. Georgi, and R. Weber. “Modellversuche zum Schizophrenieproblem Lysergsaurediathylamid und Mezcalin,” Schweizerische Medizinische Wochenschrift. Vol. 81, No. 817, August 1951. (reprint)

4 3 Fischer, R. “Factors Involved in Drug-Produced Model Psychoses,” Experientia. Vol. 10, No. 10, 1954. (reprint)

4 3 Fischer, R. “Possible Biosynthesis of D-Lysergic Acid Diethylamide- like Compounds from Mescaline,” Experientia. Vol. 11, No. 4, 1955. (reprint)

4 3 Fischer, Roland. “Out on a (Phantom) Limb, Variation on the Theme: Stability of Body Image and the Golden Section,” Perspectives in

3/14/2012 47 Biology and Medicine. Vol. 12, No. 2, Winter 1969. (reprint)

4 3 Fischer, Roland. “The Perception-Hallucination Continuum, A Re- Examination,” Diseases of the Nervous System. 30, 1969. (typed manuscript)

4 3 Fischer, R. “Prediction and Measurement of Perceptual-Behavioral Change in Drug-Induced Hallucination,” in Origin and Mechanisms of Hallucination. New York: Plenum Press, 1970. (reprint)

4 3 Fischer, R. “Uber das Rhythmisch-Ornamentale im Halluzinatorische- Schopferischen,” Confinia Psychiatrica. 13, 1970. (reprint)

4 3 Fischer, R. “On Separateness and Oneness: An I-Self Dialogue,” Confin. Psychiat. 15, 1972. (photocopy)

4 3 Fischer, Roland, Richard Hill, Karen Thatcher, and James Scheib. “Psilocybin-Induced Contraction of Nearby Visual Space,” Agents and Actions. Vol. 1, No. 4, 1970. (reprint)

4 3 Fischer, Roland, Thomas Kappeler, Philip Wisecup, and Karen Thatcher. “Personality Trait Dependent Performance Under Psilocybin,” Diseases of the Nervous System. Vol. 31, February 1970. (reprint)

4 4 Fisher, Gary. “Some Comments Concerning Dosage Levels of Psychedelic Compounds for Psychotherapy,” The Psychedelic Review. 1, 1963. (photocopy)

4 4 Fisher, Gary. Psychedelic Drug Usage: Socio-Political and Psychological Considerations. 1968. (typed manuscript) Note: Abbreviated version of this paper is published in California School of Health. No. 4, 1968.

4 4 Fisher, Gary and Joyce Martin. “The Psychotherapeutic Use of Psychodysleptic Drugs,” Voices: Art & Science of Psychotherapy. 5, 1970. (photocopy)

4 4 Flander, Judy. “Method for LSD Detection,” The Evening Star and The Washington Daily News. September 8, 1972. (photocopy)

4 4 Fluckiger, E. and R. Salzmann. “Serotoninantagonismus and der Placenta,” EXPERIENTIA. 17, 1961. (reprint)

4 4 Von Foerster, Heinz. “On Constructing Reality,” Environmental Design Research. Vol. 2, 1973. (reprint)

3/14/2012 48

4 4 Fogel, S. and A. Hoffer. “The Use of Hypnosis to Interrupt and to Reproduce an LSD-25 Experience,” Journal of Clinical and Experimental Psychopathology & Quarterly Review of Psychiatry and Neurology. Vol. 23, No. 1, January-March 1962. (reprint)

19 3 4 4 Forrer, Gordon R. and Richard D. Goldner. “Experimental Physiological Studies with Lysergic Acid Diethylamide (LSD-25),” Archives of Neurology and Psychiatry. May 1951. (reprint)

4 4 Forrer, Gordon R., Charline Draper, and James L. Grisell. “Pharmacotoxic Therapy with Atropine Sulfate,” The Journal of Nervous and Mental Disease. Vol. 117, No. 3, March 1953. (reprint)

4 4 Fort, Joel and Ralph Metzner. “LSD, Chromosomes, and Sensationalism,” Psychedelic Review. 10, 1968. (typed manuscript)

4 4 Fort, Joel. “Pot: A Rational Approach,” Playboy? (photocopy)

4 4 Fox, Ruth. Is LSD of Value in Treating Alcoholics? (preprint)

4 4 Frederking, Walter. “Uber die Verwendung von Rauschdrogen (Meskalin und Lysergsaurediaethylamid) in der Psychotherapie,” Psyche. Vol. 7, No. 6, 1953-1954. (reprint)

4 4 Frederking, Walter. “Intoxicant Drugs (Mescaline and Lysergic Acie Diethylamide) in Psychotherapy,” The Journal of Nervous and Mental Disease. Vol. 121, No. 3, March 1955. (reprint)

4 4 Freedman, Alfred M., Martin S. Deutsch, and Cynthia Deutsch. “Sensory Response of Schizophrenic Children Under Atarax: A New Method of Measurement,” Neuro-Psychopharmacology. Vol. 2, 1961. (reprint)

4 4 Freedman, Daniel X. “A Psychiatrist Comments on LSD,” The University of Chicago Magazine, March 1967.

4 4 Freedman, Daniel X. “Effects of LSD-25 on Brain Serotonin,” The Journal of Pharmacology and Experimental Therapeutics. Vo. 134, No. 2, 1961. (reprint)

3/14/2012 49 4 4 Freedman, Daniel X. “Effects of LSD-25 on Brain Serotonin,” The Journal of Pharmacology and Experimental Therapeutics. Vo. 134, No. 2, 1961. (reprint)

4 4 Freedman, Sanford J. and Milton Greenblatt. “Studies in Human Isolation I. Perceptual Findings” and “Studies in Human Isolation II. Hallucinations and Other Cognitive Findings,” U.S. Armed Forces Medical Journal. Vol. 11, No. 11, November 1960 and Vol. 11, No. 12, December 1960. (reprint)

4 4 Freeman, Harry. “Pupil Dilatation in Normal and Schizophrenic Subjects Following Lysergic Acid Diethylamide Ingestion,” A. M. A. Archives of Neurology & Psychiatry. Vo. 79, March 1958. (reprint)

4 4 Freund, Kurt, Ron Langevin, Stephen Cibiri, and Yaroslaw Zajac. “Heterosexual Aversion in Homosexual Males,” The British Journal of Psychiatry. Vol. 122 No. 567, February 1973. (reprint)

4 4 Friedhoff, Arnold J. and Bernard Abrams. “Effect of Glutamic Acid and Glutamine on the Pyretogenic Action of Lysergic Acid Diethylamide,” Journal of Clinical and Experimental Psychopathology & Quarterly Review of Psychiatry and Neurology. Vol. 21, No. 1, January-March 1960. (reprint)

4 4 Frohman, C. E., Morris Goodman, E. D. Luby, P. G. S. Beckett, and R. Senf. “Ceruloplasmin, Transferrin, and Tryptophan in Schizophrenia,” A. M. A. Archives of Neurology & Psychiatry. Vol. 79, June 1958. (reprint)

4 4 Fuster, Joaquin M. “Lysergic Acid and its Effects on Visual Discrimination in Monkeys,” The Journal of Nervous and Mental Disease. Vol. 129, No. 3, September 1959. (reprint)

Research Articles: G

5 1 Gabriel, Trip. “Call My Agent!” The New York Times Magazine. February 19, 1989. (clipping)

5 1 Ganong, William F., Alan Goldfien, Al Halevy, Julian M. Davidson, and Angela Boryczka. “Effect of Lysergic Acid Diethylamide on Adrenocortical and Adrenal Medullary Function in the Dog,” ACTA Endocrinologica. 34, 1961. (reprint)

5 1 Garson, O. Margaret and Meryl K. Robson. “Studies in a Patient with Acute Leukaemia after Lysergide Treatment,” British Medical Journal.

3/14/2012 50 2, 1969. (photocopy)

5 1 Gastaldi, G. (et al). “In tema di psicosi modello,” Rivista di Patologia nervosa e mentale. Vol. 79, 1958. (reprint)

5 1 Gerber, William F. “Congenital Malformations Induced by Mescaline, Lysergic Acid Diethylamide, and Bromolysergic Acid in the Hamster,” Science. Vol. 158, October 13, 1967. (photocopy)

5 1 Geert-Jorgensen, Einar. “Modelpsykoser og Lysergsyre- Diaethylamidebehandling,” Saertryk af Ugeskrift for Laeger. 1961. (reprint)

5 1 Geert-Jorgensen, Einar, Mogens Hertz, Knud Knudsen, and Kjaerbye Kristensen. “LSD-Treatment: Experience gained within a three-year period,” Report on the Fourteenth Congress of Scandinavian Psychiatrists, Acta Psychiatrica Scandinavica. Vol. 40, 1964. (reprint)

5 1 Geronimus, Lippman H., Harold A. Abramson, and Laura J. Ingraham. “Lysergic Acid Diethylamide (LSD-25): XXIII. Comparative Effects of LSD-25 and Related Ergot Drugs on Brain Tissue Respiration and on Human Behavior,” The Journal of Psychology. 42, 1956. (reprint)

19 3 Gervasi, Susan. “LSD and the Troubled Mind,” The Washington Post. January 15, 1986. (photocopy)

5 1 Gessner, P. K., P. A. Khairallah, W. M. McIsaac, and I. H. Page. “The Relationship Between the Metabolic Fate and Pharmacological Actions of Serotonin, Bufotenine and Psilocybin,” The Journal of Pharmacology and Experimental Therapeutics. Vol. 130, No. 2, October 1960. (reprint)

5 1 Gettner, H. H., A. Rolo, and H. A. Abramson. “Lysergic Acid Diethylamide (LSD 25): XXXIX. The Effect of High Temperatures on Stability,” The Journal of Psychology. 75, 1970. (photocopy)

5 1 Giberti, F. and L. Gregoretti. “Contributo Alla Conoscenza Dell’Isterismo Mediante L’Impiego di Farmaci Psicommetici,” Archivo di Psicologia Neurologia E Psichiatria. 19, 1958. (reprint)

5 1 Giberti, F. and Luciano Gregoretti. “Prime Esperienze Di Antagonismo Psicofarmacologico,” Sistema Nervoso. 4, 1955. (reprint)

3/14/2012 51

5 1 Giberti, F., L. Gergoretti, and G. Boeri. “L’Impiego Della Dietilamide Dell’Acido Lisergico Nelle Psiconevrosi,” Sistema Nervoso. 4, 1956. (reprint)

5 1 Giberti, F. and L. Gerogretti. “Studio Farmacopsichiatrico Di Un Caso Di Psiconevrosi Ossessiva,” Sistema Nervoso. 4, 1957. (reprint)

5 1 Giberti, F., L. Gregoretti, and S. Soriani. “Aspetti psicopatologici e rivlievi clinici nello studio farmacopsichiatrico delle sindromi ossessive e fobiche,” Note e Riviste di Psichiatria. 3, September 1958. (reprint)

5 1 Giberti, F. and L. Gregoretti. “Nouveaux Aspects Des Experiences Avec Des Drogues Psychotropes (LSD 25 Et Lae 32) Dans Les Psychonevroses,” Neuro-Psychopharmacology.

5 1 Gilbert, G. M. “Toward a Comprehensive Biosocial Theory of Human Behaviour,” The International Journal of Social Psychiatry. Vol. 9, No. 2, 1963. (reprint)

5 1 Gillin, J. Christian (et al). “5-Methoxy-N, N-Dimethyltriptamine: Behavioral and Toxicological Effects in Animals,” Biological Psychiatry. Vol. 11, No. 3, 1976. (reprint)

5 1 Ginzel, K. H. and W. Mayer-Gross. “Prevention of Psychological Effects of 3-Lysergic Acid Diethylamide (LSD 25) by its 2-Brom Derivative (BOL 148),” Nature. Vol. 178, July 28, 1956. (reprint)

5 1 Gilson, M. “Les effets tensionnels de diverses amines sympathicomimetiques (Adrianol, Effortil, Isopropylnoradrianol.” (photocopy)

5 1 Giosci, Victor. “Groovin’ on Time: fragments of a sociology of the psychedelic experience.” Delivered to the conference on Psychedelic Drugs convened by Hahneman Medical College and Hospital of Philadelphia. November 22-24, 1968. (typed manuscript)

5 1 Glickman, Lewis and Michael Bluemenfield. “Psychological Determinants of LSD Reactions,” The Journal of Nervous and Mental Disease. Vol. 145, No. 1, 1967. (reprint)

3/14/2012 52 5 1 Godfrey, Kenneth E. “The Metamorphosis of an LSD Psychotherapist,” Submitted to the Second Conference on LSD and Psychotherapy. January 1965. (preprint)

5 1 Goldstein, Leonide, Henry B. Murphree, A. Arthur Sugerman, and Carl C. Pfeiffer. “Quantitative Electroencephalographic Analysis of Naturally Occurring (Schizophrenic) and Drug-Induced Psychotic States in Human Males,” Clinical Pharmacology and Therapeutics. Vol. 4, No. 1, January-February, 1963. (photocopy)

5 1 Gomirato, G., G. Gamna, E. Pascal. “Il Disegno Dell’ Albero Applicato Allo Studio Delle Modificazioni Psicopatologiche Indotte Dalla Dietilamide Dell’ Acido D Lisergico In Schizofrenici. – Nota II.” Giornale di Psichiatria e di Neuropatologia. 2, 1958. (reprint)

5 1 Gormsen, Klaus and Jorgen Lumbye. A Comparative Study of Stanislav Grof’s and L. Ron Hubard’s Models of Consciousness. (photocopy)

5 1 Gosselin, R. E., K. E. Moore, and A. S. Milton. “Physiological Control of Molluscan Gill Cilia by 5-Hydroxytryptamine,” The Journal of General Physiology. Vol. 46, No. 2, November 1962. (reprint)

5 1 Grace, Dale, Elof Asel Carlson, Philip Goodman. “Drosophila melanogaster Treated with LSD: Absence of Mutation and Chromosome Breakage,” Science. Vol. 161, August 16, 1968. (photocopy)

5 2 Graham, J. D. P. and Alaa iddeen Khalidi. “The Actions of d-Lysergic Acid Diethylamide (LSD 52),” Journal of the Faculty of Medicine. Vol. 18, No. 1, 1954. (reprint)

5 2 Graves, Robert. “How to Avoid Mycophobia,” Nature & Mankind. Vol. 40, No. 19, May 11, 1957. (photocopy)

5 2 Greenberg, Ramon, Donald Mahler, and Chester Pearlman. “Dreaming and Nitrous Oxide,” Arch. Gen. Psychiat. Vol. 21, December 1969. (photocopy)

5 2 Greenblatt, David J. and Richard I. Shader. “Adverse Effects of LSD: A Current Perspective,” Connecticut Medicine. Vol. 34, No. 12, December 1970. (photocopy)

3/14/2012 53

5 2 Greer, George. “Using MDMA in Psychotherapy,” Advances. Vol. 2, No. 2, Spring 1985. (photocopy)

5 2 Grinspoon, Lester. “Marihuana,” International Journal of Psychiatry. (photocopy)

17 13 Grob, Charles. “Psychiatric Research with Hallucinogens: What have we learned?” Ethnomedicine and the Study of Consciousness. 3, 1994. [photocopy]

5 2 Grof, Christina. “The Thirst for Wholeness: Addicition and the Spiritual Path,” ReVision, Spring, 1993.

5 2 Grossbard, Lionel (et al). “Acute Leukemia with Ph-Like Chromosome in an LSD User,” JAMA. Vol. 205, No. 11, September 9, 1968. (photocopy)

5 2 Gye, Bill. “The East-West Dialogue and the Paradigm Shift,” COSMOS. June 1982. (photocopy)

5 2 Guiti, N., B. Djahanguiri and H. Mehdizadeh. “Analyse Quantitative D’Electroencephalogrammes Repetes Chez le Chien Soumis A L’Effet Du Diethyl Lysergamide (LSD 25),” Electroenceph. Clin. Neurophysiol. Vol. 21, 1966. (photocopy)

5 2 Gye, Bill. “The East-West Dialogue and the Paradigm Shift,” COSMOS. June 1982. (photocopy)

5 3 Halasz, Michael F., Jaroslav Fromanek, and Amedeo S. Marrazzi. “Cytogenic Effects of Cyclamate on Human Cells in Vitro,” Science. Vol. 164, May 2, 1969. (photocopy)

5 3 Haley, Jay. “The Amiable Hippie: A New Form of Dissent,” Reflections. Vol. 4, No. 2, 1969. (reprint)

5 3 Haley, Thomas J. “5-Hydroxytryptamine Antagonism by Lysergic Acid Diethylamide after Intracerebral Injection in conscious Mice,” Journal of American Pharmaceutical Association. Vol. 46, No. No. 7, 1957. (reprint)

5 3 Haley, T. J. and J. Rutschmann. “Brain Concentrations of LSD-25 (Delysid) after Intracerebral or Intravenous Administration in Conscious Animals,” Experientia. Vol. 13, No. 5, 1957. (reprint)

5 3 Haley, Thomas J. and S. R. Dasgupta. “Intracereabral Injection of

3/14/2012 54 Lysergic Acid Diethylamide in Conscious Dogs and Cats,” Archives Internationales de Pharmacodynamie et de Therapie. Vol. 113, No. 3- 4, January 1958. (reprint)

5 3 Halifax-Grof, Joan. “Hex Death,” Presented at the Twenty Second International Conference of the Parapsychology Foundation. August 29-31, 1973. (photocopy)

5 3 Haley, Thomas J. “5-Hydroxytryptamine Antagonism by Lysergic Acid Diethylamide after Intracerebral Injection in Conscious Mice,” Journal of the American Pharmaceutical Association. Vol. 46, No. 7, July 1957. (reprint)

5 3 Haley, T. J. and L. Mavis. “Effect of Psychotropic Drugs on the Kangaroo Rat,” Neuro-Psycho-pharmacology. Vol. 3, 1964. (photocopy)

5 3 Halpern, Bernard N., P. Liacopoulos, and M. Liacopoulos-Briot. “Recherches Sur Les Substances Exogenes Et Endogenes Agissant Sur La Permeabilite Capillaire et Leurs Antagonistes,” Archives Internationales de Pharmacodynamie et de Therapie. Vol. 69, No. 1-2, 1959. (reprint)

5 3 Hanaway, J. K. “Lysergic Acid Diethylamide: Effects on the Developing Mouse Lens,” Science. Vol. 164, May 2, 1969. (photocopy)

5 3 Hansen, Gustav. The psychotropic effect of Ketamine. (print out)

5 3 Hardisty, R. M. and R. S. Stacey. “5-Hydroxytryptamine in Normal Human Platelets,” Journal of Physiology. Vol. 130, No. 3, 1955. (reprint)

5 3 Hardisty, R. M. “Reserpine and Human Platelet 5 Hydroxytryptamine,” Experientia. Vol. 12, No. 11, 1956. (reprint)

5 3 Harley-Mason, J., A. H. Laird, and J. R. Smythies. “(I) The Metabolism of Mescalin in the Human (II) Delayed Clinical Reactions to Mescalin,” Confina Neurologica. Vol. 18, No. 2-4, 1958. (reprint)

5 3 Harkonen, P. and Y. Konttinen. “The Effect of Lysergic Acid Diethylamide on the White Blood Cell Count of the Guinea Pig,” Acta Pharmacol. Et Toxicol. 14, 1958. (reprint)

5 3 Harkonen, P. and Y. Konttinen. “The Effect of Lysergic Acid Diethylamide on the White Blood Cell Count of the Guinea Pig,” Acta

3/14/2012 55 Pharmacol. Et Toxicol. 14, 1958. (reprint)

5 3 Harman, Willis W. “Some Aspects of the Psychedelic-Drug Controversy,” Journal of Humanistic Psychology. Fall 1963. (reprint)

5 3 Harman, Willis W. “The Issue of the Consciousness-Expanding Drugs,” Main Currents in Modern Thought. Vol. 20, No. 1, September- October 1963. (reprint)

5 3 Harman, Willis W. (et al). “Psychedelic Agents in Creative Problem- Solving: A Pilot Study,” Psychological Reports. Vol. 19, 1966. (reprint)

5 3 Harman, Willis. W. “Old Wine in New Wineskins” Chapter 33 in Challenges of Humanistic Psychology. McGraw Hill, 1967. (reprint)

5 3 Harman, Willis W. Use of Psychedelic Agents to Facilitate Creative Problem Solving. (full report)

5 3 Harris, A. “Sensory Deprivation and Schizophrenia,” The Journal of Mental Science. Vol. 105, No. 438, January 1959. (reprint)

5 3 Hartung, Jurgen R., Sheila A. McKenna, and James C. Baxter. “Body Image and Defensiveness in an LSD-taking Subculture.” (photocopy)

5 3 Hastings, Arthur. “The Oakland Poltergeist,” The Journal of American Society for Psychical Research. Vol. 72, July 1978. (reprint)

5 3 Hatrick, John A. and Kenneth Dewhurst. “Delayed Psychosis Due to L.S.D.,” The Lancet. October 10, 1970. (photocopy)

5 3 Hausner, M. and V. Dolezal. “Group and Individual Psychotherapy under LSD,” Acta Psychother. 2, 1963. (reprint)

20 3 Hausner, M. and V. Dolezal. “Prakticke Zkusenosti S Halucinogeny V Psychotherapii,” Ceskoslovenska Psychiatrie. 59, 5, 1963. (reprint)

3/14/2012 56 5 3 Havens, Joseph. A Memo to Quakers on the Consciousness-Changing Drugs (LSD, Mescalin, Psilocybin). (typed manuscript signed by Walter Pahnke)

5 3 Heacock, R. A. and Barbara D. Scott. “The Reduction of Adrenochrome with Thiols,” Can. J. Biochem. Physiol. Vol. 37, 1959. (reprint)

5 3 Heacock, R. A. “A note on the paper chromatography of some indole derivatives on acetylated paper,” Journal of Chromatography. 6, 1961. (reprint)

5 3 Heacock, R. A. “The Hydroxyskatoles,” Experientia. 18, 1962. (reprint)

5 3 Heacock, R. A. “Noradrenolutin,” Experientia. 17, 1961. (reprint)

5 3 Healy, Joan M. and Patricia L. van Houten. “Effect of Psychotomimetic Agents on Sex Ratio,” The Lancet. September 12, 1970. (photocopy)

5 3 Heard, Gerald. “Can this Drug Enlarge Man’s Mind?” The Psychedelic Review. (photocopy)

5 3 Heath, Robert G. “Effect on Behavior in Humans with the Administration of Teraxein,” The American Journal of Psychiatry. Vol. 114 No. 1, July 1957. (reprint)

5 3 Heath, Robert G. “Psychotomimetic compounds: Their Contribution to Understanding Mechanisms and Possible Treatments of Psychosis,” Chapter 41 in The First Hahnemann Symposium on Psychosomatic Medicine. Lea & Febiger, 1962. (reprint)

5 3 Hebbard, Frederick W. and Roland Fischer. “Effect of Psilocybin, LSD, and Mescaline on Small, Involuntary Eye Movements,” Psychopharmacologia. 9, 1966. (photocopy)

5 3 Heikkila, J., L. Holbrook, and I. Brown. “Stress-Accentuation of the LSD-Induced Disaggregation of Brain Polysomes,” Life Sciences. Vol. 22, 1978. (photocopy)

5 3 Heim, Roger (et al). “Mycologie,” Academie des Sciences. 246, March 3, 1958. (reprint)

3/14/2012 57

5 3 Heim, Roger (et al). “Mycologie,” Academie des Sciences. 246, March 3, 1958. (reprint)

5 3 Hofmann, Albert, Roger Heim, and Hans Tscherter. “Phytochimie,” Academie des Sciences. 257, July 1, 1963. (reprint)

5 4 Heimann, H. “Ausdrucksphanomenologie der Modellpsychosen,” Psychiatria et Neurologia. 141, 1961. (reprint)

5 4 Heimann, Hans. “Zur Behandlung therapieresistenter Neurosen mit Modellpscyhosen (Psilocybin),” Archiv fur Neurologie, Neurochirurgie und Psychiatrie. Vol. 89, No. 1, 1962. (reprint)

5 4 Heimann, H. “Der Ausdruck beim Halluzinieren in experimentellen und andern Psychosen, mit Tonfilm,” Archiv fur Neurologie, Neurochirurgie und Psychiatrie. Vol. 92, No. 1, 1963. (reprint)

5 4 Heimann, H. “Beobachtungen uber gestortes Zeiterleben inder Modellpsychose,” Vol. 93, No. 48, 1963. (reprint)

5 4 Hendley, Edith D. and Solomon H. Snyder. “Correlation between Psychotropic Potency of Psychotomimetic Methoxyamphetamines and their Inhibition of H-Normetanephrine Uptake in Rat Cerebral Cortex,” Nature. Vol. 229, No. 5282, January 22, 1971. (reprint)

5 4 Hermon, Harry Chramoy. “Psychedelicoanalysis,” Journal. Vol. 13, No. 3, March 1968. (reprint)

5 4 Hein, G. W. Arendsen. Dimensions in Psychotherapy. (typed manuscript)

5 4 Hertle, F., K. E. Zipf, and H. Broghammer. “Beobachtungen uber Stoffwechselverhalten, Muskeltonus und einige Kreislaufgrossen beim Menschen unter LSD-25-Einwirkung,” Archiv fur Psychiatrie und Zeitschrift f. d. ges. Neurologie. 202, 1962. (reprint)

5 4 Hertz, Morgens. “Observationer og indtryk fra et ars arbejde med LSD,” Nordisk Psykiatrisk Tidsskrift. Vol. 16, No. 2, 1962. (reprint)

3/14/2012 58

5 4 Hertz, Morgens. “LSD-behandlingen som stress og katalysator for laereprocesser,” Nordisk Psykiatrisk Tidsskrift. Vol. 17, No. 2, 1963. (reprint)

5 4 Hertz, Morgens. The Mechanism of the LSD Treatment as Viewed from the Aspect of Learning Processes. (unedited typed manuscript)

5 4 Herxheimer, H. “The 5-Hydroxytryptamine Shock in the Guinea-Pig,” Journal of Physiology. Vol. 128, No. 3, 1955. (reprint)

5 4 Hinshelwood, R. D. “Schizophrenic Birth Order: the Last but One Position,” Nature. Vol. 220, November 2, 1968. (photocopy)

5 4 Hirsch, M. W., M. E. Jarvik, and H. A. Abramson. “Lysergic Acid Diethylamide (LSD-25): XVIII. Effects of LSD-25 and Six Related Drugs Upon Handwriting,” The Journal of Psychology. 41, 1956. (reprint)

5 4 Hirschhorn, Kurt and Maimon M. Cohen. “Nonpsychic Effects of Lysergic Acid Diethylamide,” Ann. Int. Med. 67, 1967. (photocopy)

5 4 Hoagland, Hudson, Max Rinkel, and Robert W. Hyde. “Adrenocortical Function and Urinary Phosphate Excretion,” A. M. A. Archives of Neurology and Psychiatry. Vol. 73, January 1955. (reprint)

5 4 Hoadland, Hudson. “A Review of Biochemical Changes Induced In Vivo By Lysergic Acid Diethylamide and Similar Drugs,” Annals of the New York Academy of Sciences. Vol. 66, Article 3, March 4, 1957. (reprint)

5 4 Hoch, Paul H. “Psychoses-Producing and Psychoses-Relieving Drugs,” The Brain and Human Behavior. Vol. 36, 1958. (reprint)

5 4 Hoff, Hans and O. H. Arnold. “Die Therapie der Schizophrenie,” Weiner klinische Wochenschrift. Vol. 66, No. 20, 1954. (reprint)

3/14/2012 59 5 4 Hoff, Kenneth M. “Effects of Prenatal and Postnatal Exposure to LSD on Brain Maturation,” Gen. Pharmac. Vol. 7, 1976. (photocopy)

5 5 Hoffer, A. “Adrenolutin as a Psychotomimetic Agent” in Hormones, Brain Function and Behaviour, H. Hoagland ed. New York: Academic Press, 1957. (photocopy)

5 5 Hoffer, A. and H. Osmond. “Concerning an Etiological Factor in Alcoholism,” Quarterly Journal of Studies on Alcohol. Vol. 20, No. 4, 1959. (reprint)

5 5 Hoffer, A. “Abnormalities of Behavior,” Annual Review of Psychology. Vol. 11, 1960. (reprint)

5 5 Hoffer, A. and M. J. Callbeck. “Drug-Induced Schizophrenia,” The Journal of Mental Science. Vol. 106, No. 442, January 1960. (reprint)

5 5 Hoffer, A. “Nicotinic Acid: An Adjunct in the Treatment of Schizophrenia,” The American Journal of Psychiatry. Vol. 120, No. 2, August 1963. (reprint)

5 5 Hoffer, A. An Alcoholism Treatment Program; LSD, Malvaria and Nicotinic Acid. (typed manuscript)

6 1 Hofmann, A. “Chemical Aspects of Psilocybin, The Psychotropic Principle from the Mexican Fungus, Psilocybe Mexicana Heim,” Neuro-Psychopharmacology. Proceedings of the 1st International Congress of Neuro-Psychopharmacology. September 1958. (reprint)

6 1 Hofmann, A., R. Heim, A. Brack, and H. Kobel. “Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen Rauschpilz Psilocybe Mexicana Heim,” EXPERIENTIA. Vol. 14, No. 3, 1958. (reprint)

6 1 Hofmann, A. and F. Troxler. “Indetifizierung von Psilocin,” EXPERIENTIA. Vol. 15, No. 3, 1959. (reprint)

6 1 Hofmann, A., R. Heim, A. Brack, and H. Kobel. “Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen Rauschpilz Psilocybe Mexicana Heim,” EXPERIENTIA. Vol. 14, No. 3, 1958. (reprint)

6 1 Hofmann, A., R. Heim, A. Brack, and H. Kobel. “Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen Rauschpilz Psilocybe

3/14/2012 60 Mexicana Heim,” EXPERIENTIA. Vol. 14, No. 3, 1958. (reprint)

6 1 Hofmann, A., A. Frey, H. Ott, Th. Petrzilka, and F. Troxler. “Konstitutionsaufklarung und Synthese von Psilocybin,” EXPERIENTIA. Vol. 14, No. 11, 1958. (reprint)

6 1 Hofmann, A., A. Brack, H. Kobel, A. Frey, H. Ott, Th. Petrzilka, and F. Troxler. “Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen,” Helvetica Chimica Acta. Vol. 42, No. 2, 1959. (reprint)

6 1 Hofmann, A. and H. Tscherter. “Isolierung von Lysergsaure-Alkaloiden aus der mexikanischen Zauberdroge Ololiuqui,” EXPERIENTIA. Vol. 16, No. 9, 1960. (reprint)

6 1 Hofmann, A. “Psychotomimetica. Chemische, Pharmakologische und Medizinische Aspekte,” Svensk Kemisk Tidskrift. Vol. 72, No. 12, 1960. (reprint)

6 1 Hofmann, A. “Psychotomimetic Drugs: Chemical and Pharmacological Aspects,” Acta Physiol. Pharmacol. Neerlandica. 8, 1959. (reprint)

6 1 Hofmann, A. “Psychotomimetica. Chemische, Pharmakologische und Medizinische Aspekte,” Svensk Kemisk Tidskrift. Vol. 72, No. 12, 1960. (photocopy)

6 1 Hofmann, A. and A. Cerletti. “Die Wirkstoffe der dritten aztekischen Zauberdroge,” Deutsche Medizinische Wochenschrift. Vol. 86, No. 18,

3/14/2012 61 May 6, 1961. (reprint)

6 1 Hofmann, A. “Die Erforschung der mexikanischen Zauberpilze.” (reprint)

6 1 Hofmann, A. “Die Wirkstoffe der mexikanischen Zauberdroge Ololiuqui,” Planta Medica. Vol. 9, No. 4, December 1961. (reprint)

6 1 Hofmann, A. “Die psychotropen Wirkstoffe der mexikanischen Zauberpilze,” CHIMIA. 14, 1960. (reprint)

6 1 Hofmann, A. “Die psychotropen Wirkstoffe der mexikanischen Zauberpilze,” Verh. Naturf. Ges. Basel. Vol. 71, No. 2, December 1960. (reprint)

6 1 Hoffman, A. and A. Cerletti. “Die Wirkstoffe der dritten aztekischen Zauberdroge,” Deutsche Medizinische Wochenschrift. Vol. 86, No. 18, May 5, 1961. (reprint)

6 1 Hofmann, A. “Psychotomimetic Drugs: Chemical and Pharmacological Aspects.” (photocopy)

6 1 Hofmann, A. “The Chemistry of LSD and Its Modifications” in D. V. Siva Sankar’s LSD – A Total Study. New York: PJD Publications Ltd., 1975. (photocopy)

6 1 Hofmann, A. “Psychotomimetic Agents” in A. Burger’s Chemical Constitution and Pharmacodynamic Action. Vol. 2. New York: M. Dekker, 1968. (reprint)

6 2 Hoffman, Roger A. “Effect of and Interaction Between Tranquilizers, Serotonin and lysergic Acid Diethylamide on the Body Temperature of Pigeons,” The American Journal of Physiology. Vol. 195, No. 3, December 1958. (reprint)

6 2 Holbrook, L. and I. R. Brown. “Disaggregation of Brain Polysomes After Administration of d-Lysergic Acid Diethylamide (LSD) In Vivo. Journal of Neurochemistry. Vol. 27, 1976. (photocopy)

6 2 Holbrook, L. and I. R. Brown. “Disaggregation of Brain Polysomes After D-Lysergic Acid Diethylamide Administration In Vivo: Mechanism and Effect of Age and Environment,” Journal of Neurochemistry. Vol. 29, 1977. (photocopy)

6 2 Holbrook, Larry and Ian Brown. “Antipsychotic Drugs Block LSD- Induced Disaggregation of Brain Polysomes,” Life Sciences. Vol. 21,

3/14/2012 62 No. 7, 1977. (photocopy)

6 2 Holender, Marc H. and Ivan Boszormenyi-Nagy. “Hallucination as an Ego Experience,” A. M. A. Archives of Neurology & Psychiatry. Vol. 80, July 1958. (reprint)

6 2 Hollister, Leo E., John J. Prusmack, James A. Paulsen, and Norma Rosenquist. The Journal of Nervous and Mental Disease. Vol. 131, No. 5, November 1960. (reprint)

6 2 Hollister, Leo E., Roger O. Degan, and S. Donald Schultz. “An Experimental Approach to Facilitation of Psychotherapy by Psychotomimetic Drugs,” The Journal of Mental Science. Vol. 108, No. 452, January 1962. (reprint)

6 2 Hollister, Leo E. and Bernard M. Sjoberg. “Clinical Syndromes and biochemical Alterations Following Mescaline, Lysergic Acid Diethylamide, Psilocybin and a Combination of the Three Psychtomimetic Drugs,” Comprehensive Psychiatry. Vol. 5, No. 3, June 1964. (photocopy)

6 2 Hollister, Leo E., M. F. Macnicol, and H. K. Gillespie. “An Hallucinogenic Amphetamine Analog (DOM) in Man,” Psychopharmacologia. 14, 1969. (photocopy)

6 2 Hollister, Leo E. “Steroids and Moods: Correlations in Schizophrenics and Subjects Treated with Lysergic Acid Diethylamide (LSD), Mescaline, Tetrahydrocannabinol, and Synhexyl,” The Journal of Clinical Pharmacology. January- February, 1969. (photocopy)

6 2 Hollister, Leo E., Saul L. Kanter, and Adrian Dronkert. “Antidiuresis in Man Following Lysergic Acid Diethylamide and Mescaline,” Behavioral Neuropsychiatry. Vol. 2, No. 3-4, June-July 1970. (clipping)

3/14/2012 63

6 2 Hollister, Leo E., John J. Prusmack, James A. Paulsen, and Norma Rosenquist. “Comparison of Three Psychotropic Drugs (Psilocybin, JB-329, and IT-290) in Volunteer Subjects.” (photocopy)

6 2 Hollister, Leo E., Roger O. Degan, and S. Donald Schultz. “An Experimental Approach to Facilitation of Psychotherapy by Psychotomimetic Drugs.” (reprint)

6 2 Hollister, Leo E. “Human Pharmacology of Lysergic Acid Diethylamide (LSD).” (reprint)

6 2 Hollister, Leo E. “Human Pharmacology of Lysergic Acid Diethylamide (LSD).” (photocopy)

6 2 Hollister, Leo E., Roger O. Degan, S. Donald Schultz. “An Experimental Approach to Facilitation of Psychotherapy by Psychotomimetic Drugs,” The Journal of Mental Science. Vol. 108, No. 452, January 1962. (typed manuscript abstract)

6 2 Hollister, Leo E., Roger O. Degan, and S. Donald Schultz. “An Experimental Approach to Facilitation of Psychotherapy by Psychotomimetic Drugs,” Journal of Mental Science. Vol. 108, No. 452, January 1962. (photocopy)

6 2 Holzinger, Rudolf. “Analytic and Integrative Therapy with the Help of LSD-25,” Psychologia. 5, 1962. (photocopy)

6 2 Honegger, Barbara. A Shamanistic Seed-Dream Interpretation of the Narrative of the Shaft at Lascaux. 1977. (typed manuscript sent to Stanislav Grof from Barbara Honegger)

6 2 Honegger, Barbara. “A Shamanistic Seed-Dream Interpretation: The Bird-Man Mural at Lascaux,” New Directions in the Study of Man. Vol. 2, No. 2, Fall-Winter 1978. (photocopy)

20 3 Horacek, J., et al. “Subsanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidrepressant effect,” Psychological Medicine. 2010. (reprint?)

3/14/2012 64 6 2 Horackova, Eva, Bedrich Mosinger, Milos Vojtechovsky. “Ciselny Ctverec Pri Sledovani Koncentrace Pozornosti V Experimentalni Psychose Vuvolane Diethylamidem Kyseliny Lysergove (LSD-25),” Ceskoslovenska Psychiatrie. Vol. 54, No. 4, 1958. (reprint)

6 2 Horackova, Eva, and Milos Vojtechovsky. “Odhad Casu V Experimentalni Psychoze PO LSD-25,” Ceskoslovenska Psychiatrie. Vol. 36, No. 5, 1960. (reprint)

6 2 Horita, Akira and James M. Dille. “Pyretogenic Effect of Lysergic Acid Diethylamide,” Science. Vol. 120, No. 3131, December 31, 1954. (reprint)

6 2 Horita, Akira and John H. Gogerty. “The Pyretogenic Effect of 5-Hydroxytryptophan and its Comparison with that of LSD,” The Journal of Pharmacology and Experimental Therapeutics. Vol. 122, No. 2, February 1958. (reprint)

6 2 Horita, A. and A. E. Hamilton. “Lysergic Acid Diethylamide: Dissocation of Is Behavior and Hyperthermic Actions by DL-α- Methyl-p-Tyrosine,” Science. Vol. 164, April 4, 1969. (photocopy)

6 2 Horita, A. and L. J. Weber. “Dephosphorylation of Psilocybin in the Intact Mouse,” Toxicology and Applied Pharmacology. Vol. 4, No. 6, November 1962. (reprint)

6 2 Horton, Paul C. “The Mystical Experience as a Suicide Preventive,” Am. J. Psychiatry. Vol. 130, No. 3, March 1973. (photocopy)

20 3 Hruza, V., S. Kratochvil, and E. Fanfulova. “LSD Intoxikace A Zmena Postoju,” Ceskoslovenska Psychiatrie. 65, 4, 1969. (photocopy)

6 2 Hulten, Major, J. Lindsten, L. Lidberg, and H. Ekelund. “Studies on Mitotic and Meiotic Chromosomes in Subjects Exposed to LSD.” (photocopy)

6 2 Humphrey, Tryphena. “Postnatal Repetition of Human Prenatal Activity Sequences with some Suggestions of their Neuroanataomical Basis” in Brain and Early Behaviour: Development in the Fetus and Infant. R. J. Robinson ed. London and New York: Academic Press, 1969. (photocopy)

3/14/2012 65 6 2 Hungerford, David A. (et al). “Cytogenetic Effects of LSD 25 Therapy in Man,” JAMA. Vol. 206, No. 10, December 2, 1968. (photocopy)

6 2 Huth, Tom. “LSD therapy explores inner harbors of mind.” November 26, 1972. (photocopy)

6 3 Idanpaan-Heikkila, Juhana (et al). “Relation of Pharmacological and Behavioral Effects of Hallucingenic Amphetamine to Distribution in Cat Brain,” Science. Vol. 164. May 30, 1969. (photocopy)

6 3 Indanpaan-Heikkila, Juhana E. and Joseph C. Schoolar. “LSD: Autoradiographic Study on the Placental Transfer and Tissue Distribution in Mice,” Science. Vol. 164, June 13, 1969. (photocopy)

6 3 Ingvar, D. H. and U. Soderberg. “The Effect of LSD-25 upon the Cerebral Blood Flow and EEG in Cats,” EXPERIENTIA. Vol. 12, No. 11, 1956. (reprint)

6 3 Iranyi, Klara. “LSD-Untersuchungen an ES-behandelten Schizophrenen,” Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie. Vol. 89, No. 2, 1962. (reprint)

6 3 Isbell, Harris (et al). “Studies on Lysergic Acid Diethylamide (LSD-25),” A. M. A. Archives of Neurology and Psychiatry. Vol. 76, November 1956. (reprint)

6 3 Isbell, Harris. “Comparison of the Reactions Induced by Psilocybin and LSD-25 in Man,” From the National Institute of Mental Health, Addiction Research Center, U. S. Public Health Service, Lexington, Kentucky. March 1977. (photocopy)

6 3 Isbell, Harris, E. J. Miner, and C. R. Logan. “Relationships of Psychotomimetic to Anti-Serotonin Potencies of Congeners of Lystergic Acid Diethylamide (LSD-25),” Psychopharmacologia. Vol. 1, No. 1, 1959. (reprint)

3/14/2012 66

6 3 Isbell, Harris. “Comparison of the Reactions Induced by Psilocybin and LSD-25 in Man,” Psychopharmacologia. Vol. 1, No. 1, 1959. (reprint)

6 3 Isbell, Harris, E. J. Minder, and C. R. Logan. “Between D-2- Brom-Lysergic Acid Diethylamide (BOL-148) and the D- Diethylamide of Lysergic Acid (LSD-25),” Psychopharmacologia. 1, 1959. (reprint)

6 3 Isbell, Harris, A. B. Wolbach, A. Wikler, and E. J. Miner. “Cross Tolerance Between LSD and Psilocybin,” Psychopharmacologia. 2, 1961. (reprint)

6 3 Ishido, Masaaki. “Psychopathologische Untersuchungen der Psychischen LSD-Storung,” Psychiatria et Neuorologia Japonica. Vol. 62, No. 8, 1960. (reprint in Japanese)

6 3 Itil, Turan M., A. Keskinger, and J. M. C. Holden. “The Use of LSD and Ditran in the Treatment of Therapy Resistant Schizophrenics,” Diseases of the Nervous System. Vol. 30, Febraury 1969. (reprint)

Research Articles: J

6 4 Jackson, Basil and Alan Reed. “Another Abusable Amphetamine,” JAMA. Vol. 211, No. 5, February 2, 1970. (photocopy)

3/14/2012 67 6 4 Jacobson, Cecil B. and Valerie L. Magyar. “Genetic Evaluation of LSD.” (photocopy)

6 4 Jagiello, Georgiana and P. E. Polani. “Mouse germ cells and LSD-25,” Cytogenetics. 8, 1969. (photocopy)

6 4 Janota, O. “Psychotonismus,” Neurologie a psychiatrie ceske. Vol. 4, No. 2. (reprint)

20 3 Janov, Arthur. “Rebirthing – Dangers and Delusions.” (photocopy)

6 4 Jarvik, M. E., H. A. Abramson, and M. W. Hirsch. “Lysergic Acid Diethylamide (LSD-25): IV. Effect on Attention and Concentration,” The Journal of Psychology. 29, 1955. (reprint)

6 4 Jarvik, M. E., H. A. Abramson, and M. W. Hirsch. “Comparative Subjective Effects of Seven Drugs Including Lysergic Acid Diethylamide (LSD-25),” The Journal of Abnormal and Social Psychology. Vol. 51, No. 3, November 1955. (reprint)

6 4 Jarvik, M. E., H. A. Abramson, and M. W. Hirsch. “Lysergic Acid Diethylamide (LSD-25): VI. Effect Upon Recall and Recognition of Various Stimuli,” The Journal of Psychology. Vol. 39, 1955. (reprint)

6 4 Jarvik, M. E. and Stephan Chorover. “Impairment by Lysergic Acid Diethylamide of Accuracy in Performance of Delayed Alternation Test in Monkeys,” Psychopharmacologia. Vol. 1, No. 3, 1960. (reprint)

3/14/2012 68 6 4 Jarvik, Lissy F. and Tkashi Kato. “Is Lysergide a Teratogen?” The Lancet. February 3, 1968. (photocopy)

6 4 Jarvik, Lissy F. (et al) “LSD and Human Chromosomes.” (photocopy)

6 4 Johnson, F. Gordon. “LSD in the Treatment of Alcoholism,” American Journal of Psychiatry. Vol. 126, No. 4, October 1969. (photocopy)

6 4 Johnsen, Gordon. “Indication for Psycholytic Treatment with Different Types of Patients.” (typed manuscript)

6 4 Jones, R. S. G. “Tyrptamine: A Neuromodulator of Neurotransmitter in Mammalian Brain?” Progress in Neurobiology. Vol. 19, 1982. (photocopy)

6 4 Jost, F. “Zur therapeutischen Verwendung des LSD XXV in der klinischen Praxis der Psychiatrie,” Wiener klinische Wochenschrift. Vol. 69, No. 36, 1957. (reprint)

6 4 Jost, F. and R. Viari. “Zu den Provokationsverfahren in der Medizin,” Die Medizinische. 8, February, 22, 1958. (reprint)

6 4 Jost, F. “Zur therapeutischen Verwendung des LSD XXV in der klinischen Praxis der Psychiatrie,” Wiener klinischen Wochenschrift. Vol. 69, No. 36, September 6, 1957. (photocopy)

6 4 Judd, Lewis L., Warren W. Brandkamp, and William H. McGlothlin. “Comparison of the Chromosomal Patterns Obtained from Groups of Continued Users, Former Users, and Nonusers of LSD-25,” American Journal of Psychiatry. Vol. 126, No. 5, November 1969. (photocopy)

Research Articles: K

6 5 Kaij, Lennart. “LSD-behandling av neuroser,” Sartryck ur Svenska Lakartidningen. Vol. 60, No. 13, 1963. (reprint)

3/14/2012 69

6 5 Kalberer, F., W. Kreis and J. Ruschmann. “The Fate of Psilocin in the Rat,” Biochemical Pharmacology. Vol. 11, 1962. (reprint)

6 5 Kalbhen, D. A. and T. W. Sargent. “Preliminary Studies of the Distribution and Fate of 82Br-labelled 2-brom-D-Lysergic Acid Diethylamide (BOL) in the Human Body,” Medicina Experimentalis. 8, 1963. (reprint)

6 5 Kalmus, H. “Drug Dangers,” Nature. Vol. 237, June 9, 1972. (photocopy)

20 3 Karsevova, D., S. Kratochvil, and J. Mullerova. “Rysy Osobnosti A Prubeh LSD Intoxikace,” Ceskoslovenska Psychiatrie. 65, 3, 1969. (photocopy)

6 5 Kety, Seymour S. “Steric and Electronic Relationships among Some Hallucinogenic Compounds,” Proceedings of the National Academy of Sciences. Vol. 67, No. 1, September 1970. (photocopy)

6 5 Karsevova, D., S. Kratochvil, and J. Mullerova. “Rysy Osobnosti A Prubeh LSD Intoxikace,” Ceskoslovenska Psychiatrie. Vol. 65, No. 3, 1969. (reprint)

6 5 Kato, K. “Pharmacopsychotherapy and Experimental Psychopathology,” International Pharmacopsychiatry. 1, 1968. (photocopy)

6 5 Katz, M. A., G. Tadjer, and W. A. Aufricht. “Direct Microanalysis of LSD by Gas Chromatography,” Journal of Chromatography. 31, 1967. (photocopy)

6 5 Kelm, Harold, S. E. Jensen, and R. W. Ramsay. “The figural After-Effect and Lysergic Acid Diethylamide (LSD-25),” The Journal of Nervous and Mental Disease. Vol. 137, No. 6, December 1963. (reprint)

6 5 Kernberg, Otto. “Borderline Personality Organization,” Journal of the American Psychoanalytic Association. Vol. 15, No. 3, July 1967. (reprint)

6 5 King, A. B., G. S. Pechet, and L. Pechet. “Intravenous Injection

3/14/2012 70 of Crude Marihuana,” JAMA. Vol. 214, No. 9, November 30, 1970. (photocopy)

6 5 Key, B. J. “The Effects of Drugs in Relation to the Afferent Collateral System of the Brain-Stem,” Electroenceph. Clin. Neurophysiol. 18, 1965. (photocopy)

6 5 Khorramzadeh, E. and A. O. Lotfy. “The Use of Ketamine in Psychiatry,” Psychosomatics. 14, November-December 1973. (photocopy)

6 5 Kies, Marian W., Dale Horst, Edward V. Evarts, and Norman P. Goldstein. “Antidiuretic Effect of Lysergic Acid Diethylamide in Humans,” A. M. A. Archives of Neurology and Psychiatry. Vol. 77, March 1957. (reprint)

6 5 Kinsley, David. “Freedom from Death in the Worship of Kali,” Numen. Vol. 22, No. 3, 1975. (reprint)

6 5 Kleinman, Joel Edward, John Christian Gillin, and Richard Jed Wyatt. “A Comparison of the Phenomenology of Hallucinogens and Schizophrenia from some Autobiographical Accounts,” Schizophrenia Bulletin. Vol. 3, No. 4, 1977. (photocopy)

6 5 Knoll, J. and E. S. Vizi. “Cross-tolerance Between Para-bromo- methamphetamine (V-III) and LSD-25,” Pharmacology. 4, 1970. (photocopy)

6 5 Knoll, J., E. S. Vizi, and Berta Knoll. “Pharmacological Studies on Para-Bromo Methamphetamine (V-III) and LSD,” Acta Physiologica Academiae Scientiarum Hungaricae. 34, 1970. (photocopy)

6 5 Knudsen, Knud. “Homicide After Treatment with Lysergic Acid Diethylamide,” Acta Psyhciatrica Scandinavica. Vol. 180, No. 40, 1964. (reprint)

3/14/2012 71 6 5 Koella, Werner P., Roger F. Beaulieu, and John r. Bergen. “The Effect of LSD-25 on the Walking Activity and Pattern of the Goat,” Chapter 2 in Joephs Wortis’ Recent Advances in Biological Psychiatry. Vol. 7. New York: Plenum Press, 1965. (photocopy)

6 5 Koella, Werner P. “Invited Discussion of Dr. J. Appel’s Paper: Neurophysiological Effects of Psychotomimetic Substances (A Supplemental Review),” Psychopharmacology. A Review of Progress 1957-1967. 1968. (photocopy)

6 5 Kohn, Bruno and M. Philip Bryden. “The Effect of Lysergic Acid Diethylamide (LSD-25) on Perception with Stabilized Images,” Psychopharmacologia. 7, 1965. (photocopy)

6 5 Konzett, H. “The Effects of 5-Hydroxytryptamine and its Antagonists on Tidal Air,” British Journal of Pharmacology and Chemotherapy. Vol. 11, No. 3, September 1956. (reprint)

6 5 Konzett, H. “Zur Wirkung von LSD (und LSD-Derivaten) auf den Blutzucker,” Congres International de Physiologie. 4, July, 30, 1956. (reprint)

6 5 Kramer, Sol. Behavioral Aspects of LSD Psychotherapy. (typed manuscript)

7 1 Krill, Alex E. (et al). “Effects of Hallucinogenic Agent in Totally Blind Subjects,” Archives of Ophthalmology. Vol. 69, February 1963. (reprint)

7 1 Krill, Alex E. (et al). “The Effect of Hallucinogenic Agents on Human Retinal Subjects,” Archives of Ophthalmology. Vol. 64, November 1960. (reprint)

7 1 Krippner, Stanley. “Psychedelic Experience and the Language Processes” Chapter 13 in General Semantics Perspectives, Lee Thayer ed. New York: Spartan Books, 1970. (reprint)

7 1 Krippner, Stanley and William Hughes. “Dreams and Human Potential,” Journal of Humanistic Psychology. Vol. 10, No. 1, Spring 1970. (reprint)

7 1 Krippner, Stanley, Martin Goldsmith, Geraldine Lenz, and Brian Washburn. “Alterations in Consciousness Among High School Students Produced by Ingestion of Illegal Drugs,” Journal of the

3/14/2012 72 Addictions. Vol. 6, No. 3, September 1971. (reprint)

7 1 Krippner, Stanley. “Research in Creativity and Psychedelic Drugs,” The International Journal of Clinical and Experimental Hypnosis. Vol. 25, No. 4, 1977. (reprint)

7 1 Krippner, Stanley. Creative Production and “Mind-Manifesting Experience”: A Study of the “Psychedelic Artist.” (typed manuscript)

7 1 Krippner, Stanley. “The Influence of Psychedelic Experience on Contemporary Art and Music,” Originally presented at the first annual meeting of the Student Association for the Study of Hallucinogens. Beloit College, Beloit, Wisconsin, October 2-4, 1969. (typed manuscript)

7 1 Krippner, Stanley. Psychedelic Experience and the Language Processes. (typed manuscript)

7 1 Kristensen, Ketty Kjaerbye. “LSD Treatment in a Copenhagen Department of Admission,” Acta Psychiatrica Scandinavica. Vol. 39, 1963. (reprint)

7 1 Krivoy, W. A. “Potentiation of Substance P By Lysergic Acid Diethylamide in Vivo,” British Journal of Pharmacology and Chemotherapy. Vol. 15, No. 3, June 1961. (reprint)

20 3 Kubicka, L., et al. “Sledovani Interpersonalnich Vztahu Ve Skupine Hospitalizaovanych Osob S Neurotickymi Obtizemi,” Ceskoslovenska Psychiatrie. 57, 2, 1966. (reprint)

3/14/2012 73

7 1 Krus, Donald M. (et al). “The Influence of Progesterone on Behavioral Changes Induced by Lysergic Acid Diethylamide (LSD-25) in Normal Males,” Psychopharmacologia. 2, 1961. (reprint)

7 1 Krus, Donald M. (et al). “Differential Behavioral Responsivity to LSD-25,” Archives of General Psychiatry. Vol. 8, June 1963. (reprint)

7 1 Kurland, Albert A., Sanford Unger, and John W. Shaffer. “The Psychedelic Procedure in the Treatment of the Alcoholic Patient – A Research Program at the Spring Grove State Hospital,” Prepared for Presentation at the Second Conference on the Use of LSD in Psychotherapy. May 8-10, 1965. (photocopy)

7 1 Kurland, Albert (et al). “Psychedelic Therapy Utilizing LSD in the Treatment of the Alcoholic Patient: A Preliminary Report,” Amer. J. Psychiat. 10, April 1967. (reprint)

7 1 Kurland, A. A. Charles Savage, and Sanford Unger. “LSD in Psychiatric Treatment,” Clinical Psychopharmacology. Vol. 1, 1968. (reprint)

7 1 Kurland, A., C. Savage, W. N. Pahnke, S. Grof, and J. E. Olsson. “LSD in the Treatment of Alcoholics,” Pharmakopsychiatrie Neuro-Psychopharmakologie. Vol. 4, No. 2, March 1971. (reprint)

20 3 Kurland, A., C. Savage, W. N. Pahnke, S. Grof, and J. E. Olsson. “LSD in the Treatment of Alcoholics,” Pharmakopsychiatrie Neuro-Psychopharmakologie. Vol. 4, No. 2, March 1971. (reprint)

20 3 Kurland, Albert A., Walter N. Pahnke, Sanford Unger, Charles Savage, and Stanislav Grof. “Psychedelic LSD Research,” Psychotropic Drugs in the Year 2000. 1971. (photocopy)

Research Articles: L

7 2 Lake, Frank. “LSD-25, Birth Trauma and Claustrophobia,” A Paper Prepared for the Second International Congress of Social

3/14/2012 74 Psychiatry. England, August 1969. (typed manuscript)

7 2 Lambert, C. “The Value of Intravenous Phencyclidine (Sernyl) in the Treatment of Neurosis” in Neuro-Psychopharmacology. Vol. 3. F. Flugel Bradley and P. H. Hoch eds. Amsterdam: Elsevier Publishing Company, 1964. (photocopy)

7 2 Langemann, Von H. “Oxytryptamin (Serotonin) als neues Hormon,” Schweizerische Medizinische Wochenschrift. Vol. 85, No. 40, October 1955. (reprint)

7 2 Lanz, Von U, A. Cerletti, and E. Rothlin. “Uber die Verteilung des Lysergsaurediathylamids im Organismus,” Pharmakologischen Laboratorium. Vol. 13, No. 3, July 1955. (reprint)

7 2 Langner, Fred W. “Six Years Experience With Lysergic Acid Therapy,” Presented at the National Association of Private Psychiatric Hospitals. Phoenix, Arizona: January 23, 1961. (preprint)

7 2 Lawson, Alvin H. “Alien Roots: Six UFO Entity Types and Some Possible Earthly Ancestors,” MUFON Symposium Proceedings. May 1979. (photocopy)

7 2 Lawson, Alvin H. Hypnosis of Imaginary UFO “Abductees.” (photocopy)

7 2 Leary, Timothy. “The Religious Experience: Its Production and Interpretation,” The Psychedelic Review. (photocopy)

7 2 Leary, Timothy and Walter Houston Clark. “Religious Implications of Consciousness Expanding Drugs,” Religious Education. May-June, 1963. (reprint)

7 2 Lebovits, Binyamin Z., Harold M. Visotsky, and Adrian M. Ostefeld. “LSD and JB318: A Comparison of Two Hallucinogens,” A. M. A. Archives of General Psychiatry. Vol. 2, April 1960. (reprint)

7 2 Lennard, H., M. E. Jarvik, and H. A. Abramson. “Lysergic Acid

3/14/2012 75 Diethylamide (LSD-25): XII. A Perliminary Statement of Its Effects Upon Interpersonal Communication,” The Journal of Psychology. 41, 1956. (reprint)

7 2 Lennard, H., M. E. Jarvik, and H. A. Abramson. “Lysergic Acid Diethylamide (LSD-25): XII. A Perliminary Statement of Its Effects Upon Interpersonal Communication,” The Journal of Psychology. 41, 1956. (reprint)

7 2 Lenox, John R. and William A. Richards. An Experimental Mysticism Scale. (photocopy of typed manuscript)

7 3 Lewis, David. Mau Pialug’s Navigation of Hokule’A From Hawaii to Tahiti. 1969. (photocopy of typed manuscript)

7 3 Leuner, H. “Uber Psychopathologische Schlusselfunktionen in der Modellpscyhose,” Medicina Experimentalis. Vol. 2, No. 2-4, 1960. (reprint)

7 3 Leuner, Hanscarl. “Uber die Uraschen von bewusstseinsstorungen bei experimentellen Psychosen,” Medicina Experimentalis. 5, 1961. (reprint)

7 3 Leuner, Hanscarl and Heinz Holfeld. “Ergebnisse und Probleme der Psychotherapie mit Hilfe von LSD-25 und Verwandten Substanzen,” Psychiatria et Neurologia. 143, 1962. (reprint)

7 3 Leuner, Hanscarl. “Die Psycholytische Therapie: Klinische Psychotherapie mit Hilfe von LSD-25 und Verwandten Substanzen,” Zeitschrift fur Psychotherapie und Medizinische Psychologie. Vol. 13, No. 2, March 1963. (reprint)

7 3 Leuner, Hanscarl. “Grundzuge einer konditional-genetischen Psychopathologie am Beispiel der Experimentellen Psychose,” Der Nervenarzt. Vol. 34, No. 5, May 1963. (reprint)

7 3 Leuner, Hanscarl. “Grundzuge einer konditional-genetischen Psychopathologie am Beispiel der Experimentellen Psychose,”

3/14/2012 76 Der Nervenarzt. Vol. 34, No. 5, May 1963. (reprint)

7 3 Leuner, H. “Zur Uberlegenheit einer durch Halluzinogene Geforderten Psychotherapie (Psycholyse),” Neuro- Psychopharmacology. Vol. 3, 1964. (photocopy)

7 3 Leuner, H. and G. Baer. “Two New Short-Acting Hallucinogens of the Psilocybin Group,” Neuro-Psychopharmacology. Vol. 4, 1965. (reprint)

7 3 Leuner, Hanscarl. “Effects of Psychotomimetic Drugs,” International Psychiatry Clinics. Vol. 2, No. 4, October 1965. (reprint)

7 3 Leuner, Hanscarl. “Basic Functions Involved in the Psychotherapeutic Effect of Psychotmimetics,” International Congress on the C.I.N.P. March 1966. (photocopy of typed manuscript)

7 3 Leuner, H. “Psychotherapie mit Hilfe von Halluzinogenen,” Arzneimittel-Forschung. 15, 1966. (reprint)

7 3 Leuner, H. “Psychotherapie mit Hilfe von Halluzinogenen,” Arzneimittel-Forschung. 15, 1966. (photocopy)

7 3 Leuner, Hanscarl. “Ist die Verwendung von LSD-25 fur die Experimentelle Psychiatrie und in der Psychotherapie heute noch vertretbar?” Der Nervenarzt. Vol. 39, No. 8, August 1968. (photocopy)

7 3 Leuner, Hanscarl. “Ist die Verwendung von LSD-25 fur die Experimentelle Psychiatrie und in der Psychotherapie heute noch vertretbar?” Der Nervenarzt. Vol. 39, No. 8, August 1968. (reprint)

7 3 Leuner, H. “Die Toxische Ekstase,” Bibl. Psychiat. Neurol. No. 134, 1968. (reprint)

7 3 Leuner, H. “Kurzpsychotherapie ihre Problematic und ihre Notwendigkeit,” Psychotherapie und Medizinische Psychologie. Vol. 14, No. 4, July 1967. (reprint)

7 3 Leuner, H. “Uber den Missbrauch von LSD-25,” Pharmakopsychiatrie Neuro-Psychopharmakologie. Vol. 1, No. 4, November 1968. (reprint)

3/14/2012 77 7 3 Leuner, H. “Guided Affective Imagery,” American Journal of Psychotherapy. Vol. 23, No. 1, January 1969. (reprint)

7 4 Levine, A. (et al). “Lysergic Acid Diethylamide (LSD-25): XIV. Effect on Personality as Observed in Psychological Tests,” The Journal of Psychology. 40, 1955. (reprint)

7 4 Levine, A. (et al). “Lysergic Acid Diethylamide (LSD-25): XVI. The Effect on Intellectual Functioning as Measured by the Wechsler-Bellevue Intelligence Scale,” The Journal of Psychology. 40, 1955. (reprint)

7 4 Levine, Jerome and Arnold Ludwig. “Alterations in Consciousness Produced by Combinations of LSD, Hypnosis and Psychotherapy,” Psychopharmacologia. 7, 1965. (photocopy)

7 4 Levine, Jerome and Arnold M. Ludwig. “The LSD Controversy,” Comprehensive Psychiatry. Vol. 5, No. 5, October 1964. (reprint)

7 4 Levine, Jerome and Arnold M. Ludwig. “The Hypnodelic Treatment Technique.” (preprint)

7 4 Levine, Jerome. “Some LSD Controversies Revisited.”

20 4 Liechti, Matthias E. and Franz X. Vollenweider. “Which neuroreceptors mediate the subjective effects of MDMA in humans? A Summary of mechanistic studies,” Human Psychopharmacology. 15, 2001. (reprint?)

7 4 Lieff, Jonathan. A Study of Psychedelic Drug Use Among Non Psychiatric Subjects Six Months After Termination of Use. May 1970. (photocopy of typed manuscript)

7 4 Lienert, G. A. “Uber die Regression Psychischer Funktionen als Folge Pharmakologischer Belastung durch LSD und Alkohol,” Neuropsychopharmakologie. 2, 1961. (reprint)

7 4 Lienert, G. A. “Konfigurationsfrequenzanalyse einiger Lysergsaurediathylamid-Wirkungen,” Arzneim-Forsch. Vol. 20, No. 7, 1970. (photocopy)

3/14/2012 78

7 4 Lienert, G. A. “Konfigurationsfrequenzanalyse einiger Lysergsaurediathylamid-Wirkungen,” Arzneim-Forsch. Vol. 20, No. 7, 1970. (photocopy)

7 4 Lifton, Robert J. “The Sense of Immortality: On Death and the Continuity of Life,” American Journal of Psychoanalysis. Vol. 33, No. 1, 1973. (photocopy)

7 4 Lilly, John C. and Jay T. Shurley. “Experiments in Solitude, in Maximum Achievable Physical Isolation with Water Suspension, of Intact Healthy Persons,” Psychophysiological Aspects of Space Flight. 1961. (reprint)

7 4 Lilly, John C. (et al). “The Effect of Ketamine in Small Doses on Normal Human Subjects.” (photocopy)

7 4 Lin, Robert C., S. H. Ngai, and E. Costa. “Lysergic Acid Diethylamide: Role in Conversion of Plasma Tryptophan to Brain Serotonin (5-Hydroxytryptamine),” Science. Vol. 166, October 1969. (photocopy)

7 4 Lindsley, D. F. (et al). “EEG Correlates of Behavior in the Cat. I. Pattern Discrimination and its Alteration by Atropine and LSD- 25,” Electroenceph. Clin. Neurophysiol. 24, 1968. (photocopy)

7 5 Lindsley, D. F. (et al). “EEG Correlates of Behavior in the Cat. I. Pattern Discrimination and its Alteration by Atropine and LSD- 25,” Electroenceph. Clin. Neurophysiol. 24, 1968. (photocopy)

7 5 Ling, T. M. “The Use of Lysergic Acid and Ritalin in the Treatment of Neurosis,” Second International Conference on the Use of LSD (25) in Psychotherapy. (photocopy of typed manuscript)

7 5 Lingjaerde, Per and Odvar E. Skaug. “A Study of the Uptake of Radioactive Phosphorus in the Brain, Endocrine and Other Organs of LSD-Treated Rats,” The Journal of Nervous and Mental Disease. Vol. 124, No. 6, December 1956. (reprint)

7 5 Linton, Harriet B. and Robert J. Langs. “Subjective Reactions to Lysergic Acid Diethylamide (LSD-25),” Archives of General Psychiatry. Vol. 5, May 1962. (photocopy)

7 5 Linton, Harriet B. and Robert J. Langs. “Subjective Reactions to Lysergic Acid Diethylamide (LSD-25),” Archives of General

3/14/2012 79 Psychiatry. Vol. 5, May 1962. (reprint)

7 5 Linton, Harriet B. and Robert J. Langs. “Placebo Reactions in a Study of Lysergic Acid Diethylamide (LSD-25),” Archives of General Psychiatry. Vol. 6, May 1962. (reprint)

7 5 Linton, Harriet B. and Robert J. Langs. “Placebo Reactions in a Study of Lysergic Acid Diethylamide (LSD-25),” Archives of General Psychiatry. Vol. 6, May 1962. (photocopy)

7 5 Livingston, Kenneth E. and Richard G. Perrin. “Central Physiological Effects of Experimental Intravenous Procaine Hydrochloride,” Journal of Neurosurgery. Vol. 37, No. 2, 1972. (reprint)

7 5 Lobell, Mimi. “Temples of the Great Goddess,” Heresies. 5, August 1978. (photocopy)

7 5 Lobell, Mimi. “The Goddess Temple.” (photocopy)

7 5 Loeb, Carlo and Franco Giberti. “Lysergic Acid Diethylamide Effects Modified by Hydroxyzine Hydrochloride,” Confina Neurologica. Vol. 19, No. 1, 1959. (reprint)

7 5 Long, Haniel. The Marvellous Adventure of Cabeza de Vaca also Malinche. London: Picador, 1987. pp. 9-54 (photocopy)

19 1 Lucas, Catherine. “When spiritual emergence becomes an emergency…,” Caduceus, Issue 68.

7 5 Ludwig, Arnold (et al). “A Clinical Study of LSD Treatment in Alcoholism,” Amer. J. Psychiat. Vol. 126, No. 1, July 1969. (photocopy)

7 5 Ludwig, Arnold. “A Model for Evaluating Clinical and Therapeutic Effects of Psychedelic Agents.” (photocopy)

Box Folder Research Articles: M

8 1 MacDonald, C. D. “Mind-Changing Drugs,” The Rosicrucian Digest. February 1963. (photocopy)

3/14/2012 80

8 1 MacLean, J. Ross (et al). “LSD-25 and Mescaline as Therapeutic Adjuvants: Experience from a seven year study.” (reprint)

8 1 MacLean, J. Ross and W. E. Wilby. “Treatment of Alcoholism with Lysergide,” Quarterly Journal of Studies on Alcohol. Vol. 28, No. 1, March 1967. (reprint)

8 1 MacLean, J. Ross (et al). “The Use of LSD-25 in the Treatment of Alcoholism and other Psychiatric Problems,” Quarterly Journal of Studies on Alcohol. Vol. 22, No. 1, March 1961. (reprint)

8 1 MacLean, J. Ross (et al). “LSD-25 and Mecaline as Therapeutic Adjuvants: Experience from a Seven Year Study,” The Use of LSD in Psychotherapy and Alcoholism. New York: Bobbs-Merrill, 1967. (reprint)

8 1 MacLean, J. Ross (et al). “The Use of LSD-25 in the Treatment of Alcoholism and Other Psychiatric Problems.” (photocopy)

8 1 Maier, G. J., D. L. Tate, and B. D. Paris. “The Use of LSD in a Therapeutic Community within a Maximum Security Setting.” (photocopy)

8 1 Malitz, Sidney, Bernard Wilkens, and Harold Esecover. “A Comparison of Drug-Induced Hallucinations With Those Seen in Spontaneously Occuring Psychoses,” Hallucinations. 1962. (reprint)

8 1 Malitz, Sidney and Maureen Kanzler. “Effects of Drugs on Perception in Man.” (photocopy)

8 1 Malitz, Sidney (et al). “A Clinical Comparison of Three Related Hallucinogens,” The Psychiatric Quarterly. April 1960. (reprint)

8 1 Malitz, Sidney (et al). “Some Observations on Psilocybin, a New Hallucinogen, in Volunteer Subjects,” Comprehensive Psychiatry. Vol. 1, No. 1, February 1960. (reprint)

8 1 Malitz, Sidney (et al). “Some Observations on Psilocybin, a New Hallucinogen, in Volunteer Subjects,” Comprehensive Psychiatry. Vol. 1, No. 1, February 1960. (photocopy)

8 1 Malleson, Nicholas. “Delayed Psychosis Due to LSD,” The Lancet. October 17, 1970. (photocopy)

8 1 Mandarino, Edson. “LSD-25-Pros e Contras,” Rev. Bras. Med. Vol.

3/14/2012 81 25, No. 1, January 1968. (photocopy)

8 1 Manzini, B. and A. Saraval. “L’intossicazione sperimentale da LSD ed I suoi rapporti con la schizofrenia,” Freniatria. Vol. 84, No. 3, September 30, 1960. (reprint)

8 1 Markowitz, Etan and Jerome H. Klotz. “LSD and Chromosomes,” JAMA. Vol. 211, No. 10, March 9, 1970. (photocopy)

8 2 Marks, John. “The Mind Benders,” The Observer Sunday Plus. September 9, 1979. (clipping)

8 2 Martin, A. Joyce. “LSD (Lysergic Acid Diethylamide) Treatment of Chronic Psychoneurotic Patients Under Day-Hospital Conditions,” The International Journal of Social Psychiatry. Vol. 3, No. 3, Winter 1957. (reprint)

8 2 Martin, A. Joyce. “LSD Analysis.” (preprint)

8 2 Martin, Robert J. and Thomas G. Alexander. “Analysis of Preparations Containing LSD (N, N-Diethyl d-Lysergamide),” Journal of the A.O.A.C. Vol. 50, No. 6, 1967. (photocopy)

8 2 Marrazzi, Amedeo. “The Effects of Certain Drugs on Cerebral Synapses,” Annals of the New York Academy of Sciences. Vol. 66, Article 3, March 14, 1957. (reprint)

8 2 Martin, Carroll. “Caring for the Bad Trip,” Hawaii Medical Journal. Vol. 29, No. 7, September-October 1970. (photocopy)

20 4 Messiha, Fathy S. and Stanislav Grof. “D-Lysergic acid diethylamide (LSD) – Effect on biogenic amines excretion in man,” Biochemical Pharmacology. Vol. 22, 1973. (reprint)

3/14/2012 82

8 2 Neuhoff, Volker, Dieter Muller, and Volker ter Meulen. “Die Wirkung von Lysergsaurediathylamid auf Ganglienzellen,” Arzneimittel- Forschung. 18, 1968. (photocopy)

8 2 Masters, Robert E. L. and Jean Houston. “Subjective Realities.” (photocopy of typed manuscript)

8 2 Review by Bernard S. Aaronson of Masters, R. E. L. and Jean Houston. “The Varieties of Psychedelic Experience,” International Journal of Parapsychology. Vol. 10, No. 3, Autumn 1968. (photocopy)

8 2 Masuda, Minoru and Theodore L. Dorpat. “Urinary Aromatic Metobolite in Normal Subjects after LSD,” The Journal of Nervous and Mental Disease. Vol. 130, No. 3, March 1960. (reprint)

8 2 Matte-Blanco. “A Study of Schizophrenic Thinking: Its Expression in Terms of Symbolic Logic and its Represenation in Terms of Multi- Dimensional Space,” Congress Report of the 2nd International Congress for Psychiatry. Vol. 1, September 1957. (reprint)

8 2 Maxwell, G. M., G. M. Kneebone, and R. B. Elliot. “The Effect of Psilocybin Upon the Systemic Pulmonary, and Coronary Circulation of the Intact Dog,” Arch. Int. Pharmacodyn. Vol. 137, No. 1-2, 1962. (reprint)

8 2 McClelland, David D. “The Harlequin Complex.” (photocopy)

8 3 McGlothlin, William H. “Long-Lasting Effects of LSD on Certain Attitudes in Normal: An Experimental Proposal.” May 1962. (reprint)

8 3 McGlothlin, William H., Sidney Cohen, and Marcella S. McGlothlin. “Short-Term Effects of LSD on Anxiety, Attitudes, and Performance.” June 1963. (reprint)

8 3 McGlothlin, William H. and Sidney Cohen. “The Use of Hallucinogenic Drugs Among College Students,” The American Journal of Psychiatry. Vol. 122, No. 5, November 1965. (reprint)

8 3 McGlothlin, William H. “Social and Para-Medical Aspects of Hallucinogenic Drugs.” (preprint)

3/14/2012 83

8 3 McGlothlin, William H. “Toward a Rational View of Hallucinogenic Drugs.” Institute of Government and Public Affiars. August 1966. (reprint)

8 3 McGlothlin, William H., Sidney Cohen, and Marcella S. McGlothlin. “Long-Lasting Effects of LSD on Normals.” Institute of Government and Public Affairs. July 1967. (reprint)

8 3 McGlothlin, William H. “Toward a Rational View of Hallucinogenic Drugs.” Institute of Government and Public Affiars. August 1966. (reprint)

8 3 McGlothlin, William H. “Toward a Rational View of Marihuana.” (photocopy)

8 3 McGlothlin, William H. “Hippies and Early Christianity.” (photocopy)

8 4 McKenna, Dennis J., G. H. N. Towers, and F. Abbot. “Monoamine Oxidase Inhibitors in South American Hallucinogenic Plants: Tryptamine and β-Carboline Constituents of Ayahuasca,” Journal of Ethnopharmacology. Vol. 10, 1984. (photocopy)

8 4 McKenna, Dennis J. and G. H. N. Towers. “Biochemistry and Pharmacology of Tryptamines and beta-Carbolines: A Minireview,” Journal of Psychoactive Drugs. Vol. 16, No. 4, Oct-Dec, 1984. (reprint)

8 4 Merils, Sidney and H. C. B. Denber. “Studies on Mescaline. V. Electroencephalographic Evidence for the Antagonism between Mescaline and Chlorpromazine Hydrochloride,” The Journal of Nervous and Mental Disease. Vol. 123, No. 6, June 1956. (reprint)

8 4 Metzner, Ralph. “On the Evolutionary Significance of Psychedelics,” Main Currents in Modern Thought. Vol. 25, No. 1, Sept.-Oct. 1968. (reprint)

8 4 Metzner, Ralph. “On the Evolutionary Significance of Psychedelics,” Main Currents in Modern Thought. Vol. 25, No. 1, Sept.-Oct. 1968. (photocopy)

3/14/2012 84 8 4 Metzner, Ralph. “Notes on Current Research,” Psychedelic Review. No. 10, 1968. (reprint)

8 4 Metzner, Ralph. “A Note on the Treatment of LSD Psychosis,” Behavioral Neuropsychiatry. Vol. 1, No. 7, October 1969. (clipping)

8 4 Metzner, Ralph. “A Note on the Treatment of LSD Psychosis: A Case Report,” Psychotherapy: Theory, Research and Practice. Vol. 6, No. 3, Summer 1969. (reprint)

8 4 Metzner, Ralph. “Reflections on LSD – Ten Years Later,” Journal of Psychedelic Drugs. Vol. 10, No. 2, Apr-June 1978. (reprint)

8 4 Missere, G., G. Tonini and M. Babbini. “Changes in the Liver Protein Pattern due to Lysergic Acid Diethylamide (LSD),” EXPERIENTIA. Vol. 17, No. 33, 1961. (reprint)

8 4 Missere, G. and G. Tonini. “Contributo sperimentale al problema della possibile assuefazione crociata tra farmaci psicotici di diversa struttura,” Dal Bollettino Della Societa’ Italiana Di Biologia Sperimentale. Vol. 35, 1959. (reprint)

8 4 McCririck, Pauline. “The Importance of Fusion in Therapy and Maturation.” (photocopy of unpublished manuscript)

8 4 Mogar, Robert E. and Charles Savage. “Personality Change Associated with Psychedelic (LSD) Therapy: A Preliminary Report,” Psychotherapy: Theory, Research and Practice. Vol. 1, No. 4, Fall 1964. (reprint)

8 4 Mogar, Robert E. “Current Status and Future Trends in Psychedelic (LSD) Research,” Journal of Humanistic Psychology. Fall 1965. (reprint)

8 4 Mogar, Robert E. “Psychedlic (LSD) Research: A Critical Review of Methods and Results,” Chapter 15 in Challenges of Humanistic Psychology. James F. T. Bugental ed. New York: McGraw-Hill, 1967. (reprint)

8 4 Mogar, Robert E. “Prospective Tests for Psychedelic Research.” (photocopy)

8 4 Mogar, Robert E. “Psychedelic States and Schizophrenia,” Existential Psychiatry. Winter 1967. (reprint)

8 4 Mogar, Robert E. “Psychedelic States and Schizophrenia.” (photocopy

3/14/2012 85 of typed manuscript)

8 4 Mogar, Robert E. “Psychedelic States and Schizophrenia.” (photocopy of typed manuscript)

8 4 Money, J. “Psychology of Intersexes,” Urol. Int. 19, 1965. (reprint)

8 5 Muneer, Razia S. “Effects of LSD on Human Chromosomes,” Mutation Research. Vol. 51, 1978. (photocopy)

8 5 Munn, Henry. “The Fable of the Vision Drink.” (photocopy of typed manuscript)

8 5 Munter, Preston K. “Abuse of Hallucinogenic Drugs: Some Observations of a College Psychiatrist.” 1970. (photocopy)

8 5 Muzio, Joseph N., Howard Roffwarg, and Edward Kaufman. “Alterations in the Nocturnal Sleep Cycle Resulting from LSD,” Electroencephalography and Clinical Neurophysiology. 21, 1966. (photocopy)

8 5 Myers, Ronald E. “Interhemispheric Communication Through Corpus Callosum: Limitations Under Conditions of Conflict,” The Journal of Comparative and Physiological Psychology. Vol. 52, No. 1, February 1959. (reprint)

8 5 Myers, William A. Letter to the Editor. Science. Vol. 160, June 1968. (photocopy)

8 5 Myseischev, V. N. “Some Problems of the Theory of Psychotherapy,” Voprosy Psichoterapii. 1958. (photocopy of typed manuscript)

Box Folder 9 1 Research Articles: N

9 1 Naranjo, Plutarco. “Drogas Psicotomimeticas,” Archivos de Criminologia, Neuropsiquiatria y disciplinas conexas. Vol. 6, No. 23, July-September 1958. (reprint)

9 1 Naranjo, C., A. T. Shulgin, and T. Sargent. “Evaluation of 3, 4- Methylenedioxyamphetamine (MDA) as an Adjunct to Psychotherapy,” Med. Pharmacol. Vol. 17, 1967. (reprint)

3/14/2012 86

9 1 Naranjo, C., A. T. Shulgin, and T. Sargent. “Evaluation of 3, 4- Methylenedioxyamphetamine (MDA) as an Adjunct to Psychotherapy,” Med. Pharmacol. Vol. 17, 1967. (reprint)

9 1 Naranjo, Claudio. “Psychotherapeutic Possibilities of New Fantasy- Enhancing Drugs,” Clinical Toxicology. Vol. 2, No. 2, June 1969. (photocopy)

9 1 Nathanson, James A. and Paul Greengard. “Serotonin-Sensitive Adenylate Cyclase in Neural Tissue and Its Similarity to the Serotonin Receptor: A Possible Site of Action of Lysergic Acid Diethylamide,” Proc. Nat. Acad. Sci. Vol. 71, No. 3, March 1974. (photocopy)

9 1 Neu, Richard (et al). “Δ8- and Δ9- Tetrahydrocannabinol: Effects on Cultured Human Leucocytes,” The Journal of Clinical Pharmacology. July-August 1970. (photocopy)

9 1 Neuhoff, Volker, Dieter Muller and Voker ter Meulen. “Die Wirkung von Lysergsaurediathylamid auf Ganglienzellen,” Arzneimittel- Forschung. Vol. 18, 1968. (photocopy)

9 1 Neuhold, K., M. Taeschler and A. Cerletti. “Beitrag zur zentralen Wirkung von LSD: Versuche uber die Lokalisation von LSD- Effekten,” Helvetica Physiologica et Pharmacologica Acta. Vol. 15, No. 1, 1957. (reprint)

9 1 Nichols, David. “MDMA Represents a New Type of Pharmacologic Agent And Cannot Be Considered To Be Either An Hallucinogenic Agent Or An Amphetamine-Type Stimulant.” (photocopy of typed manuscript)

9 1 Niedermeyer, E. “Zur Pathophysiologie der Halluzinationen,” Wiener Zeitschrift fur Nervenheilkunde und Deren Grenzgebiete. Vol. 17, No. 1, 1959. (reprint)

9 1 Noyes, Russell. “Dying and Mystical Consciousness,” Journal of

3/14/2012 87 Thanatology. Vol. 1, January-February 1971. (reprint)

9 1 Noyes, Russell. “The Experience of Dying,” Psychiatry. Vol. 35, May 1972. (photocopy)

9 2 Oh, Jang O. and Charles A. Evans. “Suppressive Effects of Pyrilamine Maleate and d-Lysergic Acid Diethylamide (LSD-25) on Early Corneal Lesions Produced in Vitro by Newcastle Disease Virus (NDV) and Compound 48/801.” Virology. Vol. 10, No. 1, January 1960. (reprint)

9 2 O’Reilly, P. O. and Genevieve Reich. “Lysergic Acid and the Alcoholic,” Diseases of the Nervous System. Vol. 23, No. 6, June 1962. (reprint)

9 2 O’Reilly, P. O. “Brief Psychotherapy, LSD and the Alcoholic.” (preprint)

9 2 O’Reilly, P. O. and Genevieve Reich. “Lysergic Acid and the Alcholic,” Diseases of the Nervous System: A Practical Journal on Psychiatry and Neurology. Vol. 23, No. 1, January 1962. (reprint)

9 2 Osmond, Humphry. “A Review of the Clinical Effects of Psychotomimetic Agents,” Annals of the New York Academy of Sciences. Vol. 66, Article 3, March 14, 1957. (reprint)

9 2 Osmond, Humphry. “La Psicofarmacologia E La Manipolazione Chimica Della Psiche,” Ulisse. Vol. 6, No. 40, April 1961. (reprint)

9 2 Osmond, Humphry. “Hallucinogenic Drugs in Psychiatric Research,” M&B Laboratory Bulletin. Vol. 6, No. 1, February 1964. (reprint)

9 2 Osmond, Humphry. “A Comment on Some Uses of Psychotomimetics in Psychiatry.” (preprint)

9 2 Ostfeld, Adrian M. (et al). “Studies with a New Hallucinogen,” A. M. A. Archives of Neurology & Psychiatry. Vol. 31, February 1959. (reprint)

9 2 Ostfeld, Adrian M. “Effects of LSD 25 and JB 318 on tests of visual and perceptual functions in man,” Fed. Proc. 20, 1961. (photocopy)

9 2 Ostertag, W., E. Duisberg, and M. Sturmann. “The mutagenic activity of caffeine in man,” Mutation Research. Vol. 2, No. 3, 1965. (photocopy)

3/14/2012 88 9 2 Ostertag, W. and J. Haake. “The Mutagenicity in Drosophila Melanogaster of Caffeine and of other Compounds which Produce Chromosome Breaking in Human Cells in Culture,” Z. Verebungsl. 98, 1966. (photocopy)

9 3 Pace, Nello (et al). Physiological Studies on Infantrymen in Combat. Berkeley and Los Angeles: University of California Press, 1956. pp. 1- 14. (photocopy)

9 3 Pare, C. M. B., M. Sandler, and R. S. Stacey. “5-Hydroxyindoles in Mental Deficiency,” Journal of Neurology, Neurosurgery and Psychiatry. Vol. 23, 1960. (reprint)

9 3 Paul, Lois. “Recruitment to a Ritual Role: The Midwife in a Maya Community,” Prepared for Symposium: Women in Ritual, for the American Anthropological Association Meeting. November 1974. (photocopy)

9 3 Penzer, Mark. “Ram Dass Interview: We Need Not Fear Death,” Mandalama Journal. (photocopy)

9 3 Perris, C. “Elektromyographische Untersuchungen der Wirkung von LSD 25 auf die neuromuskulare Reizubertragung beim Kaninchen,” EXPERIENTIA. Vol. 15, No. 9, 1959. (reprint)

9 3 Persaud, T. V. N. “Cannabis in Early Pregnancy,” The Lancet. December 16, 1967. (photocopy)

9 3 Peters, Joseph J. and Alphonse R. Vonderahe. “Behavior of the Salamander Under the Influence of LSD-25 and Frenquel, and Accompanying Electrical Activity of Brain and Spinal Cord.” The Journal of Nervous and Mental Disease. Vol. 124, No. 1, July 1956. (reprint)

9 3 Pfeiffer, Carl C. (et al). “Hallucinatory effect in man of acetylcholine inhibitors,” Neurology. Vol. 9, No. 4, 1958. (reprint)

20 4 Pahnke, Walter N., et al. “The Experimental Use of Psychedelic (LSD) Psychotherapy,” The Journal of American Medical Association. Vol. 212, June 15, 1970. (reprint)

9 3 Photiades, H. and G. Anastasopoulos. “Veranderung schizophrener Zustandsbilder durch LSD 25,” Congress Report of the 2nd International Congress for Psychiatry. Vol. 2, September 1957. (reprint0

3/14/2012 89 9 3 Pierce, J. “Zur Wirkung von Atarax auf die LSD-Modellpsychose,” Praxis. Vol. 50, No. 18, May 4, 1961. (reprint)

9 3 Pieri, Lorenzo, Margherita Pieri, and Willy Haefely. “LSD as an agonist of dopamine receptors in the striatum,” Nature. Vol. 252, December 13, 1974. (photocopy)

9 3 Pittman, Douglas. “The Use of Psychedelics in Prisoner Rehabilitation.” November-December 1971. (photocopy)

9 3 Pollard, J. C. (et al). “Controlled Sensory Input: A Note on the Technic of Drug Evaluation with Preliminary Reprot on a Comparative Study of Sernyl, Psilocybin, and LSD-25,” Comprehensive Psychiatry. Vol. 1, No. 6, December 1960. (reprint)

9 3 Potemra, Thomas A. “The Aurora!” Johns Hopkins Magazine. October 1980. (clipping)

9 3 Van Praag, H. M. “Abuse of, Dependence on and Psychoses From Anorexigenic Drugs,” Drug-Induced Diseases. Vol. 3.

9 3 Prince, Alfred M. “LSD and Chromosomes,” Psychedelic Review. (photocopy)

9 3 Purpura, Dominick P. “Electrophysiological Analysis of Psychotogenic Drug Action,” A. M. A. Archives of Neurology and Psychiatry. Vol. 75, February 1956. (reprint)

9 4 Pahnke, Walter. “The Contribution of the Psychology of Religion to the Therapeutic Use of the Psychedelic Substances.” 1960. (photocopy)

9 4 Pahnke, Walter and William Richards. “Implications of LSD and Experimental Mysticism,” Journal of Religion and Health. Vol. 5, No.

3/14/2012 90 3, July 1966. (reprint)

9 4 Pahnke, Walter and William Richards. “Implications of LSD and Experimental Mysticism,” Journal of Religion and Health. Vol. 5, No. 3, July 1966. (photocopy)

9 4 Pahnke, Walter. “The Mystical And/Or Religious Element in the Psychedelic Experience.” 1967. (photocopy)

9 4 Pahnke, Walter. “The Psychedelic Mystical Experience in the Human Encounter with Death,” Presented at Harvard University. June 12, 1968. (photocopy)

9 4 Pahnke, Walter N. “The Psychedelic Mystical Experience in the Human Encounter with Death,” Harvard Theological Review. Vol. 62, No. 1, January 1969. (reprint)

9 4 Pahnke, Walter N. “Psychedelic Drugs and Mystical Experience,” International Psychiatry Clinics. Vol. 5, No. 4, 1969. (reprint)

9 4 Pahnke, Walter (et al). “LSD-Assisted Psychotherapy with Terminal Cancer Patients,” Psychedelic Drugs. 1969. (reprint)

9 4 Pahnke, Walter N. “Psychedelic Drugs and Mystical Experience,” Clinical Psychiatry and Religion. 1969. (photocopy)

9 4 Pahnke, Walter and Helen Bonny. “The Use of Music in Psychedelic (LSD) Psychotherapy,” Journal of Music Therapy. Vol. 9, No. 2, Summer 1972. (photocopy)

20 4 “Psychedelics and the College Student.” Princeton University Press. (photocopy)

20 4 Palenicek, Tomas, et al. “Sex differences in the effects of N, N- diethyllysergamide (LSD) on behavioural activity and prepulse inhibition,” Progress in Neuro-Psychopharmacology & Biological Psychiatry. 34, 2010. (print out)

9 5 Ramsay, Ronald, Sven Jensen, and Robert Sommer. “Values in Alcoholics After LSD-25,” Quarterly Journal of Studies on Alcohol. Vol. 24, No. 3, September 1963. (reprint)

9 5 Ray, Oakley S. and Amedeo S. Marrazzi. “A Quantifiable Behavioral Correlate of Psychotogen and Tranquilizer Actions,” Science. Vol. 133, No. 3465, May 25, 1961. (reprint)

3/14/2012 91 20 4 Razmgar, David. “Spiritual madness and its many definitions, according to Hafiz, Western psychology and Stanislav Grof.” Spring 2009. (print out)

9 5 Refsnes, Carolyn C. and John Arsenian. PSYCHIATRY – Proceedings of the 4th World Congress of Psychiatry. September 5-11, 1966. (carbon copy and photocopy)

9 5 Retterstol, Nils. “Nytt Hallucinogen (STP).” (photocopy)

9 5 Reynolds, S. R. M. and W. M. Paul. “Cardiovascular Responses of Fetal Lamb in Etero to Hypoxia,” Federation Proceedings. Vol. 17, No. 1, March 1958. (reprint)

9 5 Reynolds, S. R. M. “Developmental Changes and Future Requirements,” Cold Spring Harbor Symposia on Quantitative Biology. Vol. 19, 1954. (reprint)

9 5 Reynolds, S. R. M. “Changes in the Circulation at Birth,” Modern Medicine: The Journal of Diagnosis and Treatment. November 15, 1957. (reprint)

9 5 Reynolds, S. R. M. “Regulation of the Fetal Circulation,” Clinical Obstetrics and Gynecology. Vol. 3, No. 4, December 1960. (reprint)

9 5 Reynolds, S. R. M. and John D. Mackie. “Development of chemoreceptor response sensitivity: studies in fetuses, lambs, and ewes,” The american Journal of Physiology. Vol. 201, No. 2, August 1961. (photocopy)

9 5 Reynolds, S. R. M. “Cineroentgenographically Demonstrated Changes in the Fetal Circulation Occuring at Birth,” The American Journal of Roentgenology, Radium Therapy and Nuclear Medicine. Vol. 86, No. 3, September 1961. (reprint)

9 5 Reynolds, S. R. M. and John D. Mackie. “Umbilical venous pressure and other cardiovascular responses of fetal lambs to epinephrine,” The American Journal of Physiology. Vol. 203, No. 5, November 1962. (photocopy)

9 5 Reynolds, S. R. M. “Formation of fetal cotyledons in the hemochorial

3/14/2012 92 placenta,” American Journal of Obstetrics and Gynecology. Vol. 94, No. 3, February 1, 1966. (reprint)

9 5 Reynolds, S. R. M. and David N. Danforth. “Onset of Labor and Uterine Contractions in Pregnancy” Chapter 16 in The Physiology and Course of Labor. 1966. (reprint)

20 4 Richards, William A., et al. “DPT as an Adjunct in Brief Psychotherapy with Cancer Patients,” OMEGA. Vo. 10, No. 1, 1979. (reprint)

9 5 Richards, William A. and Margret Berendes. “LSD-Assisted Psychotherapy and Dynamics of Creativity: A Case Report,” Journal of Altered States of Consciousness. Vol. 3, No. 2, 1977-78. (reprint)

9 5 Richards, William. “Entheogens in the Study of Religious Experiences: Current Status,” Journal of Religion and Health. Vol. 44, No. 4, Winter 2005. (reprint) (signed by Bill Richards)

20 4 Richards, William. “The Rebirth of Research with Entheogens: Lessons from the Past and Hypotheses for the Future,” The Journal of Tanspersonal Psychology. Vol. 41, No. 2, 2009. (reprint)

9 5 Riedlinger, Thomas J. “Trial By Mescaline: Sartre’s Rite of Passage.” 1982. (photocopy of typed manuscript)

9 5 Riedlinger, Thomas J. “Taking Birth Trauma Seriously.” 1983. (photocopy of typed manuscript)

9 5 Rinkel, Max, Robert W. Hyde, and Harry C. Solomon. “Experimental Psychiatry III A Chemical Concept of Psychosis,” Diseases of the Nervous System. Vol. 15, No. 9, September 1954. (reprint)

9 5 Rinkel, Max. “Summary of Papers on Drugs Affecting Behavior,” The Journal of Nervous and Mental Disease. Vol. 122, No. 5, November

3/14/2012 93 1955. (reprint)

9 5 Rinkel, Max, Robert W. Hyde, and Harry C. Solomon. “Experimental Psychiatry IV Hallucinogens: Tools in Experimental Psychiatry,” Diseases of the Nervous System. Vol. 16, No. 8, August 1955. (reprint)

9 5 Rinkel, Max (et al). “Experimental Psychiatry. V – Psilocybine, A New Psychotogenic Drug,” New England Journal of Medicine. 262, February 11, 1960. (reprint)

9 5 Rinkel, Max (et al). “Personality Patterns and Reaction to Psilocybine,” Presented at the Second Meeting of the Collegium Internationale Neuropsychopharmacologicum. July 1960. (photocopy)

9 5 Roberts, Thomas Bradford. “Learning,” forthcoming in Psychedelic Reflections. 1982. (photocopy of typed manuscript)

9 6 Roberts, Thomas Bradford. “New Learning” Chapter 19 in Psychedelic Reflections. Lester Grinspoon and James B. Bakalar eds. New York: Human Sciences Press, Inc., 1983.

9 6 Robinson, J. T. (et al). “A Controlled Trial of Abreaction with Lysergic Acid Diethylamide (LSD-25),” The British Journal of Psychiatry. Vol. 109, No. 458, January 1963. (reprint)

9 6 Rodin, Ernst (et al). “The Marijuana-Induced Social High,” JAMA. Vol. 213, No. 8, August 24, 1970. (photocopy)

9 6 Rodrigue, Emilio. “The Fifty Thousand Hour Patient,” The International Journal of Psycho-Analysis. Vol. 50, Part 4, 1969. (reprint)

9 6 Rolo, A. (et al). “Multitherapist Interviews Utlilizing LSD.” (preprint)

9 6 Rosen, David H. “Suicide Survivors: The Psychotherapeutic Implications of Egocide,” Presented at the 8th International Congress on Suicide Prevention. October 21, 1975. (photocopy)

9 6 Rosenbaum, Gerald (et al). “Comparison of Sernyl with Other Drugs,” A. M. A. Archives of General Psychiatry. Vol. 1, December 1959. (reprint)

9 6 Roth, Walton T. “The Effect of LSD, Mescaline, and D-Amphetamine on the Evoked Secondary Discharge,” Psychopharmacologia. 9. 1966. (photocopy)

3/14/2012 94 9 6 Rothlin, E. (et al). “Zentrale Vegetative LSD-Effekte,” EXPERIENTIA. Vol. 12, No. 4, 1956. (reprint)

9 6 Rothlin, E. “Pharmacology of Lysergic Acid Diethylamide and Some of Its Related Compounds,” The Journal of Pharmacy and Pharmacology. 9, 1957. (reprint)

9 6 Rothlin, E. and A. Cerletti. “Pharmacology of LSD-25,” Lysergic Acid Diethylamide and Mescaline in Experimental Psychiatry. 1956. (reprint)

9 6 Rouse, Larry O. “d-LSD in the Treatment of Epilepsy,” in press in Biofeedback and Self-Control. Chicago: Aldine Press, 1970. (photocopy)

9 6 Rummele, W. “Die Stellung des Psilocybins unter anderen psychotropen Substanzen,” Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie. Vol. 84, No. 1/2, 1959. (reprint)

9 6 Rummele, W. “Untersuchungen mit Psilocybin, einer psychotropen Substanz aus Psilocybe Mexicana,” Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie. Vol. 87, No. 2, 1961. (reprint)

9 6 Russel, Robert. “Preliminary Study of the Psychic Life of the Fetus and the Primary Germ by Dr. Isadore Sadger of Vienna,” The Psychoanalytic Review. Vol. 28, No. 3, July 1941. (photocopy)

9 6 Rysanek, K. “Vztah Monoaminu K Psychickym Porucham,” Activitas Nervosa Superior. Vol. 12, No. 2, May 1970. (photocopy)

Box Folder 10 1 Saavedra, J. M. and Ucha Udabe. “Quantitative Assay of Bufotenine in Psychiatric Outpatients,” Psychosomatics. Vol. 11, March-April 1970. (photocopy) Saavedra, Juan Maria. “Consideraciones acera del uso clinico de los psicodislepticos,” Pren. Med. Argent. 57, 1970. (photocopy)

10 1 Sai-Halasz, A., G. Brunecker, and St. Szara. “Dimethyltriptamin: ein neues Psychoticum,” Psychiatria et Neurologia. Vol. 135, No. 4, 1958. (reprint)

10 1 Sai-Halasz, A. and E. Endroczy. “The Effect of Tryptamine Derivatives on the Behaviour of Dogs During Brain-Stem Stimiulation,” Neuro-Psychopharmacology. (reprint)

3/14/2012 95 10 1 Salmoiraghi, G. C., J. W. Mc Cubbin, and Irvine H. Page. “Effects of d-Lysergic Acid Diethylamide and its Brom Derivative on Cardiovascular Responses to Serotonin and on Arterial Pressure,” The Journal of Pharmacology and Experimental Therapeutics. Vol. 119, No. 2, February 1957. (reprint)

10 1 Sandison, R. A. “Psychological Aspects of the LSD Treatment of the Neuroses,” The Journal of Mental Science. 100, 1954. (reprint)

10 1 Sandison, R. A., A. M. Spencer, and J. D. A. Whitelaw. “The Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness,” The Journal of Mental Science. 100, 1954. (reprint)

10 1 Sandison, R. A. and J. D. A. Whitelaw. “Further Studies in the Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness,” The Journal of Mental Science. Vol. 103, No. 332, April 1957. (reprint)

10 1 Salvatore, Santo. “Some Related Factors of the LSD 25 Reaction,” The Psychiatric Quarterly. April 1960. (reprint)

10 1 Sankar, D. V. Siva, Henry H. Broer, and Norman Cates. “Histamine- binding Action of Lysergic Acid Diethylamide,” Nature. Vol. 200, No. 4906, November 9, 1963. (reprint)

10 2 Savage, Charles. “Variation in Ego Feeling Induced by D-Lysergic Acid Diethylamide (LSD-25),” The Psychoanalytic Review. Vol. 42, No. 1, January 1955. (reprint)

10 2 Savage, Charles and Myron J. Stolaroff. “Clarifying the Confusion Regarding LSD-25,” The Journal of Nervous and Mental Disease. Vol. 140, No. 3, 1965. (reprint)

10 2 Savage, Charles, Mary Alice Hughes, and Robert Mogar. “The Effectiveness of Psychedelic (LSD) Therapy: A Preliminary Report,” The British Journal of Social Psychiatry. Vol. 2, No. 1, 1967. (reprint)

10 2 Savage, Charles. “Psychedelic Therapy,” Research in Psychotherapy. Vol. 3, 1968. (reprint)

10 2 Savage, Charles, Willis Harman, and James Fadiman. “Questionnaire Study of the Psychedelic Experience, Research Report No. 1,”

3/14/2012 96 International Foundation for Advanced Study. November 1, 1962. (photocopy)

10 2 Savage, Charles (et al). “The Effects of Psychedelic (LSD) Therapy on Values, Personality, and Behavior,” International Journal of Neuropsychiatry. Vol. 2, No. 3, 1966. (reprint)

10 2 Savage, Charles (et al). “Current Status of Psychedelic Research,” Prepared for the American Orthopsychiatric Association Meetings. March 20-23, 1967. (photocopy)

Savage, Charles (et al). “Therapeutic Applications of LSD,” Prepared for the Third Annual Conference of Friends of Psychiatric Research, Inc. March 30, 1967. (photocopy)

10 2 Savage, Charles. “Research with Psychedelic Drugs,” Psychedelic Drugs. 1969. (reprint)

10 2 Savage, Charles (et al). “Psychotherapeutic Usages of LSD and Psilocybin.” (typed manuscript)

10 2 Savage, Charles (et al). “Process and Outcome Variables in Psychedelic (LSD) Therapy.” (preprint)

10 2 Savage, Charles, O. Lee McCabe, and Albert Kurland. “LSD Therapy of Heroin Addicts: A Controlled Study.” (photocopy of typed manuscript)

10 3 Scherbel, Arthur L. and John W. Harrison. “Response to Serotonin and Its Antagonists in Patients with Rheumatoid Arthritis and Related Diseases,” Angiology. Vol. 10, No. 1, February 1959. (reprint)

10 3 Schildkraut, Joseph J., John M. Davis, and Gerald L Klerman. “Biochemistry of Depressions.” (photocopy)

10 3 Schooler, Carmi and Bethesda. “Birth Order and Schizophrenia,” Archives of General Psychiatry. Vol. 4, January 1961. (reprint)

10 3 Schultes, Richard Evans. “The Role of the Ethnobotanist in the Search for New Medicinal Plants,” Lloydia. Vol. 25, No.4, December 1962. (reprint) (signed by Walter Pahnke)

10 3 Schultes, Richard Evans. “The Future of Plants as Sources of New Biodynamic Compounds,” Plants in the Development of Modern Medicine. 1972. (reprint)

3/14/2012 97 10 3 Schwarz, Conrad J. “The Complication of LSD: A Review of the Literature.” (photocopy of typed manuscript)

19 1 Seelig, Mark. “Re-experiencing Pre- and Perinatal Imprints in Non- Ordinary States of Consciouness,” International Journal of Prenatal and Perinatal Psychology and Medicine, Vol. 10, No. 3, 1998.

10 3 Sercl, M., J. Kovarik, and O Jaros. “Klinishce Erfahrungen mit Psilocybin (CY 39 Sandoz),” Psychiatria et Neurologia. 142, 1961. (reprint)

10 3 Servadio, Emilio. “Der Gebrauch von LSD in der psychoanalytischen Behandlung eines Falles von Angsthysterie,” Zeitschrift fur Psychosomatische Medizin und Psychoanalyse. Vol. 19, No. 1, January/March 1973. (reprint)

10 3 Seymour, Richard B. “MDMA: Another View of Ecstasy,” Pharmchem Newsletter. Vol. 14, No. 3, May-June 1985. (photocopy)

10 3 Sherwood, J. N., M. J. Stolaroff, and W. W. Harman. “The Psychedelic Experience – a New Concept in Psychotherapy,” Journal of Neuropsychiatry. November-December, 1962. (reprint)

10 3 Shulgin, Alexander, Sterling Bunnell, and Thorton Sargent. “The Psychotomimetic Properties of 3, 4, 5-Trimethoxyamphetamine,” Nature. Vol. 189, No. 4769, March 25, 1961. (reprint)

10 3 Shulgin, Alexander. “What is MDMA?” (photocopy)

17 9 Shulgin, Sasha. “Drugs of Perception,” Psychedelic Conference at Santa Barbara, California, 1983

10 3 Siegel, Ronald K. “Phencyclidine and Ketamine Intoxication: A Study of Four Populations of Recreational Users,” Chapter 6 in Phencyclidine (PCP) Abuse: An Appraisal. Robert C. Petersen and Richard C. Stillman eds. NIDA Research Monograph 21. August 1978. (photocopy)

10 3 Siegel, Ronald K. and Jean Poole. “Psychedelic-Induced Social Behavior in Mice: A Preliminary Report,” Psychological Reports. 25, 1969. (photocopy)

10 3 Siegel, Ronald K. “The Psychology of Life After Death,” American Psychology. Vol. 35, No. 10, October 1980. (photocopy)

10 3 Silva, F. (et al). “Comparative Effects of the Administration of

3/14/2012 98 Taraxein, d-LSD, Mescaline, and Psilocybin to Human Volunteers,” Comprehensive Psychiatry. Vol. 1, No. 6, December 1960. (reprint)

10 4 Silverman, Julian. “Facts and Issues in Research with Psychedelic Drugs.” (photocopy of typed manuscript)

10 4 Silverman, Julian. “A Paradigm for the Study of Altered States of Consciousness,” The British Journal of Psychiatry. Vol. 114, No. 515, October 1968. (photocopy)

10 4 Silverman, Julian. “A Paradigm for the Study of Altered States of Consciousness,” to be published in The British Journal of Psychiatry. (photocopy of typed manuscript)

10 4 Silverman, Julian. “Shamans and Acute Schizophrenia,” American Anthropologist. Vol. 69, No. 1, February 1967. (reprint)

10 4 Silverman, Julian. “Research with Psychedelics,” Arch. Gen. Psychiat. Vol. 25, December 1971. (reprint)

10 4 Silverstein, Arthur B. and Gerald D. Klee. “Effects of Lysergic Acid Diethylamide (LSD-25) on Intellectual Functions,” A. M. A. Archives of Neurology & Psychiatry. Vol. 80, October 1958. (reprint)

10 4 Silverstein, Arthur B. and Gerald D. Klee. “A Psychopharmacological Test of the Body Image Hypothesis,” The Journal of Nervous and Mental Disease. Vol. 127, No. 4, October 4, 1958. (reprint)

10 4 Silverstein, Arthur B. and Gerald D. Klee. “The Effect of Lysergic Acid Diethylamide on Dual Pursuit Performance,” Journal of Clinical and Experimental Psychopathology & Quarterly Review of Psychiatry and Neurology. Vol. 21, No. 4, October-December, 1960. (reprint)

10 4 Simmons, James Q., Robert S. Sparkes, and Phillip R. Blake. “Lack of chromosomal damaging effects by moderate doses of LSD in vivo,” Clinical Genetics. 5, 1974. (photocopy)

10 4 Simopoulos, Aris M. and Hildegard H. Reissman. “Progressive Hysterical Tetraplegia with Contractures.” Bacillus Sphaericus

3/14/2012 99 Meningitis. Vol. 125, No. 1, July 1969. (reprint)

10 4 Singh, N. P. “Transtracheal jet ventilation as a new technique and experiences with ketamine and propanidid in India.” (photocopy)

10 4 Sivadjian, J. “L’action du diethylamide de l’acide lysergique (LSD-25) sur le conditionnement et la sudation,” Therapie. Vol. 25, 1970. (photocopy)

10 4 Sjoerdsma, Albert, Conan Kornetsky, and Edward V. Evarts. “Lysergic Acid Diethylamide in Patients with Excess Serotonin,” A. M. A. Archives of Neurology and Psychiatry. Vol. 75, May 1956. (reprint)

10 4 Skakkebaek, N. E. and R. A. Beatty. “Studies on Meiotic Chromosomes and Spermatozoan Heads in Mice Treated with LSD,” J. Reprod. Fert. 22, 1970. (photocopy)

10 4 Slater, Philip E., Kiyo Morimoto, and Robert W. Hyde. “The Effect of Group Administration Upon Symptom Formation Under LSD,” The Journal of Nervous and Mental Disease. Vol. 125, No. 2, April-June, 1957. (reprint)

10 4 Slatis, Herman M. “Chromosome Damage by LSD,” Science. Vol. 159, March 1968. (photocopy)

10 4 Sloane, Bruce and John W. Lovett. “Psychophysiological Investigations in Experimental Psychoses: Results of the Exhibition of D-Lysergic Acid Diethylamide to Psychiatric Patients,” Journal of Mental Science. Vol. 100, No. 418, January 1954. (reprint)

3/14/2012 100 10 4 Slaytor, M., Pennefather, J. N. and S. E. Wright. “Metabolites of LSD and Ergometrine,” EXPERIENTIA. Vol. 25, No. 3, 1959. (reprint)

10 4 Smart, Reginald G. and Dianne Fejer. “Illicit LSD Users: Their Social Backgrounds, Drug Use and Psychopathology,” Journal of Health & Social Behavior. Vol. 10, No. 4, December 1969. (photocopy)

10 4 Smit, E. M. and P. Borst. “LSD-25 Does Not Intercalate in DNA,” Nature. Vol. 232, July 16, 1971. (photocopy)

10 4 Smith, Carroll M. and Edward J. Walaszek. “Interactions of Substance P and Other Smooth Muscle stimulants with LSD-25 on the guinea Pig Ileum,” Arch. Int. Pharmacodyn. Vol. 138, No. 3-4, 1962. (reprint)

10 4 Smith, Colin M. “Some Reflections on the Possible Therapeutic Effects of the Hallucinogens with Special Reference to Alcoholism,” Quarterly Journal of Studies on Alcholol. Vol. 20, No. 2, June 1959. (reprint)

10 4 Smith, Colin M. “Some Reflections on the Possible Therapeutic Effects of the Hallucinogens with Special Reference to Alcoholism,” Quarterly Journal of Studies on Alcohol. Vol. 20, No. 2, June 1959. (photocopy of typed manuscript)

10 4 Smith, Colin M. “Exploratory and Controlled Studies of Lysergide In the Treatment of Alcoholism,” Quarterly Journal of Studies on Alcohol. Vol. 25, No. 4, December 1964. (reprint)

10 4 Smith, David E., Donald R. Wesson, and John Buffum. “MDMA: Ecstasy as an Adjunct to Psychotherapy and a Street Drug of Abuse,” California Society for the Treatment of Alcoholism and Other Drug Dependencies News. Vol. 12, No. 2, September 1985. (photocopy)

20 5 Smith, Huston. “Do Drugs Have Religious Import?,” The Journal of Philosophy. Vol. 61, No. 18, September 17, 1964. (print out)

10 4 Smith, Huston. “The Religious Significance of Artificially Induced Religious Experiences,” Presented at the University of California Extension LSD Conference. June, 18 1966. (photocopy of typed manuscript)

10 5 Smith, Huston. “Wasson’s Soma A Review Article,” Journal of the American Academy of Religion. Vol. 40, No. 4, December 1972. (reprint)

10 5 Smith, Huston. [Possibly a letter to the editor?] Journal of the

3/14/2012 101 American Academy of Religion.

10 5 Smith, Kathleen and Alfonzo Corzo Moody. “Schizophrenia and the Siamese Fighting Fish,” Diseases of the Nervous System. Vol. 17, No. 10, October 1956. (reprint)

10 5 Snyder, Solomon H. and Louis Faillace. “2,5-Cimethoxy-4-methylamphetamine (STP): A New Hallucinogenic Drug,” Science. Vol. 158, No. 3801, November 3, 1967. (reprint)

10 5 Snyder, Solomon H., Louis Faillace, and Leo Hollister. “Chromosome Damage by LSD,” Science. Vol. 159, March 29, 1968. (photocopy)

10 5 Snyder, Solomon H. and Elliot Richelson. “Psychedelic Drugs: Steric Factors that Predicts Psychotropic Activity,” Proceedings of the National Academy of Sciences. Vol. 60, No. 1, May 1968. (reprint)

10 5 Snyder, Solomon H., Louis A. Faillace, and Herbert Weingartner. “A New Psychotropic Agent,” Arch. Gen. Psychiat. Vol. 21, July 1969. (reprint)

10 5 Snyder, Solomon H., Louis A. Faillace, and Herbert Weingartner. “A New Psychotropic Agent,” Arch. Gen. Psychiat. Vol. 21, July 1969. (photocopy) 10 5 Snyder, Solomon H. (et al). “Psychotropic Methoxyamphetamines: Structure and Activity in Man,” Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacological Research. 1970. (reprint)

10 5 Snyder, Solomon H. and Elliot Richelson. “Steric Models of Drugs Predicting Psychedelic Activity,” Psychotomimetic Drugs. 1970. (reprint)

10 5 Snyder, Solomon H., Herbert Weingartner and Louis a. Faillace. “DOET (2,5-Dimethoxy-4-Ethylamphetamine) and DOM (STP) (2,5- Dimethoxy-4-Methylamphetamine), New Psychotropic Agents: Their Effects in Man,” Psychotomimetic Drugs. 1970. (reprint)

10 5 Solms, Hugo. “Chemische Struktur und Psychose bei Lysergsaure- Derivaten,” PRAXIS. Vol. 45, No. 32, August 9, 1956. (reprint)

10 5 Solms, Hugo. “Relationships Between Chemical Structure and Psychoses with the Use of Psychotoxic Substances,” Journal of

3/14/2012 102 Clinical and Experimental Psychopathology & Quarterly Review of Psychiatry and Neurology. Vol. 17, No. 4, December 1956. (reprint)

10 5 Solms, Hugo. “Relationships Between Chemical Structure and Psychoses with the Use of Psychotoxic Substances,” Journal of Clinical and Experimental Psychopathology & Quarterly Review of Psychiatry and Neurology. Vol. 17, No. 4, December 1956. (reprint)

10 5 Sommer, Robert, Robert Dewar, and Humphry Osmond. “Is There a Schizophrenic Language?” Archives of General Psychiatry. Vol. 3, December 1960. (reprint)

20 5 Soskin, Robert A., Stanislav Grof, and William A. Richards. “Low Doses of Dipropyltryptamine in Psychotherapy,” Arch. Gen. Psychiatry. Vol. 28, June 1973. (reprint)

10 5 Soskin, Robert A. “Personality and Attitude Change after Two Alcoholism Treatment Programs,” Q. J. Stud. Alcohol. Vol. 31, No. 4, December 1970. (photocopy)

10 5 Spencer, A. M. “Permissive Group Therapy with Lysergic Acid Diethylamide,” The British Journal of Psychiatry. Vol. 109, No. 458, January 1963. (photocopy)

10 5 Spencer, A. M. “Modifications in the Technique of LSD Therapy,” 10Comprehensive Psychiatry. Vol. 5, No. 4, August 1964. (p10hotocopy)

10 5 Sram, R. J. and P. Goetz. “The Mutagenic Effect of Lysergic Acid Diethylamide III. Evaluation of the Genetic Risk of LSD in Man,” Mutation Research. 26, 1974. (photocopy)

10 5 Stafford, Peter and Bonnie Golightly. “A Guide to LSD and the Law.” New York: Peter Stafford.

10 5 Stahelin, H. and M. Taeschler. “Beitrag zur Differenzierung der Fieberwung von Lipopolysaccharid-Pyrongen und D- Lysergsaurediathylamid (LSD)1),” Physiologica et Pharmacologica Acta. Vol. 14, No. 1, January 1959. (reprint)

10 5 Stahelin, H. and M. Taeschler. “Beitrag zur Differenzierung der Fieberwung von Lipopolysaccharid-Pyrongen und D- Lysergsaurediathylamid (LSD)1),” Physiologica et Pharmacologica

3/14/2012 103 Acta. Vol. 14, No. 1, January 1959. (reprint)

10 5 Steffenhagen, R. A., C. P. McAree, and L. S. Zheutlin. “Social and Academic Factors Associated with Drug Use on the University of Vermont Campus,” Int. J. Soc. Psychiatry. Vol. 15, No. 2, Spring 1969. (photocopy)

10 5 Stevenin et J. C. Benoit. “A Propos De L’Utilisation Des Substances Dysleptiques en Psychotherapie Resultats Favorables De Seances Repetees,” L’Encephale. No. 5, 1960. (reprint)

10 5 Sterescu-Volanschi, Margareta and R. Floru. “Effects of Lysergic Acid Diethylamide (LSD25) on Short-Termn Memeory in Cat,” Rev. Roum. Physiol. Vol. 7, No. 3, 1970. (photocopy)

10 5 Stern, Max M. “Fear of Death and Neurosis,” Journal of the American Psychoanalytic Association. Vol. 15, No. 1, January 1968. (photocopy)

10 5 Stevenin, Laurent and J.-C. Benoit. “L’Utilisation Des Medicaments Psychotropes En Psychotherapie,” L’Encephale. No. 5, 1962. (reprint)

10 6 Stewart, Ian. “The Seven Elementary Catastrophes,” New Scientist. November 20, 1975. (photocopy)

10 6 Stoll, W. A. “Lysegsaure-diathylamid, ein Phantastikum aus der Mutterkorngruppe,” Schweizer Archiv fur Neurologie und Psychiatrie. No. 60, 1947. (reprint)

10 6 Stoll, W. A. “Rorschach-Versuche unter Lysergsaure-Diathylamid- Wirkung,” Internationale Zeitschrift fur Rorschachforschung. Vol. 1, No. 3, 1952. (reprint)

10 6 Stoll, A. “The Impact of Studies of Natural Products on Chemical Industry,” Pure and Applied Chemisty. Vol. 2, 1961. (reprint)

10 6 Stone, D. (et al). “Cytogenetic Effects of Cyclamates on Human Cells in vitro,” Science. Vol. 164, May 2, 1969. (photocopy)

3/14/2012 104 10 6 Strassman, Rick J. “Adverse Reactions to Psychedelic Drugs, A Review of the Literature,” The Journal of Nervous and Mental Disease. Vol. 172, No. 10, October 1984. (photocopy)

10 6 Styk, Juraj. “Peak Experience und Psychotherapeutischer Prozess.”

10 6 Styk, Juraj. “Ruckblick auf die letzten sieben Jahre der Schweizerische Arztegesellschaft fur Psycholytische Therapie (SAPT),” Welten des Bewusstens. Vol. 4, 1994. (reprint)

10 6 Swartley, W. “Primal Integration.” (photocopy of typed manuscript)

10 6 Superweed, Mary Jane. “Herbal Aphrodisiacs.” San Francisco: Stone Kingdom Syndicate, 1971. (photocopy)

10 6 Superweed, Mary Jane. “Herbal Highs: A Guide to Natural & Legal Narcotics, Psychedelics and Stimulants.” San Francisco: Stone Kingdom Syndicate, 1970. (photocopy)

10 6 Sussman, David R. “A Comparative Evaluation of Ketamine Anesthesia in Children and Adults,” Anesthesiology. V. 40, No. 5, May 1974. (photocopy)

10 6 Szara, Stephen. “The Hallucinogenic Drugs-Cruse or Blessing?” Amer. J. Psychiat. Vol. 12, No.123, June 1967. (reprint)

10 6 Szara, S. “Effect of Psychotropic Tryptamine Derivatives on the Regional Distribution of Serotonin in the Brain,” Neuropsychopharmacology. Vol. 3, 1964. (reprint)

10 6 Szara, Stephen. “The Hallucinogenic Drugs Controversy,” Presented at the International Symposium on Psychotomimetic Drugs held at the Laval University. September 16-19, 1968. (photocopy of typed manuscript)

10 6 Szara, Stephen. “Enzymatic Formation of a Phenolic Metabolite From Lysergic Acid Diethylamide by Rat Liver Microsomes,” Life Sciences. No. 9, 1963. (reprint)

3/14/2012 105

10 6 Szara, S., A. Faillace, and L. B. Speck. “Metabolic and Physiological Correlates of the Psychological Reaction to Three Short-Acting Tryptamine Derivatives,” Excerpta Medica International Congress Series. No. 129, March 1966. (reprint)

10 6 Szara, S. “Hallucinogens.” 1971. (print out)

10 6 Szara, S. “Discussion of Drs. G. Aghajanian and D. Freedman”s Paper: Brain Serotonin, Dehabituation and the Hallucinogenic Drugs.” (reprint)

10 6 Schuster, E. “Uber Halluzinogene und psychotrope Substanzen, ihre Gefahren und ihre Verbreitung.” (photocopy)

Box Folder Research Articles: T

11 1 Taber, W. A. “Ergot-Type Alkaloids in Vegetative Tissue of Rivea Corymbosa (L.) Hall. f.,” Phytochemistry. Vol. 2, 1963. (reprint)

11 1 Taber, W. A. and L. C. Vinning. “Clavine and Lysergic Acid Alkaloids in Varieties of Morning Glory,” Phytochemistry. Vol. 2, 1963. (reprint)

11 1 Taeschler, M. and E. Rothlin. “Zur Charakterisierung der zentralen Wirkung von Phenothiazinderivaten,” Archiv fur exper. Pathologie und Pharmakologie. Vol. 228, No. 1/2, 1956. (reprint)

11 1 Taeschler, M. and A. Cerletti. “Some Observations on the Interaction Reserpine and LSD,” The Journal of Pharmacology and Experimental Therapeutics. Vol. 120, No. 2, June 1957. (reprint)

11 1 Taeschler, M., H. Weidmann, and A. Cerletti. “Die Wirkung von LSD auf die Reaktionszeiten bei einer bedingten Fluchtreaktion und im Analgesietest,” Helvetica Physciologica et Pharmacologica Acta. Vol. 18, No. 1, 1960. (reprint)

11 1 Taeschler, M. and A. Cerletti. “Zur Pharmakologie psychoaktiver Wirkstoffe,” Munchener Medizinische Wochenschrift. Vol. 102, No. 20, May 1960. (reprint)

3/14/2012 106

11 1 Taeschler, M. and E. Schlager. “Psychopharmaka,” Medizin und Pharmazie. No. 5, 1961. (reprint)

11 1 Taeschler, M. and A. Cerletti. “Techniques Used for Investigating Central Nervous Activity by Studying Vegatative Functions,” Acta of the International Meeting on the Techniques for the Study of Psychotropic Drugs. June 26-27, 1960. (reprint)

11 1 Takagi, Hiroshi (et al). “The Effect of LSD and Reserpine on the Central Nervous System of the Cat,” The Japanese Journal of Pharmacology. Vol. 7, No. 2, March 1958. (reprint)

11 1 Takagi, Hiroshi and Takashi Ban. “The Effect of Psychotropic Drugs on the Limbic System of the Cat,” The Japanese Journal of Pharmacology. Vol. 10, No. 1, September 1960. (reprint)

11 1 Tart, Charles T. “Models for the Explanation of Extrasensory Perception,” International Journal of Neuropsychiatry. Vol. 2, No. 5, 1966. (reprint)

11 1 Tart, Charles T. “Psychedelic Experiences Associated with a Novel Hypnotic Procedure, Mutual Hypnosis,” The American Journal of Clinical Hypnosis. Vol. 10, No. 2, October 1967. (reprint)

11 1 Tart, Charles T. “Ethics and Psychedelic Drugs,” American Psychologist. Vol. 23, No. 6, June 1968. (reprint)

11 1 Tart, Charles T. “On Scaling the Depth of Altered States of Consciousness.” 1969. (photocopy of typed manuscript)

11 1 Tart, Charles T. “Marijuana Intoxication: Common Experiences,” Nature. Vol. 226, No. 5247, May 23, 1970. (reprint)

3/14/2012 107 11 1 Tart, Charles T. “State and States of Consciousness and State-Specific Sciences,” American Association for the Advancement of Science. Vol. 176, June 16, 1972. (reprint)

11 1 Tart, Charles T. “Hypnosis, Psychedelics, and PSI: Conceptual Models,” Proceedings of an International Conference on Hypnosis, Drugs, and Dreams and PSI. June 9-12, 1967. (photocopy of typed manuscript)

11 1 Taylor, K. M. (et al). “Preliminary Data Effects of LSD on Human Chromosomes In Vivo.” September 1967. (photocopy of typed mansucript)

11 1 Techter, David. “Psychedelics: The Beginning Not The End,” The Church of the Awakening. (pamphlet)

11 1 Tenenbaum, Bertrand. “Group Therapy with LSD-25,” Diseases of the Nervous System. Vol. 22, No. 8, August 1961. (reprint)

Tenenbaum, Bertrand. “Group Therapy with LSD-25,” Diseases of the Nervous System. Vol. 22, No. 8, August 1961. (reprint)

11 1 Terrill, James. “The Nature of the LSD Experience,” The Journal of Nervous and Mental Disease. Vol. 135, No. 5, November 1962. (reprint)

11 1 Thomas, D. L. C. “LSD in Psychiatry,” The Lancet. October 24, 1970. (photocopy)

11 1 Tjio, Joe-Hin, Walter N. Pahnke, and Albert A. Kurnland. “LSD and Chromosomes,” JAMA. Vol. 210, No. 5, November 3, 1969. (reprint)

11 2 Tjio, J. H., W. N. Pahnke, and A. A. Kurland. “Pre- and Post-LSD Chromosomal Aberrations: A Comparative Study.” (photocopy)

11 2 Tomsovic, Milan and Robert V. Edwards. “Lysergic Treatment of Schizophrenic and Nonschizophrenic Alcoholics.” (1970)

3/14/2012 108 11 2 Tonini, G. and C. Montanari. “Effects of Experimentally Induced Psychoses on Artistic Expression,” Confina Neurologica. Vol. 15, No. 4, 1955. (reprint)

11 2 Tonini, G. and C. Montanari. “Effects of Experimentally Induced Psychoses on Artistic Expression,” Confina Neurologica. Vol. 15, No. 4, 1955. (reprint)

11 2 Tonini, G. “Evaluation of General Activity of Albino Rats,” Acta of the International Meeting on the Techniques for the Study of Psychotropic Drugs. June 26-27, 1960. (reprint)]

11 2 Torda, Clara. “Observations on an Effective Method to Shorten the Psychotherapy of LSD-Users.”

11 2 Troxler, F. “Oxydation von Lysergsaure-Derivaten in 2,3-Stellung,” Planta Medica. Vol. 6, No. 4, December 1958. (reprint)

11 2 Troxler, F., F. Seemann, and A. Hofman. “Abwandlungsprodukte von Psilocybin und Psilocin,” Helvetica Chemica Acta. Vol. 42, No. 6, 1959. (reprint)

11 2 Singer, Harvey S. “Tics and Tourette Syndrome,” The Johns Hopkins Medical Journal. 1982. (clipping)

11 2 Turek, I. S., R. A. Soskin, and A. A. Kurland. “Methylenedioxyamphetamine (MDA) Subjective Effects,” Journal of Psychedelic Drugs. Vol. 6, No. 1, Jan-Mar 1974. (reprint)

11 2 Turner, William J. and Sidney Merlis. “Effect of Some Indoleakylamines on Man,” A. M. A. Archives of Neurology & Psychiatry. Vol. 81, January 1959. (reprint)

11 2 Turner, William J. and Evelyn A. Mauss. “Serotonin (5- Hydroxytryptamine) and Acetylocholine in Human Ventricular and Spinal Fluids,” A. M. A. Archives of General Psychiatry. Vol. 1, December 1959. (reprint)

3/14/2012 109 11 2 Twemlow, Stuart W. “Psychedelic Drug-Induced Psychological Crises: Attitudes of the Crisis Therapist,” Adapted from a paper presented to the Kansas Drug Abust Commission’s Conference. October 12-14, 1974. (photocopy)

Research Articles: U

11 3 Underwood, Harold Wayne. “The Validity of Hypnotically Induced Visual Hallucinations,” Journal of Abnormal and Social Psychology. Vol. 61, No. 1, 1960. (reprint)

11 3 Unger, Sanford M. “Mescaline, LSD, Psilocybin, and Personality Change,” Journal for the Study of Interpersonal Processes. Vol. 26, No. 2, May 1963. (reprint)

11 3 Unger, Sanford M. “LSD and Psychotherapy: A Bibliography of the English-Language Literature,” The Psychedelic Review. Vol. 1, No. 4, 1964. (photocopy)

11 3 Unger, Sanford, Albert Kurland, John Shaffer, Charles Savage, Sidney Wolf, Robert Leighy, O. Lee McCabe, and Harry K. Shock. “Psychedelic Therapy,” Prepared for the Third Conference on Research in Psychotherapy. June 1966. (photocopy of typed manuscript)

11 3 Unger, Sanford, Albert Kurland, John W. Shaffer, Charles Savage, Sidney Wolf, Robert Leighy, O. Lee McCabe, and Harry Shock. “LSD-Type Drugs and Psychedelic Therapy,” Research in Psychotherapy. Vol. 3, 1968. (reprint)

11 3 Unger, Sanford. “The Present Status and Direction of Psychedelic LSD Research.” January 1, 1969. (photocopy of typed manuscript)

Research Articles: V

11 4 Van Der Horst, Brian. “Cartographer of Consciousness,” OMNI. (photocopy)

3/14/2012 110 11 4 Van Dusen, Wilson (et al). “Treatment of Alcoholism with Lysergide.” (photocopy)

11 4 Van Dusen, Wilson (et al). “Treatment of Alcoholism with Lysergide.” (photocopy)

11 4 Vanggaard, Thorkil. “Indications and Counter-Indications for LSD Treatment,” Acta Psychiatrica Scandinavica. Vol. 40, 1965. (reprint)

11 4 Van Rhijn, C. H. “Variables in Psycholytic Treatment.” (photocopy of typed manuscript)

11 4 Vann, Edwin. “Lethal Mutation Rate in Drosophila exposed to LSD- 25 by Injection and Ingestion,” Nature. Vol. 223, July 5, 1969. (photocopy)

11 4 Vaughan, Barbara and Michael Maliszewski. “Psychological Dimensions of Sexual Experience.” 1978. (photocopy of typed manuscript)

20 5 Vinar, O., et al. “Vztah mezi terapeutickym efektem a extrapyramidovymi priznaky vyvolanymi thioproperazinem,” Activitas Nervosa Superior. Vol. 5, No. 2, 1963. (reprint)

11 4 Vojtechovsky, M. (et al). “Psychotogenic and Hallucinogenic Properties of Large Doses of Benactyzine,”EXPERIENTIA. Vol. 14, No. 11, 1958. (reprint)

11 4 Vojtechovsky, Milos. “A Psychosis Caused by Benactyzin Intoxication,” Acta Psychiatrica et Neurologica Scandinavica. Vol. 33, No. 4, 1958. (reprint)

11 4 Vojtechovsky, M., E. Horackova, and S. Grof. “Pokus O Blokovani Experimentalni Psychozy Po LSD-25 Theadrylem,” Ceskoslovenska Psychiatrie. Vol. 41, No. 1, 1960. (reprint)

11 4 Vojtechovsky, M., K. Rysanek, and V. Vitek. “Experimental Psychoses due to High Doses of Benactyzine,” Psychiatria et Neurologia. Vol. 139, No. 6, 1960. (reprint)

3/14/2012 111

11 4 Vojtechovsky, M. (et al). “Klinische und Biochemische Studie der Zentralen Cholinolytica, Insbesondere des Benactyzins,” Acta Psychiatrica Scandinavica. 40, 1964. (photocopy)

20 5 Vojtechovsky, Milos and Stanislav Grof. “Podobnosti A Rozdily Mezi Experimentalni Psychozou Po LSD-25 A Po Mezkalinu,” Ceskoslvenska Psychiatrie. Vol. 56, No. 4, 1960. (reprint)

20 5 Vojtechovsky, Milos, et al. “Klnische und Biochemische Studie der Zentralen Cholinolytica, Insbesondere des Benactyzins,” Acta Psychiatrica Scandinavica. 40, 1964. (reprint)

20 5 Vojtechovsky, M., et al. “Experimentalpsychose als Folge der Verabreichung von 200 mg Benactyzin,” Wiener Zeitschrift fur Nervenheilkunde und deren Grenzgebiete. Vol. 17, No. 3-4, 1960. (reprint)

20 5 Vojtechovsky, M., E. Horackova, S. Grof. “Pokus O Blokovani Experimentalni Psychozy Po LSD-25 Theadrylem,” Ceskoslovenska Psychiatrie. Vol. 56, No. 1, 1960. (reprint)

20 5 Vojtechovsky, Milos and Stanislav Grof. “Podobnosti A Rozdily Mezi Experimentalni Psychozou Po LSD-25 A Po Mezkalinu,” Ceskoslovenska Psychiatrie. Vol. 56, No. 4, 1960. (reprint)

20 5 Vojtechovsky, M., S. Grof, and V. Vitek. “Klinicka A Experimentalni Studie Centralnich Ucinku Adrenochromu,” Ceskoslovenska Psychiatrie. Vol. 58, No. 6, 1962. (reprint)

20 5 Vollenweider, Franz X., et al. “Acute Psychological and Neurophysiological Effects of MDMA in Humans,” Journal of Psychoactive Drugs. Vol. 34, No. 2, April-June 2002. (reprint?)

20 5 Vollenweider, Franz X. “Brain mechanisms of hallucinogens and entactogens,” Pharmacological aspects. (photocopy)

11 4 Von Felsinger, John M., Louis Lasagna, and Henry K. Beecher. “The Response of Normal Men to Lysergic Acid Derivatives (Di-And Mono-Ethyl Amides),” Journal of Clinical and Experimental Psychopathology. Vol. 17, No. 4, December 1956. (photocopy)

11 4 Von Hungen, Kern, Sidney Roberts, and Diane F. Hill. “LSD as an agaonist and antagonist at central dopamine receptors,” Nature. Vol. 252, December 13, 1974. (photocopy)

3/14/2012 112 11 4 Votava, Z. “Antiserotoninovy Ucinek Derivatu Kyseliny D-Lysergove (Cykloalkylamidy, LSD, Ergometrin) A Chlorpromazinu U Krys,” Activitas Nervosa. 1959. (reprint)

11 4 Votava, Z. “Unterschiede in der pharmakologischen Wirkung von halluzinogenen und nicht halluzinogenen Lysergsaure-Derivaten (LSD-25, Deseril, Lysenyl, Mensenyl),” Arzneimittelforschung. Vol. 16, No. 220, 1966. (photocopy)

Research Articles: W

11 5 Watt, J. A. G. (et al). “Urine Volume and Pink Spots in Schizophrenia and Health,” Nature. Vol. 221, March 8, 1969. (photocopy)

20 6 Watts, Geoff. “Changing Death’s Perspective,” World Medicine. October 17, 1973. (photocopy)

11 5 Wertlake, Paul T. “Is a Discovery Hiding Behind Your Last Significant Figure?,” Science. Vol. 160, June 1968. (photocopy)

11 5 Walsh, John. “Narcotics and Drug Abuse: a Presidential Prescription,” Science. Vol. 165, July 25, 1969. (photocopy)

11 5 Walsh, Roger. “Psychedelics and Psychological Wellbeing.” June 1981. (photocopy of typed manuscript)

11 5 Walter, W. Grey. “The Neurophysiological Aspects of Hallucinations and Illusory Experience,” Society for Psychical Research. 1960. (photocopy)

11 5 Walter, S. (et al). “Effets Comportementaux et Electrographiques Du Diethylamide de L’Acide D-Lysergique (LSD 25) Sur Le Papio Papio Photosensible,” Electroencephalography and Clinical Neurophysiology. 30, 1971. (photocopy)

11 5 Warkany, Josef and Eva Takacs. “Lysergic Acid Diethylamide (LSD): No Teratogenicity in Rats,” Science. Vol. 159, February 16, 1968. (photocopy)

11 5 Wasson, R. Gordon. “The Role of ‘Flowers’ in Nahuatl Culture: A Suggested Interpretation,” Botanical Museum Leaflets, Harvard

3/14/2012 113 University. Vol. 23, No. 8, November 30, 1973. (photocopy)

11 5 Watts, Alan. “Psychedelics and Religious Experience,” California Law Review. Vol. 56, No. 74, 1968. (photocopy)

11 5 Weidmann, H. and A. Cerletti. “Untersuchungen Ueber Die Pressorische Wirkung des 5-Hydroxytryptamin (Serotonin),” Archives Internationales Pharmacodynamie et de Therapie. June 1957. (reprint)

11 5 Weidmann, H. and A. Cerletti. “Die Wirkung von D-Lysergsaure- diathylamid und 5-Hydroxytryptamin (Serotonin) auf spinale Reflexe der Katze,” Helvetica Physiological et Pharmacologica Acta. Vol. 15, No. 3, 1957. (reprint)

11 5 Weidmann, H. and a. Cerletti. “Weiterer Beitrag zur Pharmakologie von D-Lysergsaure-diathylamid: Die Wirkung von LSD auf Kreislaufreflexe,” Helv. Physiol. Acta. Vol. 16, 1958. (reprint)

11 5 Weidmann, H., M. Taeschler, and H. Konzett. “Zur Pharmakologie von Psilocybin, einem Wirkstoff aus Psilocybe mexicana Heim,” EXPERIENTIA. Vol. 14, No. 10, 1958. (reprint)

11 5 Weidmann, H. and A. Cerletti. “Zur Pharmakodynamischen Differenzierung der 4-Oxyindolderivate Psilocybin und Psilocin im Vergleich mit 5-Oxyindolkorpern (Serotonin, Bufotenin),” Physiologishe Chemie und Pharmakologie. 54, June 20, 1959. (reprint)

11 5 Weidmann, H. and A. Cerletti. “Studies on Psilocybin and related

3/14/2012 114 compounds,” Helvetica Physiologica et Pharmacologica Acta. Vol. 18, No. 2, 1960. (reprint)

11 5 Weidmann, H. and A. Cerletti. “Studies on Psilocybin and related compounds,” Helvetica Physiologica et Pharmacologica Acta. Vol. 18, No. 2, 1960. (reprint)

11 5 Weil, Andrew T. “Cannabis,” Science Journal. Vol. 5A, No. 3, September 1969. (reprint)

11 5 Weingartner, Herbert (et al). “Altered Free Associations: Some Cognitive Effects of Doet (2,5-Dimethoxy-Ethylamphetamine,” Behavioral Science. Vol. 15, No. 4, July 1970. (reprint)

11 5 Weisbuch, Jonathan. “Psychosis Due to LSD,” The Lancet. November 7, 1970. (photocopy)

11 5 Weiss, B. (et al). “Lysergic Acid Diethylamide (LSD-25) XXV. Effect of Potassium Cynaide and Other Oxidase and Respiratory Inhibitors on the Simaese Fighting Fish,” A. M. A. Archives of Neurology & Psychiatry. Vol. 80, September 1958. (reprint)

11 5 West, L. J. and C. M. Pierce. “Lysergic Acid Diethylamide: Its Effects on a Male Asiatic Elephant.” (photocopy of typed manuscript)

11 6 Wetzel. “Report of Two Cases of Mutilation of The Eyes During LSD Mystical Experience.” March 5, 1970. (photocopy)

11 6 Whitaker, L. Howard. “Lysergic Acid Diethylamide in Psychotherapy. Part I: Clinical Aspects,” The Medical Journal of Australia. Vol. 1, No. 5, January 4, 1964. (reprint)

11 6 White, Paul F. (et al). “Pharmacology of Ketamine Isomers in Surgical Patients,” Anesthesiology. Vol. 52, No. 3, March 1980. (reprint)

11 6 White, Richard P. (et al). “Drug-Induced Dissocation Between Evoked Reticular Potentials and the EEG,” Electroencephalography and

3/14/2012 115 Clinical Neurophysiology. Vol. 19, 1965. (photocopy)

11 6 Wicks, Mary S. “The Use of LSD in Probation Casework,” Second Conference The Use of LSD in Psychotherapy. (preprint)

11 6 Widroe, Harvey J. “A Treatment-Oreinted Schema of LSD-Induced Psychopathology,” Clinical Toxicology. Vol. 1, No. 2, June 1968. (photocopy)

11 6 Wikler, Abraham (et al). “Age and Effect of LSD-25 on Pupil Size and Kneejerk Threshold,” Psychopharmacologia. Vol. 7, 1965. (photocopy)

11 6 Wikler, Abraham. “Clinical and Social Aspects of Marihuana Intoxication,” Arch. Gen. Psychiat. Vol. 23, October 1970. (photocopy)

11 6 Wilson, Roy D. “An Investigation of Possible Immunosuppression from Ketamine and 100 Percent Oxygen in Normal Children,” Anesthesia and Analgesia. Vol. 50, No. 3, May-June 1971. (photocopy)

11 6 Winkel, Kathe. “Uber die Wirkung von Lysergsaurediathylamid auf fokale Krampfpotentiale der Hirnrinde des Kaninchens,” Pflugers Archiv. 1958. (reprint)

11 6 Winkel, Kathe. “Uber die Wirkung von Lysergsaurediathylamid auf fokale Krampfpotentiale der Hirnrinde des Kaninchens,” Pflugers Archiv. 1957. (reprint)

11 6 Winter, Charles A. “Psychotomimetic Compounds: Pharmacological and Behavioral Effects in Animals,” The First Hahnemann Symposium on Phychosomatic Medicine. 1962. (reprint)

11 6 Witt, P. N. “d-Lysergsaure-diathylamid (LSD 25) im Spinnentest,” EXPERIENTIA. Vol. 7, No. 8, 1951. (reprint)

11 6 Witt, Peter N. “Effects of Psilocybin on Web-Building Behavior of Spiders,” Pharmacologist. Vol. 2, No. 2, Fall 1960. (reprint)

11 6 Wittkower, E. D. and H. Azima. “Dynamic Aspects of Occupational Therapy,” A. M. A. Arch. Neurol. & Psychiat. Vol. 79, 1958. (reprint)

3/14/2012 116

20 6 Wobcke, Marianne. Untitled. (print out)

11 6 Wolbach, A. B., Harris Isbell, and E. J. Miner. “Cross Tolerance between Mescaline and LSD-25 with a Comparison of the Mescaline and LSD Reactions,” Psychopharmacologia. Vol. 3, 1962. (reprint)

11 6 Wolbach, A. B., E. J. Miner, and Harris Isbell. “Comparison of Psilocin with Psilocybin, Mescaline and LSD-25,” Psychopharmacologia. Vol. 3, 1962. (reprint)

20 6 Wolf, E., et al. “K Metodice Vyzkumu Socialni Maladaptace,” Metodicka Sdeleni. 11 6 Woodford, Vernon R. “Inhibition of Carbohydrate Metabolism of Rat Brain Tissue By Adrenochrome,” Can. J. Biochem. Physiol. Vol. 37, 1959. (reprint)

11 6 Woody, George E. “Visual Disturbances Experienced by Hallucinogenic Drug Abusers While Driving,” Amer. J. Psychiat. Vol. 127, No. 5, November 1970. (photocopy)

Box Folder 12 1 Research Articles: Y

12 1 Yensen, Richard. “Group Psychotherapy with a Variety of Hallucinogens,” Paper presented at the eleventh annual meeting of the Association for Humanistic Psychology. September 1973. (photocopy of typed manuscript)

12 1 Yensen, Richard (et al). “MDA-Assisted Psychotherapy with Neurotic Outpatients: A Pilot Study,” The Journal of Nervoous and Mental Disease. 1976. (photocopy)

12 1 Yensen, Richard. “From Mysteries to Paradigms: Humanity’s Journey from Sacred Plants to Psychedelic Drugs.” 1985. (photocopy)

12 1 Yielding, K. Lemone (et al). “Lysergic Acid Diethylamide (LSD) Binding to Deoxyribonucleic Acid (DNA) (33203),” Proc. Sco. Exp. Biol. Med. Vol. 128, No. 1096, 1968. (photocopy)

12 1 Yolles, Stanley F. “Statement by Stanely F. Yolles before the Subcommittee on Juvenile Delinquiency of the Committee on the Judiciary, U. S. Senate on Recent Research on LSD, Marihuana, and Other Dangerous Drugs.” March 6, 1968. (photocopy)

3/14/2012 117 Box Folder Research Articles: Z

12 2 Zaguirre, Jaime C. “Behavioural Reactions to Illusionogenic Substances,” Philippine Federation of Private Medical Practitioners. Vol. 7, No. 3, December 1957. (photocopy)

12 2 Zaguirre, Jaime C. “LSD – 25 Diagnostic and Prognostic Test,” The Journal of the Philippine Association of Military Surgeons. Vol. 7, No. 2, June 1969. (photocopy)

12 2 Zeeman, E. C. “Catastrophe Theory.” (photocopy)

12 2 Zehnder, K. and A. Cerletti. “Hemmung der Menschenserum- Pseudocholinesterase durch Lysergsaurediathylamid und 2-Brom- Lysergsaurediathylamid,” Helvetica Physiologica et Pharmacologica Acta. Vol. 14, No. 3, 1956. (reprint)

12 2 Zetterberg, Gosta. “Lysergic acid diethylamide and mutation.” October 8, 1968. (photocopy)

20 6 Zghoul, Tarek and Pierre Blier. “Enhancing action of LSD on neuronal responsiveness to serotonin in a brain structure involved in obsessive- compulsive disorder,” International Journal of Neuropsychopharmacology. 2003. (clipping?)

Research Articles: Author Unclear

16 1 “LSD-Rausch in Amerika,” Publication unknown, date unknown. (clipping)

12 3 “Whatever Happened to LSD?” from High Times (Special Edition Issue). January 1977. (clipping)

12 3 “LSD and the Drugs of the Mind,” Newsweek. May 9, 1966. (clipping)

12 3 “Halluzinogene den Betaubungsmitteln gleichgestellt,” Med. Mschr. Vol. 21, No. 5, 1967. (photocopy)

12 3 “The Effect of LSD on EEG.” (photocopy of typed manuscript)

3/14/2012 118 Box Folder 12 3 “Psychotherapy with LSD: Pro and Con.” (preprint)

12 3 “Psychotherapy with LSD: Pro and Con.” (preprint)

12 3 “Some Questions – And Their Answers.” (photocopy)

12 3 “Medicine,” Time. July 11, 1969. (photocopy)

12 3 “LSD,” Time. June 17, 1966. (photocopy)

12 3 “Study Assesses Exposure to LSD in Utero.” Spring 1969. (photocopy)

12 3 “Reserpine Action Questioned In Experiments on Rodents,” Hospital Tribune. Vol. 5, No. 4, March 8, 1971. (photocopy)

12 3 “Adjuvant With Levodopa Aids Parkisonism,” Hospital Tribune. Vol. 5, No. 4, March 8, 1971. (photocopy)

12 3 “The Subjective After-Effects of Psychelic Experiences: A Summary of Four Recent Questionnaire Studies,” The Psychedelic Review.

12 3 “LSD in Mice: Abnormalities in Meiotic Chromosomes,” Science. Vol. 160, June 1968. (photocopy)

12 3 “Down the Road to Clinical Depression,” Medical World News. January 22, 1971. (clipping)

12 3 “Morning Interview with Itzhak Ventov.” March 19, 1979. (photocopy of typed manuscript)

12 3 “Some Questions – And Their Answers.” (photocopy)

12 3 “Discussion on the Psychoactive Action of Various Tryptamine Derivatives.” (reprint)

12 3 “Acid Report on Acid,” Nature. Vol. 226, April 4, 1970. (photocopy)

12 3 “Organicity Measures Following Repeated LSD Ingestion,” Psychiatry Digest. July 1970. (photocopy)

12 4 “Lysergic Acid and Psychotic Art,” Pfizer-spectrum. Vol. 9, 1961. (reprint)

12 4 “Hallucinogenic Drugs. The Future.,” Medico-Psychol. Ass. 1961.

3/14/2012 119 Box Folder (reprint)

12 4 “Dependence on LSD and Other Hallucinogenic Drugs,” The Journal of The American Medical Association. Vol. 202, October 2, 1967. (photocopy)

12 4 “Hydroxytryptamine,” British Medical Journal. Vol. 2, July 17, 1954. (reprint)

12 4 “The Hallucinogenic Drugs,” The Pharmaceutical Journal. January 12, 1963. (reprint)

12 4 “Chemists hone tools to combat LSD abuse,” C&EN. March 11, 1968. (photocopy)

12 4 “Dependence on LSD and Other Hallucinogenic Drugs,” The Journal of The American Medical Association. Vol. 202, October 2, 1967. (reprint)

12 4 “LSD and Chromosomes,” British Medical Journal. June 29, 1968. (photocopy)

12 4 Folder of miscellaneous loose pages. (tables of contents, bibliographies, etc.)

12 4 Bos, P (?). “Vyuziti LSD V Detske Psychiatrii,” Ceskoslovenska Psychiatrie. Vol. 67, No. 4, 1971. (photocopy)

12 4 Folder of articles in Czech and Russian.

12 4 “Drugs of Human Behavior – An Overview.” (second draft)

12 4 Ex-patient. “Suicide and Samaritan Clients,” The Lancet. November 21, 1970. (photocopy)

12 4 Letters to the editor. The New England Journal of Medicine. Vol. 284, No. 14, April 8, 1971. (photocopy)

Subseries C: Conference Proceedings

3/14/2012 120 Box Folder 13 1 IV Congress of the European Medical Association for Psychoanalysis, Prague, September 1968 17 11 Pacific Symposium Esalen, 1994

Subseries D: Bibliographies, References, and Citations

Box Folder 13 2 Bibliography on Psychotomimetrics, 1943-1966 (This item has been removed from collection for cataloging.)

17 2 Books, published materials, multimedia 13 2 Catalogue on the Literature on Delysid, 1962

13 2 Adverse Effects of LSD (literature search), January 1964- August 1968

13 2 Psychedelics Selected Bibliography- Long Range Negative Effects, 1966

13 2 Annotated Bibliography Delysid LSD 25, Undated

13 3 Addendum to Annotated Bibliography Delysid LSD 25, Undated

13 3 Citations of LSD literature (Various), undated

13 3 Dipropyltryptamine (DPT) References, Undated

13 3 LSD Delysid, Catalogue of the Literature, Undated (This item has been removed from collection for cataloging.)

Subseries E: Journals, Pamphlets, and Magazines

Box Folder 19 2e, Spring/Summer, 2009.

19 2e, Spring/Summer, 2009.

19 2e, September, 2010.

18 2e, April-May-June, 2011.

3/14/2012 121 Box Folder 13 4 AHP Newsletter, April 1976 (serial publication) (This item has been removed from collection for cataloging.)

18 Anima News, Vol. 1, No. 2.

18 Anima News, Vol.2, No. 8.

18 Astrologie Heute, No. 108, April/May 2004.

19 Canamo, No. 160, April 2011.

18 CoEvolution, No. 12, 1983.

18 Cuerpomente, 2000.

18 Cuerpomente, June 2006.

19 Cuerpomente, June 2006.

18 De Ronde Tafel, November/December 1986.

19 Desillusionist, No. 12/13, 2007/08.

19 East and West, November/December 2001.

13 4 Explorations, No. 2, June/July 1965 (serial publication) (This item has been removed from collection for cataloging.)

19 Friends of Esalen, Vol. 22, Issue 2, Summer 2010.

18 Gemma, 2, 1991.

19 Gemma, 3, 1991.

19 Generation TAO, May-June-July, 2006.

19 Generation TAO, December 2010.

13 4 God in a Pill? Meher Baba on L.S.D. and The High Roads (pamphlet)

3/14/2012 122 Box Folder (This item has been removed from collection for cataloging.)

13 4 Hallucinations and Delusions, National Institute of Mental Health (pamphlet) (This item has been removed from collection for cataloging.)

13 4 The Institute for Psychedelic Research of SanFrancisco State College (pamphlet) (This item has been removed from collection for cataloging.)

19 KatapЗИC, 2009.

18 Lekarske listy, No. 19, 2006.

19 Neu Geboren Werden, 2008.

18 New Age, 136.

18 New Realities, March/April 1987.

18 Nova consciencia, October 2007.

19 Nyt aspect, October 2002.

13 4 Observer – The Frontiers of Madness, June 5, 1966 (serial publication) (This item has been removed from collection for cataloging.)

13 4 Observer – The madness of Art. June 12, 1966 (serial publication) (This item has been removed from collection for cataloging.)

18 Patek, 2007.

13 4 Phanerothyme by Lisa Biberman (pamphlet) (This item has been removed from collection for cataloging.)

18 Phoenix: Journal of Transpersonal Anthropology. Vol. 5, No. 2, 1981.

18 Psychologie, 2007.

18 Respekt, 2007.

13 4 Session Games People Play, A Manual for the Use of LSD by Lisa Bieberman (pamphlet) (This item has been removed from collection for cataloging.)

3/14/2012 123 Box Folder

18 Shaman’s Drum, No. 73, 2006.

13 4 Sphinx, April/May 1984 (serial publication) (This item has been removed from collection for cataloging.)

18 Spuren, No. 88, Summer 2008.

19 The Sun, Issue 404, August 2009.

19 Tattua, Vol. 2, No. 1, January-June 2010.

18 Tidskriften NEXUS. No. 1, 1984.

13 4 Trans-action, A Publication of Washington University, St. Louis, Missouri, Vol. 5, No. 2, December 1967 (serial publication) (This item has been removed from collection for cataloging.)

18 Ulises, No. 5, 2002.

18 Visionen, May 2008.

19 Visions, August 1993.

18 Voices: the art and science of psychotherapy, Winter 1972-1973

18 The Watkins Review, No. 16, Spring 2007.

18 What is enlightenment?, Issue 35, January-March, 2007.

19 Wisdom of the heavens, earth, body, mind & soul, August 2006.

19 Yoga Journal, Issue 93, July/August 1990.

Subseries F: Books, Reports, and Theses

Box Folder Books, Circa 1950-1985

13 5 Blewett, D.B. and N. Chwelos. Handbook for the Therapeutic Use of Lysergic Acid Diethylamide-25, Individual and Group Procedures. [Photocopy, 1959]

13 5 LaBerge, Stephen. Lucid Dreaming: The Power of Being Awake and

3/14/2012 124 Box Folder Aware In Your Dreams. New York: Ballentine Books, 1985. [This item has been removed from collection for cataloging.]

13 5 Leary, Timothy and Joanna. Neurologic. Copyright 1973 by Betsy Klein, Jack Leary, Susan Martino, Michael Horowitz, Walter H. Clark, Bruce M. Margolin. [Photocopy. Inscription: 4/23/73, #61 of 500.]

13 5 McCarthy, Mary Elizabeth. LSD as a Diagnostic Aid, A Dissertation Presented to the Faculty of the Department of Psychology, University of Santo Tomas, 1970. [This item has been removed from collection for cataloging.]

13 5 Naranjo, Claudio. How to Be: Meditation in Spirit and Practice. Los Angeles: Jeremy P. Tarcher, Inc., 1971. [This item has been removed from collection for cataloging.]

13 5 Rele, V.G. The Vedic Gods as Figures of Biology. Bombay: D.B. Taraporevala Sons and Co., 1931. [Photocopy.]

13 5 Reports, 1968 Reports (6) published by the Militarpskyologiska Institute, Stockholm. Appears to be aligned with research on LSD-25 in the year 1968.

Theses, 1987-2010 21 4 Binkert-Zerkiebel, Stephan. Juergen Bartsch und die Theorie von Stanislav Grof, 1987-88.

21 5 Viggiano, Darlene M. Critique of Grof’s Model of Spiritual Emergencies: Has it Stood the Test of Time? How Might it be Revised? February, 4, 2009.

21 6 Jacobson, Maria Luiza. Stanislav Grof E O Potencial Terapeutico Dos Estados Holotropicos: Novos Paradigmas Para A Psicologia, 2010.

Series IV: Photographs and Slides

Box Folder 13 6 Photographs and Slides, circa 1970

21 7 Photographs, undated

Series V: Correspondence

3/14/2012 125

Box Folder 22 1 Correspondence, 1979-2010

Series VI: Miscellaneous Materials

Box Folder 22 2 Miscellaneous materials, 1997-2008

Series VII: Multimedia Materials

Subseries A: Electronic Media

Box Folder 14 1 Accession 20080331, 1996-2008 Disc 1 of 4: Miscellaneous writings Disc 2 of 4: Paintings Disc 3 of 4: Gordon Wasson photos, letters Disc 4 of 4: Gordon Wasson photos

14 2 Disc 1 of 3: Presentation slides, 2005-2008 Disc 2 of 3: Presentation slides, 2004-2007 Disc 3 of 3: Writings, interviews, presentations, 1993-2008

14 3 Grof, Stan and Christina (miscellaneous for Purdue). “Holotropic Breathwork (complete) and Higgledy-Piggledy (sketch).”

14 4 Grof, Stan. “Complete Power Point Presentations.” [2 discs; 1 damaged, 1 recovered]

Subseries B: Multimedia CDs, DVDs, and VHSs

Box Item 23 1 “The Roots of Violence and Greed: Transpersonal Perspective on Current Global Crisis.” The Seventh International Conference on Science and Consciousness. 2005. [2 discs] 23 2 “The Psychology of the Future: Lessions from Modern Consciousness Research.” The Seventh International Conference on Science and Consciousness. 2005. 23 3 “The Healing Potential of Non Ordinary States of Consciousness.” PRESENT! 23 4 “The Mythic Imagination and Life of Joseph Campbell.” Connections with Duncan Campbell. January 30, 2004. 23 5 “The Mythic Imagination.” Connections with Duncan Campbell. February

3/14/2012 126 20, 2004. 23 6 “When the Impossible Happens.” Attunement with Anthony Wright. July 27, 2006. 23 7 “The Mutual Illumination of Astrology and Psychology.” Weltkongress Astrologie. April 9-12, 2004. [3 discs] 23 8 “The Healing Potential of Non-Ordinary States of Consciousness.” 2005. 23 9 “Man Isn’t Dying of Thirst.” Daniel A. Segal Productions. January 3, 1973. 23 10 “Visionary World of H. R. Giger.” 23 11 “Subject Report: Effects of Psilocybin in Advanced-Stage Cancer Patients with Anxiety.” Heffter Research Institute. November 2005. 23 12 “Psychology for the Future.” Sacred Art of Living Center. 2006. [2 discs] 23 13 “An Interview with Stanislav Grof.” In Conversation. 23 14 “Doors of Perception.” Basel, 2008. [Damaged] 23 15 Grof, Stanislav. “Lecture at the Sorbonne University.” June 1992 23 16 Grov, Stanislav. “Interview for Czech TV.” Octoer 2, 2007. 23 17 Grof, Stanislav. “The Psychology of the Future: Teachings from Modern Consciousness Research.” March 24, 2008. [3 discs] 23 18 Grof, Stanislav. “Erfahrung von Tod und Wiedergeburt: Eine Visionäre Reise.” March 24, 2008. [3 discs] 23 19 Grof, Stanislav. “Erfahrung von Tod und Wiedergeburt: Eine Visionäre Reise.” March 24, 2008. [6 discs; in English] 23 20 Stanislav Grof interview with Rajiv Mehrotra. New Delhi, India. February 2007. 23 21 “Non Oridinary States of Consciousness with Stan Grof and Mel Van Dusen.” [2 discs] 23 22 Grof, Stanislav. “Birth and its Importance for Psychology and Astrology: Observations from Modern Consciousness Research.” April 9-12, 2004. [2 discs] 23 23 Grof, Stanislav. The Prophets Conference. New York City, May 2001. 23 24 “Psychedelics and Psychiatry.” New York University School of Medicine, Department of Psychiatry, Division of Alcoholism and Drug Abuse. January- March, 2008. 22 3 “Wisdom of the Serpent.” Center for Symbolic Studies.

Subseries C: Cassette Tapes

Box Folder 24 1 Institute of the Noetic Sciences and the Fetzer Institute Gathering of the Elders Friday Evening Storytelling, 11/20/98 Tape 1, Side 1

3/14/2012 127 24 1 Institute of the Noetic Sciences and the Fetzer Institute Gathering of the Elders Friday Evening Storytelling, 11/20/98- Tape 2, Side 1

24 2 Institute of the Noetic Sciences and the Fetzer Institute Gathering of the Elders Saturday Evening Storytelling, 11/21/98 Tape 1, Side 1

24 2 Institute of the Noetic Sciences and the Fetzer Institute Gathering of the Elders Saturday Evening Storytelling, 11/21/98 Tape 2, Side 1

24 3 Mini-cassettes of interview with Ann and Sasha [Shulgin], 11/14/1987

Subseries D: Floppy Discs

24 4 IONS Council of Elders Interviews Fadiman, Grof, Stolaroff, Completed Editing, Word 5.1 Fisher, Ram Dass IONS-Alise Travel/IONS, Letter to travelers in Word 6.0 Edited Zalman [Schachter] Name Tags 24 5 IONS Council of Elders Interviews, continued [?] Elders – Ram Dass, Fisher Transfer pp 2-4 [indecipherable proper nouns] Betty Eisner WBA Etc., Pathfinding Grob, Stolaroff, Shulgin, Fadiman, Furst Laura Huxley, Betty Eisner, Huston Smith, Jim Fadiman, Stan Grof, Rabbi Zalman Schachter, Myron Stolaroff Grof, Smith, Fadiman 24 6 IONS Council of Elders Interviews, continued [?] Peter Furst Peter Furst, Corrected Peter Furst 2.0, Earlier Version (Unedited) P. Furst 2.0 Marisha, Oct. 96 Rabbi Zalman Schacter Shulgens [sic] 5.0 Laura Huxley “Alise Sound Demo” Huston Smith, Myron Stolaroff, Jim Fadiman, Zalman Schachter, Stan Grof, Laura Huxley

3/14/2012 128 Grof LSD Int. (final) 25 1 Miscellaneous Floppy Discs Trans Backup 1, Anderson, Rheingold, Pathfinding, Teachers of Transofrmation Trans Backup 2, Transcribing backup, Various files Trans Backup 3 Board Book, 4 items Transfer of Wealth: “Finding Partners in Common Work…” State of the World Forum: Garrison, Whyte, Edelman, Cronkite Teachers of Transformation, 11/02 25 2 Unlabeled Floppy Discs

Restricted Materials

16 1 Patient Notes, 1970 [Access restricted until 2045.] 16 2 Student Experiences, 1981 [Access restricted until 2056.] 16 3 Research Projects, Proposals, and Studies, 1969-1971 [Access restricted until 2046.]

3/14/2012 129

APPENDIX ONE

List of primary author names appearing in Series III-3 (Research Articles).

Aaronson, Bernard, S. Abraham, Henry David Abramson, Harold A. Abuzzahab, F.S. Adey, W. Ross Aggnernǽs, Martin Aghajanian, G.K. Agnew, N. Aiken, John Alexander, George J. Alhadeff, Benjamin Wilson Alnaes, Randolf Ames, Frances Anastasopoulos, George Appel, James B. Aprison, M.H. Apter, Julia T. Ardis, J. Amor Arenden Hein, G.W. Arnold, O.H. Aronson, H. Asher, Jules Ashley, Richard Assagioli, Roberto Avorn, Jerry Axelrod, Julius

Bain, James A. Balestrierieri, A. Baker, E.F.W. Bapat, S.K. Barker, Steven A. Barolin, G.S. Barratt, Ernest S. Bastiaans, J. Bates, Roy C. Baumann, Peter Baumeister, Roy F.

3/14/2012 130 Becker, A.M. Bender, Lauretta Benzi, Marino Berde, B. Berendes, Marget Bergen, J.R. Beuret, Lawrence Bhattacharya, B.K. Blacker, K.H. Blaine, Jack D. Bleibtreu, John N. Bleuler, M. Blewett, Duncan Bonnet, Par M.H. Bonny, Helen L. Bosomworth, Peter P. Boyd, E.S. Brack, A. Brady, A.H. Brandrup, E. Brattemo, Carl-Erik Brown, Barbara B. Browning, Luolin Buckley, Robert Buckman, John Buñag, D. Burton, Robert Main Busch, Anthony K. Bush, Anthony K.

Cabe, Robert Caldwell, Anne Carson, I.W. Carlson, V.R. Cerdeño, A. Fernandez Cerletti, A. Chandler, Arthur L. Chapman, Loring F. Cholden, Louis S. Chauchard, P. Cheek, Frances E. Chwelos, N. Clark, Walter Houton Clark, Lincoln D.

3/14/2012 131 Cline, Herbert S. Clyman, Bob Cohen, Bertram D. Cohen, Maimon M. Cohen, Sidney Collard, J. Comeau, Allan J. Condrau, Gion Coppen, Alec Copper, Clare Corssen, G. Czigány, L.G.

Dahlberg, Charles C. Davidson, Bill Davis, Emma Lou Dean, Stanley R. Delay, J. Dement, William Denber, Herman C.B. Denson, R. Derbolowsky, U. De Saint Phalle, Anne Dewhurst, Kenneth Di Leo, Francesco B. Di Mascio, Alberto Di Paolo, J.A. Ditman, Keith S. Dixon, A.K. Dobkin, Allen B. Dobkin De Rios, Marlene Doblin, Rick Doepfner, W. Dohner, Alton Doleźal, V. Domarus, Helmut V. Dorrance, David L. Downing, Joseph J. Draškoci, M. Duche, D.J. Durand, V. J. Du Toit, Brian M.

3/14/2012 132

Eberle, P. Edmonston, William E. Jr. Edwards, Allan E. Eggbert, Delmer C. Egozcue, Jose Eidleberg, E. Eisner, Betty Grover Elder, John T. Elkes, Joel J. Elkin, Edwin H. Eller, J.L. Engel, Kenneth S. R. Epstein, Arthur W. Esecover, Harold Evans, L.T. Evans, Franklin Evarts, Edward

Fabing, Howard D. Faillace, L.A. Fanchamps, A. Faretra, Gloria Farrow, John T. Feld, Myron Felsinger, John M. Fernandez, J. Ferenczi, Sándor Finney, Ben R. Fischer, Roland Fisher, Gary Flander, Judy Flückiger, E. Flügel, K.A. Foerster, Heinz Fogel, S. Forrer, Gordon R. Fort, Gordon Fort, Joel Fox, Ruth Frederking, Walter Freedman, Daniel X. Freedman, Sanford J. Freeman, Harry

3/14/2012 133 Freund, Kurt Friedhoff, Arnold J. Frohman, C.E. Fuster, Joaquin

Gabriel, Trip Ganong, William F. Garson, Margaret Gastaldi, G. Geber, William F. Geert-Jørgensen, Einar Gelpke, R. Geronimus, Lippman H. Gessner, P.K. Gettner, H.H. Gemelli, Agostino Giberti, F. Gilbert, G.M. Gillin, J. Christian Gilson, M. Ginzel, K.H. Gioscia, Victor Glickman, Lewis Godfrey, Kenneth E. Goldstein, Leonide Gomirato, G. Gorman, Klaus Gosselin, R.E. Grace, Dale Graham, J.D.P. Graves, Robert Greenberg, Ramon Greenblatt, David J. Greer, George Grinspoon, Lester Grof, Stanislav Grossbard, Lionel Guiti, N. Gye, Bill

Halasz, Michael F.

3/14/2012 134 Haley, Jay Haley, Thomas Jay Halifax-Grof, Joan Haley, Thomas J. Halpern, N. Hanaway, J.K. Hansen, Gustav Hardisty, R.M. Harley-Mason, J. Harmon, Willis W. Harris, A. Härkönen, P. Hartung, Jurgen R. Hastings, Arthur C. Hatrick, John A. Hausner, M. Havens, Jospeh Heacock, R.A. Healy, Joan M. Heard, Gerald Heath, Robert G. Hebbard, Frederick W. Heikkila, J. Heim, Arthur Brack Heim, Roger Heimann, H. Hein, G.W. Arendson Hendley, Edith D. Hermon, Harry Chramoy Hertle, F. Hertz, Mogens Herxheimer, H. Hinshelwood, R.D. Hirsch, M.W. Hirschhorn, Kurt Hoagland, Hudson Hoch, Paul H. Hoff, Kenneth Hoffer, A. Hofmann, A. Hofmann, G. Hofmann, Roger Holbrook, L. Hollender, Marc H.. Hollister, Leo E. Holzinger, Rudolf

3/14/2012 135 Honegger, Barbara Horáčková, Eva Horita, A. Horton, Paul C. Hulten, Maj. Hungerford, David A. Huth, Tom

Idänpään-Heikkila, Juhanä Ingvar, D.H. Iranyi, Klara Isbell, Harris Ishido, M. Itil, Turan M.

Jackson, Basil Jacobson, Cecil B. Jagiello, Geogiana Janota, Otakar Jarvik, M.E. Jarvik, Lissy F. Johnson, F. Gordon Jones, R.S.G. Jost, F. Judd, Lewis L.

Kaij, Lennart Kalberer, F. Kalbhen, D.A. Kalmus, H. Kang, Sunzong Karševová, D. Kato, K. Katz, M.A. Kelm, Harold Kernbverg, Otto King, A.B. Key, B.J. Khokramzadeh, E. Kies, Marian W.

3/14/2012 136 Kinsley, David Kleinman, Joel Edward Knoll, J. Knudson, Knud Koella, Werner P. Kohn, Bruno Konzett, H. Kramer, Sol Krill, Alex E. Krippner, Stanley Kristensen, Ketty Kjærbye Krivoy, W.A. Krus, Donald M. Kurland, A.

Lake, Frank Lambert, C. Langemann, H. Lanz, U. Langner, Fred W. Lawson, Alvin H. Leary, Timothy Lebovits, Binyamin Z. Lennard, H. Lenox, John R. Leuner, Hanscarl Lewis, David Levine, A. Levine, Jerome Lieff, Jonathan Lifton, Robert Lilly, John C. Lin, Robert C, Ling, T.M. Lingjaerde, Per Linton, Harriet B. Livingston, Kenneth E. Lobell, Mimi Loeb, Carlo Long, Haniel Ludwig, Arnold

3/14/2012 137 MacDonald, D.C. MacLean, J. Ross Maier, G.J. Malitz, Sidney Malleson, Nicolas Mandarino, Edson Manzini, B. Markowitz, Etan Marks, John Martin, Joyce A. Marrazzi, Amedeo S. Martin, Carroll M. Martin, A. Joyce Martin, Robert J. Maşhiff, W. Masters, Robert Masuda, Minoru Matte-Blanco, I. Maxwell, G.M. McClelland, David C. McCririck, Pauline McGlothlin, William H. McKenna, Dennis J. Meldrum, B.S. Merlis, Sidney Metzner, Ralph Missere, G. Mogar, Robert E. Money, J. Muneer, Razia S. Munn, Robert Munter, Preston K. Muzio, Joseph N. Myers, Ronald Myers, William Myseischev, V.N.

Naranjo, Plutarco Narajo, C. Nathanson, James A. Neu, Richard L. Neuhoff, Volker Nichols, David Niedermeyer, E.

3/14/2012 138 Noyes, Russell

Oh, Jang O. O Reilly, P. O. Osmond, Humphry Ostfeld, Adrian M. Ostertag, W.

Page, Nello Parte, C.M.B. Pahnke, Walter Paul, Louis Penzer, Mark Perris, C. Persaud, T.V.N. Peters, Joseph J. Pfieffer, Carl C. Photolades, H. Pierce, J. Pieri, Lorenzo Pittman, Douglas Pollard, J.C. Potemra, Thomas A. Praag, H.M. Van Prince, Alfred M. Purpura, Dominick P.

Ramsey, Ronald Ray, Oakley Refanez, Carolyn C. Retterstol, Nils Reynolds, S.R.M. Richards, William A. Riedlinger, Thomas J. Rinkel, Max Roberts, Thomas Bradford Robinson, J.T. Robinson, R.J. Rodin, Ernst A. Rodrigue, Emilio

3/14/2012 139 Rolo, A. Rosen, David H. Rosenbaum, Gerald Roth, Walton T. Rothlin, E. Rouse, Larry O. Rümmele, W. Russel, Robert Ryšānek, K.

Saavedra, Juan Maria Sai-Halász, A. Salmoiraghi, J.W. Sandison, R.A. Salvatore, Santo Sankar, Siva Scherbel, Arthur L. Schildkraut, Joseph J. Schooler, Carmi Schultes, Richard Evans Schwarz, Conrad J. Sercl, M. Servadio, Emilio Seymour, Richard B. Sherwood, J.N. Shulgin, Alexander T. Siegel, Ronald K. Sierra, Bojo Silva, F. Silverman, Julian Silverstein, Arthur B. Simmons, James Q. Singh, N.P. Sivadjian, J. Sjoerdsma, Albert Skakkebæk, N. E. Slater, Philip E. Slatis, Herman M. Sloane, Bruce Slaytor, M. Smart, Reginald Smit, E.M. Smith, Carroll M. Smith, Colin M.

3/14/2012 140 Smith, David E. Smith, Huston Smith, Kathleen Snyder, Solomon Solms, Hugo Sommer, Robert Soskin, Robert A. Spencer, A.M. Stram, R.J. Stafford, Peter Stähelin, H. Steffenhagen, R.A. Stévenin, L. Sterescu-Volanschi, Margareta Stern, Max M. Stévenin, Laurent Stewart, Ian Stoll, W.A. Stone, D. Strassman, Rick J. Styk, Juraj Swartley, Wm. Superweed, Maryjane Sussman, David R. Szara, Stephen

Taber, W.A. Taeschler, M. Takagi, Hiroshi Tart, Charles Taylor, K.M. Techter, David Tenenbaum, Bertrand Terrill, James Thomas, D.L.C. Tjio, Joe-Hin Tomsovic, Milan Tonini, G. Torda, Clara Tunr, Larry E. Troxler, Von Turek, I.S. Turner, William J. Twemlow, Stuart

3/14/2012 141

Underwood, Harold Wayne Unger, Sanford

Van Der Horst, Brian Van Dusen, Wilson Vanggaard, Thorkil Van Rhijn, C.H. Vann, Edwin Vaughn, Barbara Vojtéchovský, M. Von Felsinger, John M. Von Hungen, Kern

Waff, J.A.G. Walsh, John Walsh, Roger Walter, W. Grey Walter, S. Warkany, Josef Wasson, Gordon Watts, Alan Weidmann, H. Weil, Andrew T. Weingartner, Herbert Weisbuch, Jonathan Weiss, B. Wertlake, Paul West, L.J. Wetzel Whitaker, Howard White, Paul F. White, Richard Wicks, Mary Widroe, Harvey J. Wikler, Abraham Wilson, Roy D. Winkel, K. Winter, Charles A. Witt

3/14/2012 142 Wittkower, E.D. Wolbach, A.B. Woodford, Vernon Woody, George

Yensen, Richard Yielding, K. Lemone Yolles, Stanley F.

Zaguirre, Jaime C. Zeeman, C. Zehnder, K. Zetterberg, Gösta

3/14/2012 143